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                                                SUMMARY 
Due to their ambiphilic nature, 1,3-dicarbonyls and their derivatives, 
phenylacetones and phenylacetophenones, are versatile synthons for the 
construction of polysubstituted heterocycles by multiple C-X/C-X (X = C, N, O) 
bond formations. A wide variety of 1,3-dicarbonyls, including substituted ones, 
are commercially available and relatively inexpensive. The aim of this thesis is to 
develop novel simple one-pot protocols for synthesizing polysubstituted 
heterocycles using reagents and catalysts of low toxicity under mild reaction 
conditions and with an expansive scope of reactions. The synthesis protocol 
should be readily scalable so that the target molecules could be produced in larger 
volume for example by the pharmaceutical industry. 
   Novel methods of synthesizing 4H-pyrido[1,2-a]pyrimidin-4-ones, imidazo[1,2-
a]pyridines and pyrroles and furans are discussed with an emphasis on providing 
a minimalistic approach of employing simple and green alternatives whenever 
possible, without compromising yield. The methods include newly conceived 2-
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1.1     Cross-coupling Reactions 
1.1.1 Brief History of Coupling Reactions 
A coupling reaction is traditionally defined as the C-C bond formation between 
two hydrocarbon fragments. This includes homocoupling of two identical 
substrates or cross coupling between two different substrates. This definition has 
since been extended to include C-X bond formations (X = O, N, S etc.) as well. 
Many coupling reactions have been applied to the pharmaceutical industry and 
into conjugated organic materials since its early days, with significant 
developments in this field of study [1]. 
   The first coupling reactions can be traced back to the mid 19th-century with the 
Wurtz reaction, the homocoupling of alkyl halides using sodium metal [2] and 
Glaser’s homocoupling of terminal alkynes using copper catalyst [3]. The turn of 
the century saw the synthesis of symmetric biphenyls via Ullman’s copper 
catalyzed homocoupling of phenyl moieties (Scheme 1.1, top) [4].  
Scheme 1.1: Early examples of Ullman’s homocoupling (top) and Gomberg-
Bachmann’s cross-coupling (bottom) of aryls for synthesis of biaryls.  
2 
 
   The main drawback of homocoupling reactions is the restriction to only 
symmetrical products, paving way to the advent of cross-coupling reactions. 
Gomberg-Bachmann synthesis of biphenyl moieties using stoichiometric base, 
was the first cross-coupling attempt (Scheme 1.1, bottom) [5], followed by 
Cadiot-Chodkiewicz’s base-promoted alkyne-alkyne cross-coupling reaction [6]. 
Both these reactions suffer from low yields due to side reactions. The need for a 
more discriminating catalyst to increase selectivity led to the rise of palladium-
catalyzed cross-coupling reactions in the 1970s.  
   These reactions employ Pd(0) or Pd(II) catalyst in the coupling of aryl or vinyl 
halides with an organometallic partner to form biaryl or styrene derivatives 
(Scheme 1.2). Examples include Kumada [7, 8], Suzuki-Miyaura [9], Stille [10], 
and Negishi coupling reactions [11]. By substituting the organometallic partner 
to organosilanes, alkenes, terminal alkynes and secondary amines, Hiyama [12], 
Mizoroki-Heck [13, 14], Sonogashira [15] and Buchwald-Hartwig coupling 
reactions [16] were also introduced. Phosphine ligands, co-catalysts and base 
additives are also employed in some of these reactions.  
 
Scheme 1.2: Examples of some Pd-catalyzed cross-coupling reactions with their 




   Introduction of chiral phosphine ligands then gave rise to asymmetric cross-
coupling reactions that produces optically active compounds, which are very 
important in the food, fragrance and pharmaceutical industry [17]. In the early 
70s, the first ever asymmetric cross-coupling reaction employed a Ni(II) 
complex with the (-) form of (2,3-O-isopropylidene-2,3-dihydroxy-1,4-
bis(diphenylphosphino)butane) (DIOP) phosphine ligand, coupling Grignard 
reagents with aryl chlorides, achieving 14 % enentiomeric purity (e.e) (Scheme 
1.3) [18, 19].  
 
Scheme 1.3: First asymmetric cross-coupling example, employing optically 
active diop ligand. 
 
In the next decade, incorporation of more sterically demanding phosphine 
ligands like 2-(1-(dimethylamino)ethyl)-1-(diphenylphosphino)ferrocene (PPFA) 
to Pd(II) and Ni(II) catalyzed asymmetric cross-coupling reactions allow (e.e) to 
increase up till 95 % e.e and higher [20-24]. 
   At the turn of the 21st century, C-H functionalization reactions emerged, 
replacing the need for reactive organometallic coupling partners for synthesis of 
biaryls, styrenes and arylacetylene derivatives. This requires cleavage of a Csp2-
H bond, followed by coupling with a C atom or heteroatom fragment. Various Pd 
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catalyzed direct arylation [25-28], olefination [29-31], alkynylation [32-35] and 
intramolecular arylation [36-37] protocols have been developed (Scheme 1.4). In  
Scheme 1.4: Examples of Pd(II)-catalyzed direct arylation (top) [26] and 
olefination (bottom) [29] via initial Csp2-H cleavage.  
 
addition Rh, [38-41] and Ru [42-43] catalyzed C-H transformations have also 
been reported. Since then there are examples of cleavage of Csp3-H for C-C 
coupling reactions in the literature [44-46]. Cleavage of Csp3-H bonds of 1,3-
dicarbonyls and their derivatives is one of the primary focus of this project, as it 
is the intial step towards C-X/C-X bond formations towards formation of various 
heterocyles as seen in chapters 3 - 7 (Figure 1.1). 
   The research community soon realizes that it was possible to use cheaper 3rd 
row transition metal catalysts for C-H functionalization reactions. For example, 
protocols for alkynylation, alkenylation and arylation have been reported using 
Fe [47-49] (Scheme 1.5, top), Co [50-51], Ni [52-53], Cu [54-56] and more. Due 
to the inherent nature of transition metal catalyzed reactions that may require air 
and moisture sensitive reagents, there are trends in coupling reactions employing 
air-stable and moisture stable main group metals and lanthanide group metals as 
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catalyst. Examples of this C-C or C-X bond formation reactions includes Bi [57-
58], In [59-61] (Scheme 1.5 middle) and Yb (Scheme 1.5 bottom) [62].  
 
 
Scheme 1.5: Examples of 3rd row transition metal (top) [47], main group metal 
(middle) [60] and lanthanide group [62] metal-catalyzed C-H functionalization 
reactions.  
 
      Last but not least, it was realized that certain coupling reactions could be 
done without the requirement of metal catalyst or mediators and ligands. These 
metal-free syntheses provide a cheaper alternative without the requirement for 
metal catalysts or mediators and their associated high cost and acute toxicity 
[63]. These metal-free coupling reactions have been a rising trend over the past 
decade [64]. These coupling reactions employs oxidant like molecular iodine and 
tert-butyl hydroperoxide (TBHP) [65], hypervalent iodine species like 
PhI(OAc)2 [66-69], tert-butyl ammonium iodide (TBAI) or a combination of 
both [70-75] (Scheme 1.6, top). There are also examples of base and 
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organocatalysts, or a combination of both, in these metal-free C-H 
transformations as well [76-79]. Metal-free direct arylation [80-82], olefination 
[83-84], alkynylation [85] and alkynylation of aldehydes [86-88] and α-keto 
acids [89] have since been reported as well (Scheme 1.6, bottom). 
 
Scheme 1.6: Examples of metal-free cross coupling reactions employing TBAI-
TBHP system (top) [72] and NaOtBu mediated system (bottom) [82].  
 
   These early examples provide a stepping stone for further exploration into 
metal-free coupling reactions towards a greener, cheaper and straightforward 
approach of cross-coupling reactions. In this project, three chapters were devoted 
to metal-free synthesis of imidazo[1,2-a]pyridines, phenylimidazo[1,2-
a]pyridines and pyrroles via C-X/C-X bond formations (Chapters 4, 5 and 6). 
 
1.1.2     Synthesis of Heterocycles Via C-X/C-X Bond Formation and Tandem 
Reactions. 
 
   In the past decade, many protocols for multiple bond C-X/C-X (X = C, N, O) 
couplings in a single reaction were developed with many examples proceeding 
via tandem reactions to form cyclic products. These tandem reactions can be 
broken down into 2 parts (Figure 1.1). The first step is a C-H or C-H/C-H 
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functionalization step and this is followed by C-X bond formation. 
Cycloisomerization or ring-closing condensation of the intermediate then ensues, 
forming the product.  
    
 
Figure 1.1: Illustration of two syntheses of heteroaromatics developed in our lab; 
One proceed via C-H/C-H functionalization followed by ring-closing 
condensation (left) and the other proceed via C-H functionalization followed by 
cycloisomerization.  
 
   Cycloisomerization involves isomerization of the intermediate into its cyclic 
isomer, with at least one degree of unsaturation consumed and no loss of atoms 
[90]. This is an atom-economical and efficient way of forming cyclized 
heterocycles since it minimizes waste [91]. Ring-closing condensation reaction 
on the other hand, releases water, alcohols etc. during the cyclization process. An 
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exhaustive amount of research has been done on this field of study with 
ingenious metal-catalyzed protocols that provided unprecedented synthesis of 
large variety of polysubstituted heterocycles via coupling reaction [92-100] 
(Scheme 1.7). In this project, one chapter employed a 3rd row transition metal 
cobalt catalyst for the synthesis of furans via C-C/C-O bond formation, whereas 
the other employed a main group metal bismuth catalyst for the synthesis of 
pyrido[1,2-a]pyrimidin-4-one via C-N/C-N bond formation. 
Scheme 1.7: Examples of transition-metal catalyzed cross coupling reactions 
employing multiple bond formations for the synthesis of isoquinoline (top) [99] 
and quinoline (bottom) [100].  
 
   Metal-free approaches for constructing heterocycles employing these multiple 
bond forming strategies have also been significantly developed as there has been 
a shift towards green chemistry, which promotes development of protocols that 
are as simple, straightforward, using few different types of catalyst and reagents, 
preferably with ‘green’ or no solvent (solventless synthesis) and with minimal 
wastage without significantly affecting the reaction yield [101]. As such, over 
the last few years, there has been a surge in metal-free synthesis of heterocycles 
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Scheme 1.8: Examples of metal-free cross coupling reactions employing 
multiple bond formations for the synthesis of oxazole (top) [102], quinazoline 
(middle) [104] and quinoline (bottom) [106]. 
 
   In this project, three out of five chapters employed metal-free protocols for the 
synthesis of imidazo[1,2-a]pyridines via C-N/C-N ond formation and pyrroles 
via a multicomponent reaction with 2x C-C and 2x C-N bond formation 
(Chapters 4 - 6).  
 
1.1.3     1,3-Dicarbonyls as Versatile Synthons for Coupling Reactions 
 
1,3-dicarbonyls are versatile synthons for the synthesis of heterocycles via 
multiple bond formations. Depending on the nature of their coupling partner, β-
ketoesters could act as a dielectrophile, dinucleophile or ambiphile (Figure 1.2).  
With dielectrophilic coupling partners like α-β unsaturated ketones, 
(bromoethynyl)benzene, ethyl phenylpropiolate and 2-bromobenzyl bromide, β-
ketoesters act as dinucleophiles, forming 4H-pyran [111], furan [112], 2H-pyran-
2-one [113] and 4H-Chromene [114] respectively. On the other hand, presence 




Figure 1.2: Illustration of the versatility of β-ketoesters as a dinucleophile, 
ambiphile and dielectrophile, and also further functionalization of β-ketoesters, 
forming a wide scope of heterocycles via a coupling reaction, with C-X/C-X 
bond formations.  
 
β-ketoesters act as a mutual ambiphile, forming indole [115], isoquinoline [116] 
and quinoline [117] respectively. Moreover, dinucleophilic molecules like 
phenol, aniline, 2-aminopyridine and aldimine couple with β-ketoesters acting as 
dielectrophiles, forming 2H-chromen-2one [118], quinolone [119], 4H-
pyridopyrimidinone [120] and pyrimidine [121] respectively.  
   β-ketoesters can also undergo radical reactions, forming an unpaired electron at 
the α-position, with oxidants like TBHP or di-tertbutylperoxide (DTBP). The 
radical species can then react with vinyl azide, phenol and methyl 
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phenylpropiolate to construct pyrrole [122], benzofuran [123] and furan [124] 
respectively.  
   The reactivity of β-ketoesters can be further activated by functionalization with 
leaving groups such as halides and diazo, forming a dielectrophile. These 
activated β-ketoesters can couple with dinucleophiles such as benzylamine, 2-
aminopyridine and thiourea, forming oxazole [125], imidazopyridine [126] and 
thiazole [127] respectively.  
  Moreover, reacting β-ketoesters with secondary amines forms an ambiphilic 
adduct, which can couple with 2-formylpiperidinium chloride to form 
tetrahydroindolizne [128]. A 1,3-cycloaddition of the adduct with benzonitrile 
oxide also forms isoxazole [129]. On the other hand, reaction of β-ketoesters 
with primary amine leads to the β-iminoester, which can act as a dinucleophile in 
a Hantzsch coupling of α-bromoketone, forming N-phenylpyrrole [130].  
   β-ketoesters can undergo cyclopropanation by reacting with ethylene bromide 
(EDB). This forms an ambiphilic adduct, which can react with aniline, forming 
N-phenylpyrrole [131] as well.  
   1,3-Diketones have the same ability as β-ketoesters, to form heterocycles 
carrying an acetyl group instead of an ester. However, due to the presence of the 
additional ketone group, it has additional dielectrophile reactivity, allowing 
formation of additonal heterocyles that is not possible for β-ketoesters (Figure 
1.3). Acetylacetone, acting as a dielectrophile, couples with phenylhydrazine to 
form pyrazole [132]. Coupling hydroxylamine with acetylacetone on the other 
hand allows formation of isoxazole [133]. Urea, thiourea and guanidine can also 
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couple with acetylacetone, forming pyrimidinone, pyrimidinthione and 
pyrimidine respectively [121].  
   It is worth mentioning that the illustrations depicting coupling of β-ketoesters 
and β-diketones with various substrates are not exhaustive and there are many 
more examples in the literature for the formation of polusybstituted heterocycles 
from these 1,3-dicarbonyls as one of the coupling partners.  
  
 
Figure 1.3: Illustration of the versatility of β-diketones as coupling partners in 
synthesis of various heterocylces, in addition to similar reactions as β-ketoesters. 
 
 
  To further illustrate the versatility of 1,3-dicarbonyls and their derivatives, in 
this project we employed 1,3-dicarbonyls, and their derivatives, including 
phenylacetones and phenylacetophenones as one of the substrates in the 
synthesis of various heterocycles via multiple bond formations by initial C-H 





1.1.4     One-pot Synthesis and Multicomponent Reactions (MCR) 
 
One of the most important aims of organic syntheses nowadays is synthethic 
efficiency, which includes atom economy, step economy and redox economy 
[134]. Atom economy is the conversion efficiency of a reaction, in terms of all 
the atoms involved, with the emphasis on minimizing wastage of atoms [135]. 
Step economy refers to minimizing the number of steps taken for a synthesis, 
which translates to savings in costs and time expended to get the desired product. 
[136]. Lastly, redox economy aims to minimize non-strategic redox reactions 
[137], because reduction and/or oxidation reactions are usually not atom 
economical and frequently not very selective [138]. Strategic reactions in a 
synthesis of complex molecules is regarded by Hendrickson in 1975 as those that 
either form the skeletal backbone or those that induce functionality or control 
stereochemistry [139]. Thus, a synthetically efficient reaction must have a fine 
balance between atom, step and redox economy, without sacrificing reaction 
yield. 
   With the desire for synthetic protocols to achieve more with the smallest effort, 
the fusion of multiple steps into a one-pot reaction is a powerful tool for 
achieving synthetic efficiency. A one-pot reaction is defined as one where 
substrates are subjected to subsequent reactions in one reaction flask. One-pot 
reactions condense a number of bond-formation steps without the need for 
isolation of intermediates. This prevents the need for separation and purification 
of intermediates, which not only minimizes wastage, but also reduces cost and 
time. In one-pot reactions, substrates and reagents can be added all together at 
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the beginning of the reaction, or some components may be added dropwise over 
the course of reaction, or added at a predetermined time during reaction. 
   One of the approaches of one-pot reaction is multicomponent reaction (MCR). 
Ugi defined a multicomponent reaction as a convergent reaction, whereby three 
or more starting materials react to form a product, with all or most of the atoms 
contributing to desired product [140]. Such reactions proceed through a series of 
sequential cascade reactions, starting with a network of equilibrium reactions 
that will be passed on to the final irreversible steps to form the desired product.  
The main challenge of research work done on MCR is to reduce possible side 
products by fine-tuning reaction conditions, solvent, temperature, catalyst(s), 
substrates and their functional group(s). One main advantage of MCR is that a 
complex skeletal backbone can be easily constructed in minimal number of steps 
using three or more substrates. Relatively small amounts of each individual 
substrate can lead to a significant amount of the desired product when they are 
coupled together in a MCR. Last but not least, due to the propensity of MCR in 
coupling many substrates together, large libraries of products can be synthesized 
with relatively little effort, with expansive permutations of the three or more 
substrates [141]. This is advantageous especially in the development of 
biological asssays for identifying pharmacophores in drug discovery.  
   1,3-dicarbonyls have been incorporated in many different types of MCR, not 
only due to their availability and low cost, but also due to their versatility as 
well. This is illustrated in Figure 1.4, whereby β-ketoesters are one of the 





























































Figure 1.4: Various MCR reactions employing β-ketoesters for synthesis of 
heterocycles.  
 
   In a silica nanoparticle catalyzed 3-component reaction of methyl acetoacetate, 
benaldehyde and malonitrile, polysubstituted 4H-pyrans were synthesized using 
ethanol as solvent under ambient temperature [142]. Polysubstituted thiophenes 
can also be constructed via the Gewald reaction, employing a 3-component 
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reaction with methyl acetoacetate, methyl cyanoacetate and elemental sulfur 
using diethylamine as base and pyridine as solvent [143]. On the other hand, 
methyl acetoacetate can couple with benzaldehyde and phenylhydrazine in a 
solvent-free 3-component synthesis of polysubstituted pyrazoles catalyzed by 
Ytterbium(III) perfluorooctanate [144]. A Pd(II)-catalyzed 3-component 
synthesis of polysubstituted furans by coupling methyl acetoacetate with 
propargyl carbonate and iodobenzene has also been reported [145]. Another 
example of a 3-component reaction is the synthesis of polysubstituted pyridines 
from coupling of methyl acetoacetate, 4-phenylbut-3-yn-2-one and ammonium 
acetate, catalyzed by ZnBr2 in toluene, under reflux [146]. The final MCR 
example is that of an FeCl3 catalyzed 4-component synthesis of polysubstituted 
pyrroles employing methyl acetoacetate, benzaldehyde, aniline and nitromethane 
[147]. This list is not exhaustive as there are many examples for multicomponent 
reaction examples that use 1,3-dicarbonyls as one of the substrates.  
   In this project, all five chapters employ the one-pot synthesis for construction 
of heterocycles via employing 1,3-dicarbonyls and their derivatives as one of the 
substrates, proceeding through a series of domino reactions. Chapter 6 is also a 
multicomponent reaction, employing 4 substrates, including 1,3-dicarbonyls to 
construct pyrroles. 
 
1.2     Lewis Base Activation of Lewis Acid 
The activation of a Lewis base by a Lewis acid is a concept that has been 
developed recently by Scott Denmark of the University of Illinois [148]. It is 
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based on the somewhat counterintuitive notion that binding of a Lewis base 
donor to a Lewis acid acceptor causes an enhanced electrophilic character of the 
acceptor, rather than an enhanced nucleophilic character (Figure 1.5). This 
concept is based on earlier work by Gutmann on Lewis acid-base adducts, who 
recognized that while formation of Lewis acid-base adduct leads to an increase in 
electron density on the acceptor, the electron density was not distributed equally 
among the atoms of the acceptor. [149]. 
   The fourth of Gutmann’s four rules of molecular adduct formation states that 
even though a donor–acceptor interaction results in a net transfer of electron 
density from the donor to acceptor species, in the case of hypervalent species, it  
 
Figure 1.5: Electronic distribution for a Lewis acid-base adduct resulting from 
an interaction between main group Lewis acid acceptor and a Lewis base donor.  
 
actually leads to a net increase (pileup) in donor atom’s electron density and to a 
net decrease (spillover) of the electron density at the acceptor atom [150]. During 
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the donor-acceptor interaction, there are changes in the intramolular charge 
distribution caused by dispersing the net change in electron density among all the 
atoms to overcompensate the initial changes induced at the donor and acceptor 
atoms.  
   This can be seen in Figure 1.6, whereby the Mulliken charges shown for group 
13 and 14 Lewis acids are lower compared to those of their adducts [151-152]. 
Mulliken charges can be obtained from Mulliken proportional analysis, which is 
a computation calculation method for estimating partial atomic charges [153].    
One important condition for this pileup and spillover effect to take place, as  
 
 
Figure 1.6: Mulliken charges of GaCl3 and SiCl4 before and after complexing to 
their respective Lewis base donors. 
 
mentioned by Gutmann, is the need for Lewis acidic acceptor be able to expand 
its coordination sphere and become hypervalent. The ability of main group 
elements to expand their coordination sphrere and engage in hypervalent bonding 
is due to the ability of their unhybridized p orbital(s) in forming electron rich 3-





Figure 1.7: Hybridization and orbital picture of silicon complexes as adapted 
from [148]. 
 
   The molecular orbital diagram of the 3 center-4-electron hybrid shows that the 
highest occupied molecular orbital (HOMO) is a non-bonding orbital containing 
a node at the central atom, with electron density at the peripheral atoms (Figure 
1.8). This implies that for the hypervalent Lewis acid, the central atom is electron 
deficient at the central atom but electron rich at the peripheral atoms.  
 
Figure 1.8: Molecular orbital diagram of the 3-center-4-electron hybrid as 
adapted from [148]. 
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   Thus, for main group metal Lewis acids, their electrophilic character can be 
enhanced by Lewis base, due to the availability of the unhybridized p orbitals to 
engage in 3-center-4-electron bondings. These hypervalency can also go on to 
ionization, forming ion pairs with hyperactive nucleophiles and electrophiles 
(Figure 1.9). The type of counteranion of the main group metal Lewis acid does 
play an important role in determining preference for hypervalent state or 
ionization state. Presence of bulky anions with less electronegative or poorly 
delocalizing substituents will stabilize the metal center, thus favouring the 
hypervalent state. On the other hand, the presence of anions with strongly  
 
 
Figure 1.9: Lewis acid-base adduct and the transition from hypervalency to 
ionization, forming hyperactive electrophiles and nucleophiles.  
 
electronegative or delocalizing substituents tend to favour the ionization state, 
forming the hyperactive eleectrophiles and nucleophiles [155]. 
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   In Chapter 3 of this project, main group metal salt Bi(III) was employed as a 
Lewis acid catalyst for the synthesis of pyrido[1,2-a]pyrimidin-4-ones from 2-
aminopyridine and β-ketoesters. 2-aminopyridine is not only the substrate for 
these reaction but also functions as a Lewis base to enhance the electrophilicity 
of the Bi(III) catalyst by the spillover effect as mentioned in this subchapter. This 
not only increases the electrophilicity of the Bi metal center, but also increases 
the hypervalent nucleophilicity of the Cl anion, allowing deprotonation of acidic 
protons towards formation of the desired product (Figure 3.2).  
 
1.3     Zeolite Molecular Sieves 
Molecular sieves are materials with very small pores of uniform sizes. These 
pores are in the Angstrom (Å) or nanometer (nm) scale. They are divided into 
three catogeries based on their pore size; microporous (<2 nm), mesoporous (2-
50 nm) and macroporous (>50 nm) [156]. Due to their small pore sizes, they are 
usually employed as absorbents for gases and liquids and dessicants. 
   Zeolite molecular sieves are microporous highly crystalline aluminosilicates 
with 3-dimensional pores. The skeletal backbone consists of neutral SiO4 and 
anionic AlO4- tetrahedra [157]. The pores can accommodate a large variety of 




Figure 1.10: Topology of Zeolite type A, showing two types of cages present in 
the structure, along with the pore and cation sites as adapted from [158]. 
 
framework. The zeolite molecular sieves to be discussed here are the Zeolite 
LTA (Linde Type A) zeolites with pore diameters of 3, 4 and 5 Å (Also known 
as 3Å, 4Å and 5Å MS respectively). Zeolite LTA or Zeolite A in short, consists 
of an α cage (supercage) surrounded by 8 β-cages (sodalite cage) (Figure 1.10). 
They have pores that run perpedendicularly to each other in x, y and z axes 
[159]. Also, these types of zeolites have a low Si/Al ratio of 1. The cations could 
be located in both α cage and β-cages. 
   The main difference between the three different Zeolite LTA molecular sieves 
is their pore size, which is determined by the dimensions of the charge 
compensating cation present. 4 Å molecular sieves have the idealized chemical 
formula {Na12[Al12Si12O48].27H2O}8 in its fully hydrated form [157]. The 
presence of Na+ cations results in an effective pore size of 4 Å so that only 
molecules with a critical diameter of less than 4 Å can be absorbed. This allows 
absorption of molecules such as water CO2, NH3, SO2 and H2S while excluding 
propane, methanol, ethylene oxide and many more from absorbing.  
   A table of molecules with their critical diameters is shown in Table 1.1. 4 Å  
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Helium 2.0 Propylene 5.0 
Hydrogen 2.4 Ethyl mercaptan 5.1 
Acetylene 2.4 1-Butene 5.1 
Oxygen 2.8 trans-2-Butene 5.1 
Carbon monoxide 2.8 1,3-Butadiene 5.2 
Carbon dioxide 2.8 Chlorodifluoromethane 5.3 
Nitrogen  3.0 Thiophene 5.3 
Water 3.2 Isobutane 5.6 
Ammonia 3.6 Cyclohexane 6.1 
Hydrogen sulfide 3.6 Benzene 6.7 
Argon 3.8 Toluene 6.7 
Methane 4.0 p-Xylene 6.7 
Ethylene 4.2 Carbon Tetrachloride 6.9 
Ethylene oxide 4.2 Chloroform 6.9 
Ethane 4.4 Neopentane 6.9 
Methanol 4.4 m-Xylene 7.1 
Methyl mercaptan 4.5 o-Xylene 7.4 
Propane 4.9 Triethylamine 8.4 
 
 
molecular sieve is widely used in drying and purification of organic solvents and 
gases. 
   3 Å molecular sieves are made by ion exchanging some of the Na+ with an 
ionic radius of 102 pm, with larger K+ cations of ionic radius of 138 pm [161]. 
The chemical formula of the fully hydrated form is 
{Na4.8K7.2[Al12Si12O48].27H2O}8. Due to their larger size, K+ cations take up a 
larger space inside the pores as compared to Na+ cations, and the effective pore 
diameter decreased from 4 Å to about 3 Å after the cation exchange. Thus, any 
molecules with a critical diameter of 3 Å or less can be absorbed inside. This 
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includes water, H2 and He gases. Molecular sieve 3 Å are widely used in drying 
of methanol and ethanol and saturated hydrocarbons.  
   5 Å molecular sieves are made by ion exchanging some of the Na+ with an 
ionic radius of 102 pm, with Ca2+ cations of ionic radius of 100 pm [161]. The 
chemical formula of the fully hydrated form is {Ca4.8Na2.4 
[Al12Si12O48].27H2O}8. In 5 Å MS, only every other cation site is occupied by 
Ca2+ since it can compensate two negative charges of the framewerk. Because of 
this, the effective diameter increases from 4 Å to about 5 Å after the cation 
exchange. Thus, any molecule with a critical diameter of 5 or less can be 
absorbed inside. This includes propane, methanol, ethylene oxide and many 
more. 5 Å molecular sieves are widely used in the petroleum industry for 
purification of gas streams.  
   The most common forms of commercial molecular sieves are as beads of 1 to 5 
mm diameter or as powder. Powders are usually employed for gas phase 
applications whereas the bead form is preferred for liquid phase reactions.  
Before use, these molecular sieves have to be activated to remove occluded water 
molecules. This usually requires heating at a temperature range of 175 to 315 °C, 
depending on the type of molecular sieves [160]. Because of their good thermal 
stability, molecular sieves can be regenerated after every use. 
   Due to their size selectivity, these zeolite molecular sieves are used for a wide 
range of applications in the petrochemical industry, especially in processes 
related to catalysis and separation [162]. This includes catalytic cracking, 
adsorptive separation of hydrocarbons and purification of gases and liquids. 
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They are also widely used in the research laboratories as dessicants. 
Furthermore, there has been a rise in applications of these zeolite molecular 
sieves in organic synthesis as promoters of organic reactions. These will be 
further shown in introduction of initial studies subchapter of Chapter 6. 
   Also in Chapter 6 of this project we devised a protocol of employing 4Å MS to 
promote the multicomponent reaction for the synthesis of pyrroles. These 
molecular sieves promote the reaction by converting aldimine side product back 
to its precursor substrates via hydrolysis, thus having more substrates available to 
couple with their respective partners towards pyrrole formation. This will be 
further discussed in Chapter 6.  
 
1.4   Bismuth(III)-catalyzed Synthesis of Heterocycles 
With an emphasis on Green chemistry nowadays, there has been a surge in the 
number of publications on bismuth catalysis over the turn of the century. This is 
due to low toxicity of bismuth salts, associated with low cost and low catalytic 
loadings and also air and moisture stable [163]. Over the past decade or so, there 
have been a lot of interest in employing bismuth(III)-salts as Lewis acid catalysts 
in the synthesis of heterocycles.  
   Yadav et al. reported in 2004 an efficient Bi(OTf)3 catalyzed synthesis of 
trisubstituted quinolines from 1,3-dicarbonyls and 2-aminoarylketones via the 
Friedlander reaction (Scheme 1.9, top) [164]. This protocol provides a greener 






Scheme 1.9: Bismuth(III)-catalyzed synthesis of quinolines (top), 2-
aryloxazolines (middle) and coumarins (bottom).  
 
acids like trifluoroacetic acid. The versatility of this method is demonstrated with 
the reaction proceeding even with β-ketoesters and cyclic 1,3-diketones. The 
following year, Hojati’s group reported the bismuth(III)-catalyzed synthesis of 2-
aryloxazolines, which are versatile organic intermediates, from excess β-
aminoalcohols and benzonitriles (Scheme 1.9, middle) [165]. However, this 
protocol only works for aromatic nitriles, as aliphatic nitriles, including both 
cyclic and acyclic derivatives are not suitable under the reaction conditions 
reported. Also in 2005, De and Gibbs introduced a BiCl3-catalyzed synthesis of 
4-substituted coumarins from ethyl acetoacetate and phenols via Pechmann 
reaction (Scheme 1.9, bottom) [166]. While resorcinol reacts efficiently at 75 °C 
and 1 h, phenol required harsher conditions of 4 h and 125 °C. Hoffmann’s group 
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reported in 2008, a Bi(III)-catalyzed Pictet-Spengler reaction in the synthesis of 
isothiochroman and isochroman from coupling of aromatic aldehydes with 
phenylethanethiol and phenylethanol respectively (Scheme 1.10, top) [167]. The 
main drawback however is a requirement of a strong electron-withdrawing 
subsitutent on the benzaldeyde moiety for an efficient synthesis. Electron 
donating OMe proceeded with just 40 % yield.  
 
Scheme 1.10: Bismuth(III)-catalyzed synthesis of iso(thio)chroman (top) and 
chiral tetrahydroisoquinolines with proposed chelation intermediate (bottom).  
 
   So far, all previous bismuth(III) catalyzed examples are show greener 
alternatives to well known synthehic routes like Pechmann and Friedlander. A 
progress is needed whereby a reaction works best when catalyzed by Bi(III) after 
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screening a variety of metal salt catalysts. This is the case for Takaki’s group in 
2008, whereby Bi(OTf)3 was superior to other screened catalysts like Cu(II), 
Fe(II), Ni(II), Zn(II), Sc(III) etc. in the carbo-oxycarbonylation of 3-alkynyl 
esters to lactones (Scheme 1.10, middle) [168]. To propose Bi(Iii) superiority 
over other metal catalysts, it was proposed that bismuth being a borderline metal 
could bind to the hard O atom (σ-activation) as well as π-coordinate to the soft 
triple bond of the alkyne group (π activation) (Figure 1.11).  
 
Figure 1.11: Illustration of dual activation of borderline metal catalyst like 
Bi(III) salts.  
 
   The following year, Kawai et al. reported a direct intramolecular amination of 
chiral allylic alcohol to form chiral tetrahydroisoquinoline (Scheme 1.10, 
bottom) [169]. This reaction proceeds via a 1,3 chiral transfer and the author also 
proposed a chelation intermediate to explain Bi(III) superiority over other metal 
catalysts. Due to its dual activation ability: binding to both hard O atoms of 
hydroxyl and ketone moiety (σ-activation) of the Boc protecting group as well as 
π-coordinate to the soft double bond of the alkene group (π activation). This 
work, together with a few others at that time open up the field of work to other 
Bi(III) catalyzed intramolecular reactions including cycloisomerization of enynes 




Scheme 1.11: Bismuth(III)-catalyzed synthesis of pyrrolidines (top) and 
dihydroquinolones (bottom).  
 
catalyzed tandem Meyer-Schuster rearrangement of electron rich propargylic 
alcohols and 1,4 addition to dihydroquinone (Scheme 1.11, bottom) [171]. A 
representative mechanism for the Bi(III)-catalyzed cycloisomerization of enynes 
to pyrrolidines further manifest the ability of Bi(III) to not only bind to the O 
atoms of the sulfone moiety (σ-activation) but also to the triple bond (π 
activation) of alkyne substrate as well (Figure 1.12).  
   One challenge faced by researchers in this field as manifested by the small 
number of scope given in these Bi(III)-catalyzed intramolecular cyclization 
reactions to form their respective heterocycles, is the fact that most of these 
substrates are not commercially available and thus have to be presynthesized by 
one or even multiple steps. This makes it costly if the protocol were to be 
conducted in the large scale in the industry or even for applicaton in 
development of bioassays for drug development. Furthermore, yields are mostly 




Figure 1.12: Proposed mechanism for Bi(III)-catalyzed cycloisomerization of 
enynes to pyrrolidines with emphasis on intermediate A having dual activation of 
the Bi(III) metal center to the substrate.  
 
This challenge also apply to intermolecular reactions catalyzed by Bi(III) metal 
salts as well. While being borderline metal catalysts allow it to bind to both hard 
and soft atoms thus increasing its versatility to various substrates and reactions, 
one main drawback of being borderline metal catalysts is modest yields and 
selectivity. Perhaps one way to overcome these challenges would be to activate 
these Bi(III) catalysts, in view of Prof S. Denmark’s Lewis based activated 
Lewis acid catalyzed reactions as explained in depth in Chapter 1.2. Whereas 
there are a few examples of using pyridine and its derivatives as additives to 
promote Bi(III) catalyzed reactions [172-173], they are formally no mention of 
Lewis base activation of Bi(III) salts in the literature. Thus, more work should be 
done in this area to further expand this field of study. In this thesis, 2-
aminopyridine is used both as substrate and as a Lewis base to activate the 
Bi(III) catalyst in synthesis of 4H-pyrido[1,2-a]pyrimidin-4-ones. 
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1.5   Synthesis of Heteroaromatics via Tandem in situ α-Halogenation and 
Cyclization of 1,3-dicarbonyls and Acetophenones 
 
There have been a lot of interest in the last decade on in situ α-halogenation of 
1,3-dicarbonyls, acetophenones towards synthesis of various heteroaromatics. 
This is because, by halogenating the α-carbon, the carbon is activated and makes 
it susceptible to nucleophilic attack, which opens up new ideas for one-pot 
synthetic protocols of various heteroaromatics that were previously not possible. 
Also, having a one-pot reaction with in situ α-halogenation of the substrates is 
always superior, as compared to using these active methylene compounds with 
halogens at the α-carbon, which for many cases are either not commercially 
available or costly, and thus needs to be presynthesized.  
   The traditional method of α-halogenation of compounds with the acetyl 
moiety, including acetophenones and 1,3 dicarbonyls, is via triiodomethane 
(iodoform) reaction, which employs overstoichiometric amounts of molecular 
iodine and strong bases like NaOH or KI with a strong oxidant like sodium 
chlorate. For the former condition, the α-proton would be deprotonated and the 
resulting enol form attack I2 to form the α-iodinated product. This process would 
however proceed twice more, releasing CHI3 and a carboxylate salt. This is of 
course undesirable to the chemist who wanted to stop at monohalogenation to 
couple with another substrate for heterocycle synthesis. 
   Taking inspiration from the iodoform test, many protocols still employs I2 for 
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Scheme 1.12: Synthesis of thiazole, imidazopyridine and oxazole employing the 
Cu(II)/I2 system. 
 
synthesis. One of the most common method used is the Cu(II)/I2 system as 
mediators in the reaction, proceeding via oxidative cyclization (Scheme 1.12). 
Wu’s group reported in 2012 the synthesis of 2-aminothiazoles from thioureas 
and acetophenones employing a CuO/I2 system (Scheme 1.12, top) [174]. 1.1 
equivalents of I2 and CuO is used with the reaction done in ethanol under reflux. 
It was noted that 2-aminopyridines were added during later parts of the reaction, 
upon full conversion of acetophenone, monitored by TLC. Reaction does not 
proceed with aliphatic derivatives of ketone moiety whereas acetophenones with 
substituted phenyl groups and their respective heteroaromtaic counterparts 
proceeded with moderate to good yields. Wu’s group also employed similar 
protocol in 2015 for the synthesis of imidazo[1,2-a]pyridines from 2-
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aminopyridines and acetophenones (Scheme 1.12, middle) [175]. It was noted 
that similarly, only aromatic ketones are reactive substrate under the reaction 
conditions stated. In addition, Wan et. Al reported the synthesis of trisubstituted 
oxazoles from benzylamines and 1,3 dicarbonyls (Scheme 1.12, bottom) [125].    
While still requiring overstoichiometric amounts of I2 like both of Wu’s 
protocols, catalytic amounts of Cu(OAc)2.H2O is required but with the use of 2 
equivalents of peroxide TBHP as oxidant. 2 equivalence of benzylamine is 
required for the reaction to proceed with good to xcellent yield. β-ketoesters, β-
diketones and β-ketoamides were suitable substrates for this reaction, illustrating 
the expansive scope of this protocol. However, β-ketoamides proceeded with 
poor yield of 38 %. A representative mechanism for the Cu(II)/I2 system is 
described (Figure 1.13) [174]. The enol tautomer of acetophenone reacts with I2 
with CuO as oxidizing agent and catalyst to convert I2 to I+. The resulting α-
iodinated acetophenone is attacked by 2-aminopyridine via its pyridine N atom.  
 
 





to form a salt. CuO then neutralizes the HI released and subsequent attack on the 
benzoyl group then forms the product, releasing water. The authors proposed that 
I- is oxidized back to I2, forming CuI and H2O. Even though I2 can be regerated 
back, overstoichiometric amounts of I2 is still needed. This could be due to I2 
loss through sublimation, especially at refluxing conditions.  
   Another system employing I2 for tandem in situ α-iodination-cyclization 
reaction is the I2/DMSO system (Scheme 1.13). This metal-free system involves 
initial α-iodination before employing DMSO as an oxidant to form a glyoxal 
moiety. This is followed by a nucleophilic attack and subsequent cyclization to 
form the desired heteroaromatic.  In 2002, Wu’s group reported the synthesis of 
benzothiazole from o-aminobenzenethiols and acetophenone, using 1.5 
equivalence of I2 and using DMSO as oxidant and solvent (Scheme 1.13, top) 
[176]. 1.2 equivalents of the aminobenzenethiol is required for the reaction to 
proceed efficiently. Unlike his previous works in Cu(II)/I2 system [174-175],  
 
 





both reactants can be added at the start of the reaction. 1,3-diacetlybenzene could 
also couple two 2 equivalents of o-aminobenzenethiol to form the 
dibenzothiazole product. In another simiar study by Wu’s group, they employed 
similar reaction conditions to synthesize 2,5-disubstituted oxazoles from 
acetophenones and 1.5 equivalents of benzylamine (Schemre 1.13, bottom) 
[177]. This shows the versatility of the I2/DMSO protocol for the synthesis of 
various heterocycles and recently they also applied this protocol in the synthesis 
of imidazo[1,2-a]pyridines as well [179]. A representative mechanism for the 
I2/DMSO system is described (Figure 1.14) [176]. Reaction begins with α-
iodination of acetophenone. This is followed by oxidation of the α-carbon by 
DMSO, forming a reactive phenylglyoxal intermediate, which is susceptible to 
attack by o-aminobenzenethiol via the NH2 group producing an imine 
intermediate. A nucleophilic attak by thiol followed and firther oxidative 
dehydrogenative reaction by regerated I2 then forms the desired product. I2 can  
 
 




be regenerated by the oxidation of HI by DMSO, forming Dimethyl sulfide 
(DMS) and water in the process. The I2/DMSO protocol for synthesis of 
benzothiazole, oxazole and imidazo[1,2-a]pyridines from acetophenone is 
definitely an interesting and ingenius one, as it forms the very reactive and 
unstable phenylglyoxal intermediate from cheap, air and moisture stable and 
abundant acetophenone precursor. 
   Another similar method that is recently developed is I2/O2 system, where  
atmospheric oxygen is used as the oxidant. Xie et al. employed this method in 
the synthesis of pyrido[1,2-a]benzimidazoles from the coupling of 
cyclohexanone and 2-aminopyridines, with reaction temperatures of 160 °C for 
24 hours (Scheme 1.14, top) [179]. An excess of cyclohexanone is needed for 
reaction to proceed efficiently. While many 2-aminopyridine derivatives with 



































PTSA: p -Toluenesulfonic acid  
Scheme 1.14: Synthesis of and pyrido[1,2-a]benzimidazoles and 2-




4-substituted cyclohexanones are good substrate under this protocol. Substituents 
at the 2 and 3 position cause a couple of products to form, due to regioselectivity 
issues. Another drawback of this protocol is also the high reaction temperature 
required, which is just higher than the boiling point of cyclohexanone at 155.6 
°C. This might be one of the reason why 1.5 equivalence of cyclohexanone was 
used, too offset any loss through boiling off. In a different report by Jiang’s 
group, the I2/O2 method was used in the synthesis of benzothiazole by coupling 
of cyclohexanone and thiourea (Scheme 1.14, bottom) [180]. While only 
catalytic amounts of I2 and atmospheric O2 are needed, 5 equivalence of 
corrosive PTSA is employed in this protocol. However, compared to similar 
work done by Xie et al. their reaction temperature of 75 °C was significantly 
lower. Similar regioselectivity problems were also faced in this study when 2 or 
3-substituted cyclohexanone were used. A representative mechanism for the 
I2/O2 system is described (Figure 1.15) [180]. The enol tautomer is favoured over 
 





its keto form in the presence of Brønsted acid PTSA. The enol form than attack 
I2, forming the α-iodinated intermediate and releasing I-, which is oxidez back to 
I2 by molecular oxygen. A nucleophilic attack by the S atom of the thiourea 
coupling partner ensues and an intramolecular nucleophilic addition forms 
intermediate B. Futher dehydration and subsequent dehydrogenation by I2 forms 
the desired benzotazole product.  
   While molecular iodine has many advantageous and protocols using them are 
considered green, its inherent ability to sublime at elevated temeperatures makes 
it a hassle and not a feasible protocol of choice especially in large scale 
synthesis. Thus, many alternatives to I2 system have been introduced for the 
synthesis of various heteroaromatics via tandem α-iodination cyclization 
reactions. These includes tertutylammonium iodide (TBAI)/TBHP system [181, 
126], hypervalent iodine reagents like PhI(OAc)2 [182] and NIS/TBHP system 
[183] (Scheme 1.15).  
   Zhu’s group employed the TBAI/TBHP system for the synthesis of oxazoles 
from the coupling of 2 equivalence of benzylamine and 1,3 dicarbonyls at 40 °C 
(Scheme 1.15, top) [181]. While catalytic amount of TBAI is needed, a large 
excess of TBHP is required to regenerate the active I species. While the scope 
can be extended to both β-ketoesters and β-diketones, yields obtained were 
modest with majority of them around 50 to 70 % yields. The proposed 
mechanism for this reaction is as shown (Figure 1.16). TBAI is oxidized twice 
by TBHP, releasing 2 equivalence of tert-butanol in the process. Ammonium 




Scheme 1.15: Synthesis of oxazoles, imidazo[1,2-a]pyridines and imidazo[1,5-
a]pyridines employing alternative systems to I2. 
 
Figure 1.16: Proposed mechanism for TBAI/TBHP synthesis of oxazoles. 
 
hand, ethyl acetoacetate reacts with benzylamine to form β-enaminoester 
intermediate, which reacts with ammonium iodite 2 to forms intermediate 3 with 
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hypervalent iodine leaving group. A nucleophilic substitution occurs with 
another molecule of benzylamine to form 4, which is converted to the imine 
intermediate 5 with the help of an oxidant. Hydrolysis reforms back the ketone 
group as in intermediate 6, where a intramolecular nucleophilic addition 
followed by further oxidation affords the desired oxazole product.  
   The formation of α-hyprevalent iodine active species is also seen in the work 
of Wang et al. whereby they employ a PhI(OAc)2 system to couple 2-
aminopyridine and 1,3-dicarbonyls in a BF3.OEt2 catalyzed synthesis of 
imidazo[1,2-a]pyridines (Scheme 1.15, middle) [182]. Mild reaction conditions 
were employed with.good to moderate yields obtained after 2 to 16 hours. Last 
but not least, Wang’s group employed a NIS/TBHP system for the synthesis of 
imidazo[1,5-a]pyridines from benzylamines and β-pyridylesters and ketones 
(Scheme 1.15, bottom) [183].  The unique use of β-pyridylesters and ketones as 
substrates allows an unprecendented access to the structural isomers of the 
ubiquitous  imidazo[1,2-a]pyridines. However, most of these substrates are not 
commercially available andneeds to be presynthesized.  
   It is good to mention that employing system involving brominating reagents for 
tandem α-bromination cyclization for heteroaromatics synthesis is rare and lesser 
as compared to its iodine relative. So far the only brominating reagent used for 
these tandem reactions to heteroaromatics is NBS (Scheme 1.16). In the first 
example, Rao’s group reported the NBS-mediated synthesis of 2-aminothiazoles 
by coupling thiourea and β-ketoesters. (Scheme 1.16, top) [184]. This interesting 
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Scheme 1.16: Synthesis of and thiazoles and imidazo[1,2-a]pyridines employing 
NBS. 
 
transfer reagent. However only 5 examples were shown in the scope of reaction, 
and no examples of other 1,3 dicarbonyls like β-diketones and β-diketoamides 
and other substituted thioureas like N-phenylthiourea or N-acetylthiourea. It 
could be the scope of reaction is limited due to the limited solubility of certain 
substrate scope in water and also steric constraints brough about by the inclusion 
size of the supramolecular host. In another interesting example, Shinde et al. 
reported the NBS-assisted synthesis of imidazo[1,2-a]pyridines by coupling 
styrene and 2-aminopyridines (Scheme 1.16, top) [185]. This protocol uses water 
both as a substrate and solvent. The NBS and water is both needed to form the α-
bromoacetophenone intermediate, The 2-aminopyridine is then added, forming 9 
different examples of imidazo[1,2-a]pyridines with 72 to 89 % yields (Figure 
1.17). It is noted that only monosubstituted arylalkenes were suitable substeates, 
limiting the scope of this protocol.  




Figure 1.17: Proposed mechanism for NBS assisted synthesis of imidazo[1,2-
a]pyridines in H2O.. 
 
   It is to be noted that these are representative examples and are not exhaustive. 
Many other heteroaromatics are also synthesized employing the methods as 
described in this subchapter. As can be seen from these examples, a huge 
majority of the protocols employed for this tandem α-halogenation cyclization 
reaction to heteroaromatics employ overstoichiometric amounts of molecular 
Iodine and its derivatives including NIS, TBAI, hypervalent iodine reagents like 
PhI(OAc)2 and IBX, or a mixture of them. Majority of these protocols including 
a few which uses catalytic amounts of iodine reagents, require huge excess of 
hazardous peroxides as oxidants, which makes large scale applications not 
feasible. Futhermore, majority of them that employ these oxidative cyclization 
strategy suffer from low to moderate yields as redox reactions are known to be 
particularly less selective, thus a drawback In terms of redox economy. Little 
work has been done on bromine derivatives, perhaps due to perceived lower 
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reactivity as bromine is a weaker leaving group than iodine. The known two 
examples employ stoichiometric amounts NBS. Reactions employing N-
halosuccinimide are known to be highly exothermic in nature, thus limiting its 
use in large scale synthesis. With that in mind, more research should be put into 
finding alternative brominating agents. In this thesis, bromotrichloromethane 
CBrCl3 is used as an α-brominating reagent in the synthesis of imidazo[1,2-
a]pyridines via in situ α-bromination of 1,3-dicarbonyls and their derivatives, 
phenylacetones and phenylacetophenones. Unlike NBS, CBrCl3 have a relatively 
low boiling point and is easily removed by rotary evaporation, making this a 
synthetic advantage. It is hoped that this research on using CBrCl3 as an α-
brominating reagent opens up more areas in employing brominating reagents in 
the near future. 
 
1.6   Aims of the Project and Outline of the Thesis 
We have shown in Chapter 1.1.1 that multiple bond formations in one-pot 
coupling reactions for the synthesis of polysubstituted heterocycles have been a 
hot topic in recent years. This is motivated by the step economy realized when a 
cyclic skeletal backbone is constructed without the need for multiple steps. 
However, these protocols do still have shortcomings and can be improved, 
especially if these methods were to be employed for scaled-up synthesis. Current 
drawbacks include substrates that have to be prefunctionalized, work-up that 
requires several separate steps, expensive and/or toxic metal catalysts and 
ligands that need additional steps to be effectively removed from the reaction 
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mixture, also the use of oxidants like TBHP, NBS and NIS, that are highly 
exothermic and toxic, which will be hazardous when applied to a large scale.  
   We also demonstrated in Chapter 1.1.2 the versatility of 1,3-dicarbonyls as 
coupling partners for multiple bond formations in the synthesis of various 
heterocycles, which originated from their ambiphilic nature and the ease with 
which they can be functionalised to intermediates. Many 1,3-dicarbonyls, 
including their derivatives, phenylacetones and phenylacetophenones are also 
commercially available and are inexpensive. This implies that the synthesis of 
heterocycles with two or more substitutents (polysubstituted heterocycles) will 
be cheap as well, without the need for additional steps to synthesize substrates 
that are not commercially available. This is especially important in the 
development of biological assays, where the use of protocols that employ cheap 
and commercially available substrate could significantly reduce the number of 
steps and save time and money.  
   Thus, the aim of this project is to introduce new protocols that combine these 
two benefits by employing versatile, cheap and inexpensive 1,3-dicarbonyls and 
their derivatives as coupling partners for the one-pot multi-step synthesis of 
various heterocycles, using multiple bond formations etc. C-X/C-X (X = C, N, 
O) and tandem or multicomponent reactions. Our focus is on developing novel 
simple one-pot protocols for synthesizing polysubstituted heterocycles from 
inexpensive reagents of low toxicity with mild reaction conditions, whereever 
possible with high synthetic efficiency, balanced atom economy, step economy 
and redox economy. This should be done without compromising the product 
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yield significantly. The emphasis is on providing a minimalistic approach of 
employing simple and green alternatives, using as little reagents as possible 
without compromising yields. We also aim to find protocols with an expansive 
scope of reaction, employing substrates that are cheap and inexpensive. This is a 
step towards finding viable methods for applications in the development of 
biological assays and large scale production of these molecules in the food, 
fragrance and pharmaceutical industry. 
   For chapter 2, a green protocol for the solvent-free synthesis of 4H-pyrido[1,2-
a]pyrimidin-4-ones was employed using an air stable and moisture stable main-
group metal catalyst. With the help of 2-aminopyridine, which also functions as a 
Lewis base, the Bi(III) salt’s electrophilicity was enhanced, allowing it to be a 
stronger catalyst for this reaction, where other third row transition metals like 
Ni(II), Co(II) and Zn(II) failed. Bismuth is also essentially non toxic, being even 
less toxic than NaCl. This is thus a green approach for metal-catalyzed synthesis 
of heterocycles via C-X/C-X coupling. 
   In chapters 3 and 4, a new novel and simple CBrCl3-2-aminopyridine system is 
introduced as a brominating agent for activating α-carbons. This is a greener 
alternative to the ubiquitous methods in literature that employs iodination 
analogues that are toxic, or are highly exothermic like NIS, to hypervalent iodine 
regents like PhI(OAc)2 and (Bis(trifluoroacetoxy)iodo)benzene (PIFA), which 
are costly and may be required to be presynthesized. Catalytic iodination sources 
like TBAI and I2 still require an overstoichiometric amount of oxidants (usually 
2 to 10 equivalents) that are highly reactive including TBHP and 
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ditertbutylperoxide (DTBP) for oxidative coupling of substrates. These protocols 
are thus less green and atom economy, and due to the highly reactive oxidants 
employed, not suitable for scaled-up synthesis. CBrCl3 on the other hand is 
mildly toxic, if at all, easy to separate due to its low boiling point, with no 
requirements of any oxidants.  
      Chapter 5, provides a simple metal-free, oxidant-free multicomponent 
approach for the synthesis of polysubstituted pyrroles by employing 
commercially available and cheap 4Å MS to promote the reactions. 4Å MS can 
be recycled, which increases the applicability for scaled-up synthesis. This is a 
step forward as compared to similar multicomponent synthesis of pyrroles, 
which uses catalysts or promoters that are non recyclable like FeCl3, NiCl2 and 
iodine.  
   Chapter 6 provides an alternative synthesis of polysubstituted furans by 
employing an activated Br group to the terminal alkyne with the hopes of further 
expanding the scope of the reaction. CoCl2 is needed as catalyst before the 
reaction can proceed with high yield. The Br group can be easily attached to the 
terminal alkyne without the usage of the highly exothermic NBS, which also 
requires further purification step by column chromatography to remove the 
succinimide side product. Instead CBrCl3 can be employed, and no column 
chromatography is needed due to the low boiling point of the brominating agent. 
Indeed, the reaction was indeed milder, requiring short reaction times and no 
requirement of inert atmosphere with a more estensive scope of reaction.  
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   Last but not least, since most of these developed methodologies are new and 
recent, mechanistic studies were also conducted to lead to a better understanding 
of the reaction. Structure-activity relationshsips were also investigated to see 
how electronic, resonance or steric effects affects the reactivity of substrates in 
their respective reactions. Lastly, mechanisms have also been proposed for the 
formation of products and side products.  
 
In summary, the outline of the thesis is as follows: 
1. Bismuth-catalyzed synthesis of 4H-pyrido[1,2-a]pyrimidin-4-ones. 
- C-N/C-N coupling of β-ketoesters, amides or thioesters with 2-aminopyridines 
or 2-aminothiazoles.  
- 2-aminopyridines enhanced the Lewis acidity of Bismuth catalyst. 
- Effect of type of solvents on the extent of keto-enol tautomerization and their 
ability to disrupt Lewis acid - Lewis base interactions via competing H-bonding.  
- Mechanistic studies done on β-diesters, 1,3-diketones and ethyl diacetoacetate. 
- Proposed mechanism for formation of desired product and side products. 
 
2. Transition metal-free synthesis of imidazo[1,2-a]pyrimidines using 2-
aminopyridine as an α-bromination shuttle.  
- C-N/C-N coupling of β-ketoesters, amides or 1,3-diketones with 2-
aminopyridines, 2-aminoquinolines or 1-aminoisoquinolines. 
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- Bifunctional role of 2-Aminopyridine as a substrate and an α-bromination 
shuttle. 2-aminopyridine is involved in transferring of the Br atom from CBrCl3 
to the α-carbon of the 1,3 dicarbonyl coupling partner.  
- Effect of bicarbonate salt on rection activity as compared to phosphate dibasic 
and monobasic salts, and also potassium salts as compared to sodium salts.  
- Illustrating benzyl acetoacetate as a poor substrate, due to presence of multiple 
α hydrogens. 
- Mechanistic studies conducted to prove reaction proceeded via radical pathway 
and that 2-aminopyridine is not acting as a base in the reaction. 
- Reaction mechanism proposed for desired product and side products. 
- NMR studies for further proof of α-brominating shuttle hypothesis. 
 
3. Transition metal free synthesis of 2-phenylimidazo[1,2-a]pyrimidines and 
2,3-diphenylimidazo[1,2-a]pyridines using 2-aminopyridine as an α-
bromination shuttle.  
- C-N/C-N coupling of phenylacetones, phenylacetophenones or β-tetralones 
with 2-aminopyridines, 2-aminothiazoles, 2-aminoquinolines or 1-
aminoisoquinolines. 
- Working model to illustrate steric effect of having methyl substituent on the 6-
position of the 2-aminopyridine moiety and its effect on reaction activity. 
- Comparing reactivity of 1,3-dicarbonyls, phenylacetophenones and 
phenylacetones as substrates for this reaction and relating their reactivity to the 
extent of keto-enol tautomerization. 
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- Reaction mechanism proposed. 
 
4. 4Å MS promoted metal-free synthesis of polysubstituted pyrroles via a 4-
component reaction. 
- C-C/C-N coupling of aldehydes and nitromethane with C-C/C-N coupling of 
amines and 1,3-dicarbonyls.  
- Kinetic study done to determine role of 4Å MS in the reaction. 
- A reaction mechanism is proposed that illustrates how 4Å MS promotes the 
reaction by converting aldimine back to its substrates. 
- Inductive effects: Electronwithdrawing substitutents on anilines slows done rate 
of reaction significantly.  
- Resonance effect: Benzaldehydes more reactive substrates than aliphatic 
aldehydes due to stability of intermediate formed (E)-nitrostyrene derivatives. 
 
5. Co(II) catalyzed synthesis of polysubstituted furans via π-π activation. 
- C-C/C-O coupling of β-ketoester, β-ketoamide or β-diketones with 
(bromoethynyl)benzene derivatives.  
- Investigation of steric effect of tert-butyl groups and iodide, on reaction yield.  
- Mechanistic studies with phenylacetylene, silver phenylacetylide and methyl 2-
bromoacetoacatete to disprove certain hypothesis. 
- Proposed mechanism shown, illustrtating the π-π activation with a working 
model. 
- UV studies done to have some qualitative proof of the hypothesis.  
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A Novel and Green Bismuth(III)-Catalyzed Solvent-Free Synthesis of 
Polysubtituted 4H-Pyrido[1,2-a]pyrimidin-4-ones* 
 
2.1   Introduction 
4H-pyrido[1,2-a]pyrimidin-4-ones are an important class of heterocyclic 
compounds possessing privileged scaffolds that fulfill Lipinski’s rule of fives for 
orally active drugs with good bioavailability [1, 2]. Lipinki’s rule of fives states 
that an orally active drug should not violate more than one of these conditions: 
the molecules should have no more than 5 hydrogen bond donors, no more than 
10 hydrogen bond acceptors, a molecular mass of less than 500 Daltons and an 
octanol-water partition coefficient, log P [3] of not more than 5. Thus, it is not 
surprising that there are several derivatives of compounds bearing the 4H-
pyrido[1,2-a]pyrimidin-4-one backbones, with diverse biological activities [4-6]. 
This skeletal structure can be found in drugs with anti-allergic [7,8], anti-
proliferative and anti-tumour [9, 10], anti-depressant [11], anti-hypertensive [12], 
anti-malarial [13], anti-microbial [14], anti-oxidant [15], anti-psychotic [16,17], 
anti-ulcerative [18], tranquillizing [19], and analgesic [20] properties as well as a 
human leukocyte elastase inhibitor (Figure 2.1) [21]. Compounds with similar 
4H-pyrido[1,2-a]pyrimidin-4-one backbones have also been used as 
photographic sensitizers, curing agents for polyisocyanates, dyes for acrylic 
nylon and polyester fibres [22], organic blue-emitting compounds [23] and as 
synthetic intermediates [22].  




































(human leukocyte elastase inhibitor)
N
   
Figure 2.1: Drugs possessing the 4H-pyrido[1,2-a]pyrimidin-4-ones skeleton. 
   
   4H-pyrido[1,2-a]pyrimidin-4-ones are traditionally constructed from 2-
aminopyridines and β-ketoesters but the main drawback is the requirement of 
high reaction temperatures of 150 – 200 °C and corrosive Brønsted acids like 
polyphosphoric acid, sulfuric acid and phosphoryl chloride [24, 25]. Cassis et al. 
then introduced a non-corrosive synthesis of 2-aminopyridines with Meldrum’s 
acid. However, a high temperature of 250 °C is still required [26]. Other groups 
have tried substituting β-ketoesters with (2-alkoxymethylene)malonic esters, 3-
alkoxy acrylic esters, succinic esters and glutaric esters [27, 28]. However, these 
alternative substrates are not commercially available and require additional steps 
for their synthesis. Recent methods allow for lower reaction temperatures but 
still require harsh acidic conditions or activated starting materials that have to be 
synthesized [29-32]. Bonacorso et al. proposed a method of forming 4H- 
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pyrido[1,2-a]pyrimidin-4-ones using β-alkoxyvinyl trichloromethyl ketones and 
2-aminopyridines under reflux in ethanol, but the method suffers from low to 
moderate yields of up to 81 % only [33]. A solid-phase synthesis of 4H-
pyrido[1,2-a]pyrimidin-4-ones that could be carried out at 90 °C has been 
reported, but it still required the use of corrosive acetic acid as a cosolvent 
together with the high boiling point solvent, dimethyl formamide (DMF), and 
also needed long reaction times of 16 h [34]. The use of activated 1,4-enediones 
and Cu(OAc)2·H2O as catalyst enabled the synthesis of 4H-pyrido[1,2-
a]pyrimidin-4-ones at 80 °C with good to moderate yields of up to 91 % after 6 h 
[35]. Most recently, the reaction of arylidenemalonitriles with 2-aminopyridines 
using CuI as catalyst and stoichiometric amounts of tert-butyl ammonium 
bromide (TBAI) as additive, under O2 atmosphere, has been reported as a 
convenient way to synthesize 4-oxo-pyrido[1,2-a]pyrimidine-3-carbonitriles 
containing the 4H-pyrido[1,2-a]pyrimidin-4-one structure moiety [36].  
   We envisioned that by replacing corrosive Brønsted acids with mild, moisture- 
and air-stable Lewis acids like Bi(OTf)3 and BiCl3, the reaction between 2-
aminopyridines and β-ketoesters could proceed under more benign conditions 
and provide a more environmentally friendly route. Bismuth catalysis has gained 
attention over the past decade due to an increasing focus on green chemistry [37-
39]. Although bismuth is a heavy metal, it is non-carcinogenic [40]. Bismuth 
salts are non-toxic with a lower toxicity than NaCl [41]. They are cheap, readily 
available and easy to handle, being moisture- and air-stable. Thus, in this 
chapter, we evaluate the use of bismuth(III) salts as catalysts in this C-N/C-N 
67 
 
bond formations via a series of tandem reaction, forming various polysubstituted 
4H-pyrido[1,2-a]pyrimidin-4-ones are formed from cheap and commercially 
available starting materials like 2-aminopyridines and their derivatives together 
with β-ketoesters and their derivatives (Scheme 2.1). Motivated by the fact that 
many 4H-pyrido[1,2-a]pyrimidin-4-ones possess biological activities, we aim to 
develop an easy synthetic route to a wide variety of polysubstituted 4H-
pyrido[1,2-a]pyrimidin-4-ones for biological assays.  
 
 
Scheme 2.1: Retrosynthesis of 4H-pyrido[1,2-a]pyrimidin-4-ones. 
 
2.2   Experimental 
2.2.1   General Information  
Thin layer chromatography (TLC) was performed using TLC silica gel 60 F254 
glass plates. Silica gel 60 (230 – 400 mesh) was used for column 
chromatography. The 1H NMR and 13C NMR of samples in CDCl3 or DMSO-d6 
were measured using a Bruker Avance 300 (AV300) spectrometer with 
tetramethylsilane (TMS) as an internal standard. For 1H NMR spectra, chemical 
shifts were reported in ppm (δ), multiplicity (s = singlet, d = doublet, t = triplet, q 
= quartet, m = multiplet) and coupling constant (Hz). Detection of compounds by 
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gas chromatography and gas-chromatography-mass spectrometry was performed 
using an Agilent 6890N gas chromatograph equipped with a HP-5 column and an 
FID detector for the former. Low resolution mass spectrometry measurements 
were recorded on Thermo-Finnigan LCQ mass spectrometer, while high 
resolution mass spectrometry (HRMS) measurements were done by a technician 
using Bruker micrOTOFQII, both under ESI mode. 
 
2.2.2   Materials 
The following chemicals were obtained from Alfa-Aesar, Sigma-Aldrich, GCE 
chemicals and TCI and used as received: BiCl3, Bi(OTf)3, Bi(OAc)3, methyl 
acetoacetate and other 1,3-dicarbonyl derivatives, 2-aminopyridine and other 2-
aminopyridine derivatives.  
 
2.2.3   General Procedure for Synthesis of 4H-Pyrido[1,2-a]pyrimidin-4-ones 
A 5 mL round-bottomed flask was charged with methyl acetoacetate 2-1 (107.9 
µL, 1 mmol), 2-aminopyridine 2-2 (47.1 mg, 0.5 mmol) and BiCl3 (7.9 mg, 
0.025 mmol). The reaction mixture was stirred at 100 ˚C for 3 h. After cooling 
down to room temperature, the mixture was diluted with the minimum amount of 
ethanol necessary to subject the suspension to filtration. The filtrate was then 
purified by column chromatography over a very short column, using ethyl 





2.2.4   Procedure for Scaled-up Synthesis of 4H-Pyrido[1,2-a]pyrimidin-4-ones. 
Procedure is similar to that of 2.2.2 but at a 15 mmol scale. Ethyl 2-benzyl-3-
oxobutanoate is used in placeof 2-1, in a 50 mL round-bottomed flask and stirred 
for 5 h instead. Column chromatography conducted using ethyl acetate and 
hexane (v/v = 2/3) as eluent and further recrystallization with ethanol, providing 
2-3ma as white needle-like crystals in 89 % yield. 
 
2.3   Results and Discussion 
2.3.1   Optimization 
In Chapter 2.3.1, a series of optimization reactions were conducted to find the 
optimized conditions to be used during scope of reaction. We begin the study by 
using, 5 mol% Bi(OTf)3 as the catalyst, running the reaction at 100 °C for 8 h. 
 
2.3.1.1 Solvent Effect 
The solvent effect on the reaction between methyl acetoacetate 2-1 and 2-
aminopyridine 2-2 was first investigated (Table 2.1, entries 1 - 5). The best result 
was achieved with the non-polar solvent toluene, with 88 % yield. On the other 
hand, both polar aprotic and polar protic solvents were less suitable for this 
reaction, and proceeded in all cases with low yields. This implies that polar 
solvents affect the ability of the dinucleophile 2-2. It is possible that H-bonding 
occurs between the hydrogen bond donors and acceptors of polar solvents and 
that of both nitrogen atoms of the aminopyridine 2-2, thereby reducing their 
ability to act as a Lewis base for activation of the catalyst (Scheme 2.2). 
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5 mol% Lewis acid
+ MeOH + H2O
 
Entry Solvent Catalyst T (° C) t (h) Yield (%)b 
1 Dioxane Bi(OTf)3 100 8 37 (28) 
2 NO2Me Bi(OTf)3 100 8 38 (28) 
3 H2O Bi(OTf)3 100 8 41 (35) 
4 EtOH Bi(OTf)3 100 8 18 
5 Toluene Bi(OTf)3 100 8 88 (85) 
6 - Bi(OTf)3 100 8 100 (100) 
7 - - 100 8 Traces 
8 - Bi(OAc)3 100 8 21 (10) 
9 - BiCl3 100 8 100 (99) 
10 - BiCl3 100 5 99 (98) 
11 - In(OTf)3 100 5 90 (88) 
12 - InCl3 100 5 Traces 
13 - ZnCl2 100 5 0 
14 - NiCl2 100 5 0 
15 - CoCl2 100 5 0 
16 - BiCl3 100 3 97 (95) 
17 - BiCl3 100 1 85 (82) 
18 - BiCl3 80 3 75 (70) 
19 - BiCl3 50 3 52 (46) 
a) Reaction conditions: 2-2 (0.5 mmol), 2-1 (2 equiv.) and Lewis acid (0.025 mmol) in 4 mL 
solvent. b)  Yield determined by GC analysis. Isolated yields are in parenthesis.  
 
 
Solvent-free bismuth catalyzed reactions had been reported in the literature [42-








indeed proceeded with >99 % yield (Table 3.1, entry 6). In neat form, only 8 % 
of 2-1 exists in the enol form, explaining its high reaction reactivity [47].    
 
2.3.1.2 Effect of Type of Lewis Acids 
   A blank reaction was conducted without catalyst and only traces of 2-3aa were 
formed, confirming that Bi(III) salts are necessary to catalyze the reaction (Table 
2.1, entry 7). Other Bi(III) salts were also screened for the reaction and BiCl3 
was found to give >99 % yield of 2-3aa (Table 2.1, entries 8 – 10). Other metal 
salts were also tested in this reaction. Reaction with In(OTf)3 proceeded with 
high yield whereas its chloride formed only traces of product. It seems that the 
counteranion plays an important role in terms of reaction yield. On the other 
hand, no products were observed with transition metal salts such CoCl2, NiCl2 
and ZnCl2 as catalyst (Table 2.1, entries 11 – 15). These results agree with the 
theory of Lewis base activation by main group Lewis acid salts as explained in 
Chapter 1.2, whereby Lewis bases increase the electrophilicity of a main group 
Lewis acid due to a spillover effect, and a more electron withdrawing counter 
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anion increases this effect and thus enhances the Lewis acidity [48, 49]. Because 
of its much lower cost compared to Bi(OTf)3, BiCl3 was chosen as the preferred 
catalyst for further optimization studies. 
 
2.3.1.3 Fine-tuning of Reaction Conditions 
   Reducing the reaction time from 8 to 3 h did not affect the reaction, but a 
further decrease to 1 h resulted in a significant drop in 2-3aa yield to 85 % 
(Table 2.1, entries 9, 10, 16, 17). Lowering the reaction temperature from 100 to 
80 °C and further to 50 °C led to a reduction in yield to 75 and 52 %, 
respectively (Table 2.1, entries 10, 18, 19). Hence, the optimized conditions 
under which the reaction can be carried out with acceptable yields of 2-3aa using 
0.5 mmol of aminopyridine 2-2, two equivalents of methyl acetoacetate 2-1, and 
5 mol % BiCl3 (relative to 2-2) as Lewis acid catalyst, in neat, at 100 C for 3 h.  
 
2.3.2   Scope of Reaction 
Next, the scope of the reaction was investigated using the optimized conditions 
(Table 2.2). Excellent yields were obtained when β-ketothioesters and β-
ketoamides were reacted with 2-2 (Table 2.2, 2-3aa’’ and 2-3aa’’’). The reaction 
also proceeded well with ethyl carboxylates of β-ketoesters (Table 2.2, 2-3aa’). 
Bulky R1 substituents at the C-2 position were well tolerated and the reactions 
proceeded with good to excellent yields. However, a slightly lower yield was 









100% 2-3aa' (R3 = OEt)
99% 2-3aa'' (R3 = SEt)








































































































































[a] Reaction conditions: 2-2 (0.5 mmol), 2-1 (1.0 mmol) and BiCl3 (0.025 mmol) in neat at 100 °C 
for 3h. Percentage isolated yields. [b] The ethyl carboxylate derivative is used instead of the 
methyl carboxylate. [c] Reaction is done in 4 mL toluene. 
 
   Interestingly, diethyl 3-oxopentanedioate and diethyl oxalpropionate were also 
suitable substrates for this reaction, with good yields of 2-3fa and 2-3ga 
respectively. With ethyl 4-chloroacetoacetate as substrate, dilution with toluene 
is neccesarry (Table 2.2, 2-3ha) because under solvent-free conditions, the -Cl 
group was replaced by an -OEt moiety, via an SN2 reaction (Scheme 2.3). 
   Good yields were also obtained with a strong electron withdrawing R1 
substituent like CF3 at the C-2 position (Table 2.2, 2-3ia). Even with a R2  
 
 
Scheme 2.3: Comparison between solventless reaction of 2-1h with 2-2 (top) 
and dilution with toluene (bottom). 
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substituent at the C-3 position, the reaction still proceeded with excellent yields 
(Table 2.2, 2-3ja - 2-3ma). Comparing 2-3ea and 2-3la, introducing a bulky 
substituent at the C-3 position affected the reaction more compared to C-2 
position of the desired product. Cyclic β-ketoesters with five to seven membered 
rings were also accepted as substrates in the reaction, and formed the respective 
products in good to excellent yields (Table 2.2, 2-3na - 2-3pa).  
   Several substituted 2-aminopyridines and the sulfur-containing heterocyle, 
thiazole, were also screened using the optimized conditions. Excellent yields 
were obtained with a methyl substituent at C-3, C-4, C-5 and C-6 position of 2-
aminopyridine and similarly results were also observed for an ethyl group at the 
C-4 position (Table 2.2, 2-3ab - 2-3af). Substrates bearing a halogen substituent 
at the C-5 position also gave high yields of 95 – 97 % (Table 2.2, 2-3ag - 2-3aj). 
The reaction tolerates also a -OH and -CO2Et group at the C-3 position, forming 
2-3ak and 2-3am with 97 and 86 % yield, respectively. However, only a 
moderate yield of 65 % of 2-3al was obtained when the strongly electron 
withdrawing -NO2 group was present at the C-5 position. 2-aminothiazole was 
suitable as a substrate for the reaction, with a high yield of 94 % but only traces 
of 2-3an were formed with 2-aminopyrimidine as the substrate.  
 
2.3.3   Mechanistic Studies 
In Chapter 2.3.3, a series of reactions were conducted to obtain a better 




Scheme 2.4: Mechanistic studies of the reaction between 2-2 with various 1,3-
dicarbonyls. [a]Yield calculated using GC. [b] Isolated yields. [c] Molecular weight 
determined by GC-MS. 
 
 
2.3.3.1 Studies on 1,3-Dicarbonyl Moiety 
In the first study, 2-aminopyridine 2-2 were reacted with other 1,3-dicarbonyls, 
including acetyacetone 2-4, dimethyl malonate 2-5 and ethyl diacetoacetate 2-6 
using 5 mol % BiCl3 in a neat reaction at 100 °C.  
   Reaction of 2-2 with 2 equivalents of 2-4 does not produce any cyclized 
product but interestingly formed the acylated side product 2-4a in moderate 
yields and the β-enaminone product 2-4b. Lewis acids like Bi(OTf)3, Fe(OTf)3 
and Yb(OTf)3 have been known to catalyze formation of (Z)-β-enaminones from 
aromatic amines and 1,3-diketones at room temperature [50-54]. It is thus 
interesting to see a preference of 2-4a compared to 2-4b at elevated 
temperatures. Also, reaction of 2-2 with 2 equivalents of dimethyl malonate 2-5 
produced traces of cyclised product 2-5a. 
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   Assuming that the mechanism was similar to that of a previously published 
Bi(III)-catalyzed formation of coumarins from phenols and β-ketoesters [55], it 
was initially thought that the reaction might proceed via a Pechmann 
condensation reaction, whereby the pyridine N atom attacks the ester group of 
the β-ketoester, forming an amide intermediate, follwed by a nucleophilic attack 
of the -NH2 group on the ketone moiety of the β-ketoester to form the cyclized 
product [56]. However, reactions A and B (Scheme 2.4) make us believe that the 
more electrophilic ketone group is favoured for the initial attack, rather than the 
ester group, and thus a different mechanism has to be proposed. Last but not 
least, reaction of 2-aminopyridine 2-2 with 2 equivalents of ethyl diacetoacetate 
2-6 interestingly produced both 2-4a and 2-3aa. This supports the hypothesis that 
the presence of two acetyl groups at β-position from each other causes acylation 
at the -NH2 group. Removal of the acetyl group from 2-6 then formed the ethyl 
acetoacetate, which reacts with the remaining 2-2 to form 2-3aa. 
 
 2.3.3.2 Studies on the Aminopyridine Moiety 
One trend observed in the scope of reaction was that the reaction was not tolerant 
of 2-aminopyrimidine as a substrate (Table 2.2, 2-3an) and that 2-amino-5-
nitropyridine reacted rather sluggishly to form 2-3al in only 65 % yield. For the 
former, this could be due to the inductive effect of the additional N-atom on the 
pyrimidine ring, which causes a mutual reduction of the Lewis basicity of both 
pyrimidine N atoms. Moreover, for the latter, a strong electron withdrawing -
NO2 group could also pull significant electron density away from the N-atom of 
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the pyridine ring, reducing its Lewis basicity abililty. These inductive effect is 
however less pronounced compared to that of 2-aminopyrimidine as the 
magnitude of the inductive effect decreases significantly with distance. 
 
2.3.4   Proposed Mechanism 
A plausible mechanism for the reaction is proposed (Figure 2.2). 2-
aminopyridine is activated by BiCl3 by coordination via the more basic pyridine 
N atom, forming a Lewis acid ‒ Lewis base adduct A. This increases the 
elctrophilicity of the catalyst, due to the spillover effect. Previous Bismuth-
catalyzed examples in literature which employs pyridine and its derivatives as 
additives to promote reaction efficiency has been reported as well [57-58]. 2-1 
also binds to Bi metal center. This is followed by a nucleophilic addition by the -
NH2 group on the ketone moiety of 2-1, which is activated by the 
hyperelectrophilic Lewis acid, then ensues, forming C. Another 
hypernucleophilic Cl then abstracts the acidic α-hydrogen of the β-hemiaminal-
ester intermediate, releasing HCl. Transfer of an oxygen atom to the Bismuth 
metal center follows. This generates bismuth oxychloride intermediate D and 
also releases intermediate E. The catalyst can then be regenerated via the reaction 
of D with the 2 equivalents of HCl released during the reaction, and the catalytic 
cycle is repeated. This reaction of converting bismuth oxychloride to bismuth 
trichloride is an equilibrium reaction and has been reported since the early 20th 
century, and has even been applied to undergraduate lab practical to demonstrate 























































Figure 2.2: Proposed mechanism. 
 
Finally, intermediate E undergoes a ring-closing condensation reaction releasing 
methanol and forming the desired product 2-3aa. Mechanism for reactions A, B 
and C in Scheme 2.4 will be shown in appendix. To prove that intermediate D is 
indeed the active species in the reaction and can be regenerated to BiCl3, a 
80 
 
control test was conducted using BiOCl as the catalyst, with added concentrated 
acid HCl (Scheme 2.5). 4 Å molecular sieves were added, to remove water 
during the reaction and drive the equilibrium towards the formation of BiCl3. 87 
% of desired product 2-3a indeed gives us further proof that intermediate D is 





Scheme 2.5: Control reaction using intermediate D, BiOCl and HCl. [a]Isolated 
yield.  
 
2.3.5   Scaled-up Synthesis 
With a wide scope of reaction, it had now to be tested if the reaction could be 
done at a preparative scale. Thus, to further explore the usefulness of this novel 
method, the synthesis of 2-3ma was scaled-up using 1.41 g (15 mmol) of 2-2 and 
6.38 ml (30 mmol, 2 equivalents) of ethyl 2-benzyl-3-oxobutanoate (Scheme 
3.6). An isolated yield of 3.34 g (89 %) of white needle-like crystals of 2-3ma 
was obtained after work-up, purification via column chromatography and 




Scheme 2.6: Scaled-up synthesis of 2-3ma. 
 
2.4 Conclusion 
In summary, an effictive new method of synthesizing privileged polysubstituted 
4H-pyrido[1,2-a]pyrimidin-4-ones backbones using BiCl3 as catalyst has been 
developed. The reaction works well with a wide spectrum of cyclic and acyclic 
β-ketoesters in combination with 2-aminopyridine substrates with both electron 
withdrawing and electron donating groups. Both substrate classes are cheap and 
commercially available. Excellent yields are obtained with short reaction times 
under mild reaction conditions without the need for any solvent or for an inert 
atmosphere. Because the reaction forms only water and alcohol as co-products, it 
can be classified as a green reaction with relatively high atom efficiency. Thus, 
we achieved our aim to develop a simple and easy synthetic route, using minimal 
reagents and cheap substrates, to construct a wide variety of polysubstituted 4H-
pyrido[1,2-a]pyrimidin-4-ones for applications in biological assays. The 
proposed mechanism involves a Lewis base-activated Lewis acid catalysis 
similar to that proposed by Denmark [50], whereby the main group metal 
catalyst BiCl3 is activated by one of its substrate 2-2, before a tandem 
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A Novel Transition Metal-Free One-Pot Synthesis of Polysubstituted 
Imidazo[1,2-a]pyridines Using 2-Aminopyridines as an α-Bromination 
Shuttle.* 
 
3.1     Introduction 
Imidazo[1,2-a]pyridines are an important class of fused heterocyclic compounds 
having a privileged scaffold that fulfill Lipinski’s rule of fives for drugs with 
good oral bioavailability[1]. This backbone can be found in compounds with a 
wide spectrum of biological activities including antifungal [2], antiproliferative 
[3], anti-inflammatory [4], antiulcer [5], antiapoptotic [6], and antiviral 
properties [7]. 
   Several drugs containing the imidazo[1,2-a]pyridine framework have been 
developed, including zolpidem[8] for treatment of insomnia,  alpidem and 
saripidem [9] which are drugs to treat anxiety, olprinone [10] for treatment of 
acute heart failure, zolimidine [11] for treatment of peptic ulcers and miroprofen 
[12], an antiplatelet drug (Figure 3.1).  
 
Figure 3.1: Compounds possessing the imidazo[1,2-a]pyridines skeleton. 
* This chapter is based on a publication: Adv. Synth. Catal. 2015, 358, 364-369.. 
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Compounds bearing these imidazo[1,2-a]pyridines backbones are also known to 
be highly potent respiratory syncytial virus fusion inhibitors [13], mitotic kinesin 
inhibitors [14], and have also been developed as potent GABAA receptor positive 
allosteric modulator [15]. There are even examples of applications of 
imidazo[1,2-a]pyridines in the field of material sciences [16]. 
   With such diverse properties, the synthesis of polysubstituted imidazo[1,2-
a]pyridines has attracted the interest of both organic and medicinal chemists over 
the last decade [17]. The majority of routes that have been explored involve the 
condensation of 2-aminopyridines with either α-diazoketones [18], 1-bromo-2-
phenylacetylenes [19], α-haloketones [20], or nitroolefins [21]. There are also 
examples of multicomponent reactions involving 2-aminopyridine and 
aldehydes, together with isonitriles [22] or alkyne [23]. Recently, oxidative 
coupling has been employed for the synthesis of imidazo[1,2-a]pyridines 
coupling 2-aminopyridines with alkenes [24], alkynes [25] or ketones [26], using 
readily available substrates and catalysts.  
   The reaction between 2-aminopyridines and α-halocarbonyl or α-halo-1,3-
dicarbonyls is a very practical method with wide range of applications in both 
medicinal chemistry and drug synthesis [27 - 29]. However, most of these α-halo 
substituted compounds are expensive or are not commercially available. Thus, an 
additional halogenations step is required for their synthesis, and separation and 
purification add to the cost of these starting materials.  
   In 2011, Yu’s group pioneered a protocol that allows the synthesis of 
imidazo[1,2-a]pyridines from 2-aminopyridines and unfunctionalized 1,3-
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dicarbonyls [30]. In his reaction, phenyliodine diacetate (PIDA) was used as an 
oxidant, together with BF3·Et2O as a catalyst. α-Iodination of the β-ketoester 
occured in situ, forming the intermediate. This intermediate then reacts with 2-
aminopyridine to form various examples of imidazo[1,2-a]pyridines. Yu’s group 
also proposed an alternative synthetic route employing tert-butyl hydroperoxide 
(TBHP) as an oxidant instead. Here, the tetrabutylammonium iodide (TBAI)-
BF3·Et2O system was employed as the catalyst [31]. The main drawback of this 
reaction is the long reaction times of 9 to 48 h, and the isolated yield never 
exceeded 83 %. Moreover, the use of the highly toxic BF3·Et2O and highly 
reactive oxidant TBHP makes the reaction unsuitable for large scale synthesis. 
   In contrast to these methodologies, we devise a simple oxidant-free strategy 
using CBrCl3 as cosolvent and source of Br with 2-aminopyridine as an α-
bromination shuttle (Figure 3.2). To the best of our knowledge, this is the first 
example where the substrate is used as a Br shuttle, transferring the Br atom to 
another substrate molecule before initiating a domino reaction which ultimately 
forms the cyclized product.  
   In this chapter, the development of a one step and one-pot transition-metal-free 
synthesis of imidazo[1,2-a]pyridines from 2-aminopyridines and 1,3-dicarbonyls 
is described. A retrosynthetic analysis for the construction of the bicycle is 
shown in Scheme 3.1. In this unique reaction, the 2-aminopyridines are not only 




Figure 3.2: 2-Aminopyridine acting as an α-bromination shuttle, transferring Br 
atom from CBrCl3 to the alpha carbon of 1,3-dicarbonyls. 
    
 
 
Scheme 3.1: Retrosynthesis of imidazo[1,2-a]pyridines. 
 
to the α-carbon of 1,3-dicarbonyls (Figure 3.2). In this way, they act as an α-
bromination shuttle. Because CBrCl3 has a relatively low boiling point, 105 oC, 
unreacted material can be easily separated from the reaction mixture. CBrCl3 is 
also of relatively low toxicity. These two properties make it a greener alternative 
compared to other brominating or iodinating reagents like N-bromosuccinimide 
(NBS) or N-iodosuccinimide (NIS), which are not only toxic and undergo highly 
exothermic reactions, but also require additional steps for separation via column 
chromatography due to their high boiling point. Because imidazo[1,2-a]pyridines 
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possess diverse biological activities, we aim to develop a aimple and easy one-
pot synthetic route to a wide variety of polysubstituted imidazo[1,2-a]pyridines, 
using minimal reagents and cheap substrates for development in biological 
assays and application in the industry. 
 
3.2     Experimental 
3.2.1 General Information 
The instrumental methods were the same as described in Chapter 2.2.1, with the 




The following chemicals were obtained from Alfa-Aesar, Sigma-Aldrich, GCE 
chemicals and TCI and used as received: CBrCl3, KHCO3, MeCN, methyl 
acetoacetate and other 1,3-dicarbonyls, 2-aminopyridine and their derivatives.  
 
3.2.3 General Procedure For Synthesis of Iimidazo[1,2-a]pyridines 
A 10 mL round-bottomed flask was charged with methyl acetoacetate 3-1 (107.9 
µL, 1 mmol), 2-aminopyridine 3-2 (94.1 mg, 1 mmol) and KHCO3 (110 mg, 1.1 
mmol and 2 mL of CBrCl3/MeCN solvent mixture (1/9 v/v, 2 equiv. CBrCl3 wrt 
3-1). The reaction mixture was stirred at 80 °C for 5 h. The mixture was then 
diluted with H2O and extracted with EtOAc (15 mL x 5). The combined organic 
layer was washed with brine and dried with anhydrous Na2SO4. After filtration, 
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the solvent was removed by rotary evaporation and the residue was cleaned up 
by column chromatography using ethyl acetate and hexane (v/v = 2/1) as eluent 
to afford 3-3aa in 95 % yield. 
 
3.2.4: Procedure for Scaled-up Synthesis of Imidazo[1,2-a]pyridines 
Procedure is similar to that of Chapter 3.2.3 but at a 15 mmol scale, using ethyl 
benzoylacetate instead of 3-1, in a 100 mL round-bottomed flask and reacted for 
7 h instead. Column chromatography was performed using hexane and ethyl 
acetate (v/v = 5/1) as eluent and further recrystallization with ethanol, affording 
3-3oa in 78 % yield as white crystals.  
 
3.3     Results and Discusion 
As shown in the retrosynthetic analysis (Scheme 4.1), it should be possible to 
construct the imidazo[1,2-a]pyridine bicycle from methyl acetylacetonate 3-1 
and aminopyridine 3-2. We assumed that a concerted α-bromination-
condensation reaction would form an α-bromo-hemiaminal. A nucleophilic 
attack then ensues, forming the 5-membered ring. Deprotonation of an acidic α-
proton is needed to complete the reaction and to establish the aromatic system.  
 
3.3.1 Optimization 
In Chapter 3.3.1, a series of optimization studies were conducted to obtain an 
optimized condition to be employed during the scope of reaction. 
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1 DME NaHCO3 8 38 35 (15) 3 
2 NO2Me NaHCO3 8 58 45 (29) 13 
3 MeCN NaHCO3 8 94 92 (85) 2 
4 DMF NaHCO3 8 85 83 (73) 2 
5 DMSO NaHCO3 8 0 0 0 
6 dioxane NaHCO3 8 8 8 0 
7 toluene NaHCO3 8 0 0 0 
8 MeCN - 8 98 63 (39) 0 
9 MeCN NaHCO3 5 77 77 (71) 0 
10 MeCN KHCO3 5 98 98 (97) 0 
11 MeCN K2CO3 5 98 69 (61) 0 
12 MeCN Na2HPO4 5 36 36 (14) 0 
13 MeCN K2HPO4 5 62 62 (47) 0 
14 MeCN KH2PO4 5 46 46 (34) 0 
15[d] MeCN KHCO3 5 99 99 (95) 0 
16[e] MeCN KHCO3 5 97 97 (93) 0 
17[f] MeCN KHCO3 5 66 66 (60) 0 
18[f],[g] MeCN KHCO3 5 68 68 (60) 0 
19[h] MeCN KHCO3 5 85 85 (81) 0 
[a] Reaction conditions: 3-1 (1.0 mmol), 3-2 (1.5 equiv) and base (1.1 mmol) in 2 mL of 1:9  
(v/v) CBrCl3/solvent mixture (2.0 mmol wrt CBrCl3). [b] Conversion (from GC) with respect to 
3-1. [c] Isolated yields in parenthesis. [d] 1.25 equiv. of 3-2 was used. [e] 1.0 equiv. of 3-2 was 
used. [f] Reaction carried out at 50 °C. [g] Ratio of CBrCl3/MeCN inceased to 2:9 (v/v) (4 equiv. 





3.3.1.1 Solvent Effect 
Initial studies were carried out to identify the best solvent for the reaction. 
Various solvent mixtures, always containing 10% v/v of CBrCl3 (2 equivalents, 
wrt 3-1), were first tested for the reaction between methyl acetoacetate 3-1 and 
1.5 equivalents of 2-aminopyridine 3-2, using NaHCO3 as a base additive at 
80 °C for 8 h (Table 3.1, entries 1 - 7). Two products were formed: 3-3aa is the 
major product whereas the N-acylated 3-4 is the minor product. While high 
yields of 3-3aa were obtained in polar aprotic solvents, non-polar solvents were 
found to be not suitable for this reaction (Table 3.1, entries 1-4, 6, 7). A highly 
polar solvent is needed to dissolve the inorganic base additives, implying the 
importance of base additives in this reaction. The only exception under the polar 
aprotic solvents is DMSO, which gave essentially no conversion. DMSO is 
known to be a radical scavenger, especially for hydroxyl radicals [32]. This 
might imply that the reaction proceeds or is initiated via a radical pathway and 
that DMSO quenches any radicals present, thus preventing the formation of 3-
3aa. The hypothesis that the reaction proceeds by a radical mechanism was 
tested further in the mechanistic studies described later. The highest yield of 3-
3aa, 92 %, was achieved with MeCN as solvent.  
 
3.3.1.2 Effect of Additives 
Without NaHCO3, the yield of 3-3aa dropped significantly (Table 3.1, entry 8). 
This is because of a competing reaction forming the side product 4H-pyrido[1,2-
a]pyrimidin-4-one. It was shown in Chapter 2 that the coupling of methyl 
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acetoacetate 3-1 with 2-aminopyridine 3-2 forms 4H-pyrido[1,2-a]pyrimidin-4-
ones, when catalyzed by Bronsted or Lewis acids [33-35]. Thus, by adding 
NaHCO3, the liberated HBr is neutralized, and the formation of this heterocyclic 
side product can be prevented, thus increasing the yield of 3-3aa. Next, a few 
basic alkali metal salts were screened as a base additive for the reaction (Table 
3.1, entries 9 - 14). These bases were choosen because of their ability to act as a 
buffer for the reaction, since the reaction is sensitive to Brønsted acid. These 
additives would also remove HBr released during the reaction. It was interesting 
to see that KHCO3 produced better yields than NaHCO3. Similarly, K2HPO4 also 
performed better than their corresponding Na+ salt, although the yield was 
significantly lower than both bicarbonate salts (Table 3.1, entries 12 and 13). In 
addition, K2CO3 produced lower yield as compared to KHCO3. 
   This implies that both the nature of the cation and anion of the additives plays 
an important role in increasing yield of 3-3aa. This will be investigated further 
and explained in the proposed mechanism sub-chapter. Comparing between the 
dibasic and monobasic salt of potassium phosphate reveals that the stronger base 
resulted in a higher yield of 3-3aa (Tale 3.1, entries 13 and 14).  
 
3.3.1.3 Fine-tuning of Reaction Conditions 
Reducing the concentration of 2-aminopyridine from 1.5 equivalents to a 
stoichiometric amount (1 equivalent) with respect to 3-1 did not affect the yield 
(Table 3.1, entries 10, 15 and 16). However, reducing the reaction temperature to 
50 °C reduces the yield significantly (Table 3.1, entry 17). Even increasing the 
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amount of CBrCl3 to four equivalents at a similar reaction temperature of 50 °C 
causes a huge drop in yield (Table 3.1, entry 18), implying that the generation of 
Br does not depend on temperature and is not the rate determining step. On the 
other hand, a later step of the mechanism may be the rate determining step. 
Reducing the number of equivalents of CBrCl3 from 2 to 1 reduces the yield of 
3-3aa significantly (Table 3.1, entry 19).  
  
3.3.2 Scope of Reaction 
Next, the scope of reaction was investigated using the optimized conditions 
(Table 3.2). The reaction tolerates a wide scope of β-ketoesters, including alkyl, 
cyclic and methoxyethyl acetoacetates, in most cases with excellent isolated 
yields (Table 3.2, 3-3aa - 3-3ga). The only exception is benzyl acetoacetate 
which when reacted with 2-aminopyridine 3-2, formed only traces of 3-3ra. This 
could be because it has additional acidic protons that could be brominated, 
instead of those at the α-carbon. This will lower the selectivity to the desired 
product (Figure 3.3). It is worth mentioning that no double bromination occurs in 
this CBrCl3-2-aminopyridine shuttle system. Good to excellent yields were 
obtained with β-ketoamides containing diethyl amine or pirperidine as R2 
substitutent (Table 3.2, 3-3ha - 3-3ja). Substitutents at the R1 position were also 
tested in the reaction, with good to excellent yields for both branched and linear 
aliphatic alkyl groups (Table 3.2, 3-3ka - 3-3ma). Sterically demanding tert-

















































































95% 3-3aa 97% 3-3ba 94% 3-3ca 91% 3-3da
95% 3-3ea 91% 3-3fa 92% 3-3ga 95% 3-3ha
95% 3-3ia 83% 3-3ja 94% 3-3ka 92% 3-3la
92% 3-3ma 93% 3-3na[b] 89% 3-3oa[b] 92% 3-3pa
84% 3-3qa[b] 92% 3-3ab 97% 3-3ac




























95% 3-3ah 85% 3-3ai[c] 88% 3-3aj[b]
95% 3-3ak[c] 87% 3-3al[c] 94% 3-3am[c]
Cl Br
 
[a] Reaction conditions: 3-1 (1.0 mmol), 3-2 (1.0 equiv) and KHCO3 (1.1 equiv) in 2 mL of 1:9 
(v/v) CBrCl3/MeCN mixture (2.0 equiv. wrt 3-1) at 80 °C for 5 h. Percentage isolated yields. [b] 










Figure 3.3: Benzyl acetoacetate having 4 acidic hydrogens can form two 
possible mono-brominated and one di-brominated intermediates. 
 
 
required longer reaction times of 7 – 10 h (Table 3.2, 3-3na - 3-3oa). Both 
acetylacetone and its cyclic derivative, 1,3 cyclohexanedione, reacted with 3-2 
under the optimized conditions to form 3-3pa and 3-3qa with proceeded with 





















   Various substituted aminopyridines were also tested in the reaction. The 
reaction is tolerant to methyl groups at C-3, C-4, C-5 or C-6 of the 2-
aminopyridine structural motif, proceeding with excellent yields. Even ethyl or 
dimethyl substituted 2-aminopyridines reacted smoothly (Table 3.2, 3-3ab - 3-
3ag). The reaction also tolerates both electron-donating and electron-
withdrawing substituents, including OMe, Cl, Br, and CO2Me but longer reaction 
times were needed when the aminopyridine contained an electron-withdrawing 
substituent (Table 3.2, 3-3ah - 3-3ak). Reactions of 3-1 with 2-aminoquinoline 
or 1-aminoisoquinolines also proceeded with excellent yields of 3-3al and 3-3am 
under the optimized conditions. 
 
3.3.3 Mechanistic Studies 
To gain some insights into the reaction mechanism, additional studies were 
performed (Scheme 3.2). There is some disagreement on the nature of α-
bromination of 1,3-dicarbonyls and their derivatives with CBrCl3 as brominating 
reagent. Meyers et al. reported that the α-bromination proceeded via a base-
initiated (KOH-tBuOH) radical anion-radical pair (RARP) mechanism [36]. 
However, an ionic mechanism has also been proposed [37]. To determine if the 
reaction proceeds via a radical or an ionic pathway, a series of experiments were 
conducted. Firstly, a radical scavenger, 2,2,6,6-tetramethyl piperidinoxyl 
(TEMPO), was added into a typical reaction using the optimized conditions 
(Scheme 3.2, reaction A, parts i and ii). Addition of 1 equivalent of TEMPO 




















80 °C, 5 h
3-1 3-2 3-3aa
*TEMPO
* i) 1 equivalent TEMPO: 3-3aa 52% Yield[c]



























i) 3-Aminopyridine 3-2': 3-4' 28% Yield[c]

















Scheme 3.2: Mechanistic studies to distinguish between a radical or ionic 
pathway (A and B), and to determine the role of KHCO3 and 3/4-aminopyridines 
as a base in the α-bromination reaction (C and D, respectively). [a]Reaction 
conditions: 3-1 (1.0 mmol) and/or 3-2/3-2’/3-2’’ (1.0 equiv) and KHCO3 (1.1 equiv) in 2 mL of 
1:9 (v/v) CBrCl3/MeCN (2.0 mmol wrt CBrCl3). [b]Reaction conditions: 3-1 (1 mmol) and 3-2 
(1.25 equiv) and KHCO3 (1.1 equiv) in 4 mL of 1:9 (v/v) CBrCl3/MeCN at r.t. for 10 h. [c]Yield 
determined by GC and M.W of 3-4’ and 3-4’’ determined by GC-MS. [d] Isolated yield. 
 
Secondly, the reaction mixture was subjected to UV irradiation (30 W, UVC) at 
room temperature (Scheme 4.2, reaction B). Gratifyingly, when the reaction 
mixture was worked up after 10 h, 3-3aa was obtained in 78 % isolated yield. 
These results provide support that the reaction proceeds via a radical pathway 
involving homolytic fission of the C-Br bond in CBrCl3 to CCl3• and Br•. This 
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can also occur under uv irradiation as CBrCl3 absorbs with maxima at 
approximately 140, 240 and 280 nm [38-42]. The addition of TEMPO reduces 
the concentration of Br• for α-bromination, thus lowering the yield of the 
product.    
   The α-bromination reaction using CBrCl3 is also investigated. Hori et al. 
reported the use of 1,8-diazabicyclo[5.4.0]-undecene-7 (DBU) to mediate the 
bromination of 1,3-dicarbonyl compounds with CBrCl3 [43], whereas Sasson’s 
group reported a quaternary ammonium fluoride-catalyzed bromination of 
similar functionalities [44]. To determine if the bromintion reaction is catalyzed 
by bases (KHCO3 or aminopyridine) in the reaction mixture, three sets of 
experiments were conducted. This is to determine if KHCO3, 3-aminopyridine 
and 4-aminopyridine could act as a base to brominate 3-1 at the α-position 
(Scheme 3.2, reactions C and D). However, no monobrominated or dibrominated 
products were observed in any of these experiments, ruling out KHCO3 and 3- or 
4-aminopyridine as bases for the α-bromination of 3-1. Interestingly, in the 
presence of 3- and 4-aminopyridines, the N-acylated side products 3-4’ and 3-4’’ 
were formed, albeit in low yields, whereas 2-aminopyridines formed no 3-4 
(Table 3.1, entry 9). The relative reactivity of isomers of aminopyridines (4-
aminopyridine > 3-aminopyridine > 2-aminopyridine) towards N-acylation via 
acetic anhydride in literature gives more evidence that having an -NH2 group at 
the 2 position from the pyridine N atom supresses the competing N-acylation 




3.3.4 Proposed Mechanism 
Based on the optimization studies, scope of reaction and mechanistic studies, a 
plausible mechanism for the synthesis of 3-3aa is proposed (Figure 3.4, 
mechanism A). The C-Br bond in CBrCl3 undergoes homolytic fission under UV 
irradiation or heat, forming CCl3• and Br• as part of the initiation step of chain 
radical mechanism. This is followed by 2 propogations steps: the attack of CCl3• 
on the N-H bond in 2-aimnopyridine, forming a radical on the amine N atom and 
a subsequent attack on another equivalent of CBrCl3, forming the N-brominated 
2-aminopyridine intermediate A and regenerating CCl3• radicals to continue the 
propagation step. A then rearranges to form intermediate B. On the other hand, 
3-1 undergoes keto-enol tautomerisation, with the enol form being the 
predominant tautomer, due to stabilization by intramolecular H-bonding. The 
enol tautomer of 3-1 then undergoes an additon reaction with B via concerted C-
Br and C-N bond formations. These bonds formed simultaneously via a 6-
membered transition state to form the bromo-hemiaminal intermediate C, 
transferring Br to the α-carbon. A similar intermediate has been proposed and 
proven with NMR studies by Lee et al. in the one-pot two-step synthesis of 3-
aryl imidazo[1,2-a]pyridines using N-iodosuccinimide (NIS) as the α-iodination 
source [46]. The group was able to isolate the intermediate as it would not 
cyclize without the presence of the bicarbonate additive. 2D NMR COSY and 
HSQC studies proved the formation of the structure. We believe that our 
intermediate C is the bromo derivative of this hemiaminal. Dehydration of C 
results in the α-bromo imine intermediate D. A ring-closing SN2-type of 
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nucleophilic attack at the α-carbon then forms E. Deprotonation of the most 




















































































Figure 3.4: Proposed mechanisms for the formation of 3-3aa (Mechanism A) 
including the propagation step of radical chain mechanism during initial 
bromination of 3-2 to intermediate A and the competing reaction for formation of 




   A proposed mechanism for the competing reaction of the formation of the N-
acylated side product is as follows (Figure 3.4, mechanism B). The NH2-group 
undergoes a nucloephilic addition on the ketone moiety of the β-ketoester, 
forming the hemiaminal intermediate F. This is followed by a 1,5 H shift, 
forming the N-acylated product 3-4 and releasing methyl acetate in the process.  
 
3.3.4.1 Effect of Basic Additives 
It was shown in subchapter 3.3.1.2 that the role of cation of the base additive 
seemed to play a significant role in terms of reaction activity. This is observed 
when the yield of desired product is significantly higher when potassium 
bicarbonate salts are used instead of the sodium (Table 3.1, entries 9 -10). This is 
also observed when comparing the yield of desired product for potassium 
phosphate dibasic and that sodium as well. As shown in mechanism A (Figure 
3.4), methyl acetoacetate 3-1 have to be in its enol form to be able to react with 
the N-brominated intermediate B. Only then can the cyclic 6π transition state 
form which is required for the transfer of Br to the α-carbon. As mentioned in 
Chapter 3.3.1.1, polar aprotic solvents like MeCN and DMF are the best solvents 
for the reaction, due to their ability in dissolving KHCO3 best. However, polar 
aprotic solvents can disrupt the intramolecular H-bonding of the enol form of 3-1 
as well, which could interfere in forming intermediate C, since these solvents are 
in large excess. However, cations such as Na+ and K+ could reduce this H-
bonding disruption via forming a more stable ion-dipole interaction with MeCN 
and thus promote the enol form further. This interaction will be stronger with the 
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more electropositive K+ ion, which could explain the increase in reactivity, 
compared to that of Na+ (Table 3.1, entries 9 and 10). 
   Another interesting observation is that both potassium and sodium bicarbonate 
salts fared significantly better than their respective phosphate dibasic and 
carbonate salts (Table 3.1, entries 9 - 13). As shown in mechanism A (Figure 
3.4), intermediate E has a very acidic α proton, due to its proximity to 3 
electronwithdrawing moieties, N atom of bicycle, ester and imine functionality. 
This will be drprotonated by the basic additive. Using a bicarbonate salt allows 
formation of H2CO3, which dissociate into H2O and CO2. The CO2 gas could 
then leave the system, providing a driving force to shift reaction towards product 
formation. It is noted however that the main driving force is still aromatization, 
and that extrusion of CO2 only provides additional driving force in addition to 
that of aromatization. For phosphate dibasic salts, protonation would form 
KH2PO4 salt instead of releasing any further molecules, thus no extra driving 
force, in addition to driving force from aromatization. Thus, it is possible to 
roughly gauge qualitatively the effect of the additional driving force by extrusion 
of CO2 on the yield of the desired product, by comparing entries 9 with 12 or 
entries 10 with 11 and 13 in Table 3.1.  
   Furthermore, using a potassium phosphate monobasic salt fared even 
significantly worst than the dibasic salt. A look at the pKb table at ambient 
conditions show that the pKb value for HPO42- is 6.8 whereas that of H2PO4- is 
11.85, which is a 5-fold difference in basic strength [47]. We feel that this 
difference would be smaller at reaction temperature of 80 °C and in MeCN. 
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However, it shows further support to the difference in reactivity of these two 
potassium phosphate salts.  
 
3.3.4.2 Effect of Position of NH2 Group of Aminopyridine on Side Reaction.  
It was seen in Scheme 3.2, reaction D that when 4-aminopyridine and 3-
aminopyridines are reacted with methyl acetoacetate 3-1 under optimized 
conditions, 35 % and 28 % of the N-acylated side product was formed. On the 
other hand, using 2-aminopyridine instead produced only small amounts of this 
side product compared to the desired product 3-3aa (Table 3.1, entry 10). As 
shown in mechanism B (Figure 3.4), the reaction begins with a nucleophilic 
attack of the NH2 group on the elcctrophilic ketone moiety. We feel that for 2-
aminopyridine, the probability of a nucleophilic attack on 3-1 (mechanism B) is 
low compared to the bromination step of mechanism A. Furthermore, for the 
NH2-group at the 2-position of the pyridine, there is an additional stabilization by 
the resonance with the pyridine N atom. Furthermore, the electronwithdrawing N 
pyridine atom could also inductively pull more electron density away from the 
NH2 group, further decreasing its nucleophilicity. In contrast, 3-aminopyridine 
cannot form such a transition state. Also, for 3 and 4-aminopyridine, the pyridine 
N atom is 2 and 3 carbon atoms away respectively, whereby inductive effect 
decreases effectively with distance. With these two factors in hand, therefore 3-
aminopyridine and 4-aminopyridine shows a higher tendency to undergo the 




3.3.5 NMR Studies 
   The only other possible pathway for the formation of the hemiaminal 
intermediate C is a direct nucleophilic addition of the -NH2 group of 
aminopyridine 3-2 to the ketone moiety of methyl acetoacetate 3-1, forming 
intermediate B prior to bromination at the α carbon of B, which then gives C 
(Scheme 3.3). To disprove this hypothesis, a typical reaction of 0.5 mmol 3-1 
with 0.5 mmol 3-2 was conducted using CD3CN, but without adding CBrCl3 at 




Scheme 3.3: The hypothesis of direct nucleophilic attack of NH2 on ketone 
moiety of 3-1 forming intermediate B before bromination forms intermediate C 
towards formation of desired product 3-3aa. 
 
 
   Both 1H and 13C spectrum showed that no visible reaction is occurring after 2 h 
of reaction at 50 °C. It implies that the reaction mixture contains only mixtures 
of methyl acetoacetate 3-1 and aminopyridine 3-2 in CD3CN. Thus, these results 
disprove the hypothesis presented in Scheme 3.3 and lend further support to the 
hypothesis that 2-aminopyridines are acting as substrate as well as α-bromination 




Figure 3.5: 1H NMR spectra of reaction between 3-1 and 3-2 in CD3CN as 
shown in Scheme 3.3. 
 
 
Figure 3.6: 13C NMR spectra of reaction between 3-1 and 3-2 in CD3CN as 
shown in Scheme 4.3. Peaks at 118 ppm and the multiplet at around 1ppm are 
solvent peaks (CD3CN). 
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4.3.6   Scaled-up Synthesis 
A scaled-up synthesis was conducted at a 15 mmol scale to confirm the 
versatility of this reaction and to demonstrate its application to the industry. The 
scaled up synthesis of ethyl 2-phenylimidazo[1,2-a]pyridine-3-carboxylate 3-3oa 
used 15 mmol of 3-1, 15 mmol of 3-2 with 1.1 equivalents of KHCO3 and 30 mL 
of 1/9 (v/v) CBrCl3/CD3CN solvent mixture and the reaction is heated up at 
80 °C and stirred for 7 h. (Scheme 4.4). An isolated yield of 78 % of white 
crystals of 3-3oa was obtained after work-up, purification via column 
chromatography and recrystallization with ethanol. 
 
 
Scheme 3.4: Scaled up synthesis of 3-3oa. 
 
3.4     Conclusion  
In summary, a new α-bromination system involving CBrCl3/2-aminopyridine has 
been developed and used for a transition-metal free one-pot synthesis of 
imidazo[1,2-a]pyridines via a direct C-N/C-N coupling of 2-aminopyridines and 
1,3-dicarbonyls. The 2-aminopyridine is not only a substrate for this reaction but 
is also essential as an α-bromination shuttle, transferring the Br atom from 
CBrCl3 to the α-carbon of the enol tautomer of the 1,3-dicarbonyl. This is 
followed by a series of tandem reactions, including dehydration and ring-closing 
SN2 type nucleophilic attack, forming isolated yields of 83 - 97 %. The role of 
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the KHCO3 is to absorb HBr, preventing the formation of side product 4H-
pyrido[1,2-a]pyrimidin-4-ones and also to drive the reaction forward to form the 
desired product, by producing CO2, that can then be removed from the system. 
This reaction has an extensive scope of reaction, and uses cheap commercially 
available starting materials and reagents, under mild reaction conditions, without 
the requirement of oxidants and highly exothermic halogenating reagents and 
with short reaction times and has been scaled up for larger scale synthesis. Thus, 
we achieved our aim to develop a simple and easy one-pot transition-metal free 
synthetic route to a wide variety of polysubstituted imidazo[1,2-a]pyridines with 
minimal usage of reagents and inexpensive substrates for applications in 
biological assays and industry.  
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A Novel Transition Metal-Free One-Pot Synthesis of Polysubstituted 3-
Phenylimidazo[1,2-a]pyridines and 2,3-Diphenylimidazo[1,2-a]pyridines 
Using 2-Aminopyridines as an α Bromination Shuttle. 
 
4.1   Introduction 
Phenylimidazo[1,2-a]pyridines belong to an important class of fused nitrogen-
containing heteroaromatics that have diverse biological properties [1]. They 
possess antiprotozoal [2], antipyretic [3], anticonvulsant [4], antileishmanial [5] 
and antimicrobial [6] activities. Phenylimidazo[1,2-a]pyridines are also used as a 
β-amyloid formation inhibitor [7], ligand for detecting β-amyloid plaques in 
brain [8],  benzodiazepine receptor agonist [9], cardiotonic agents [10] and as a 
bioisosteric allosteric modulator ligand of GABAA receptor [11]. Many 
pharmaceutical drugs containing aryl substituent(s) at either the 2 or 3 position, 
or both, of the parent imidazo[1,2-a]pyridines are commercially available. They 
include Necopidem [12] and TP-003 [13] (anxiolytic agents), Miroprofen 
(antiplatelet aggregation) [14] and Olprinone (cardiotonic agent) [15]. This is not 
surprising as these phenylimidazo[1,2-a]pyridines containing drugs fulfill the 
Lipinski’s rule of fives for orally active drugs [16]. 
   Recent developments have also found that the phenylimidazo[1,2-a]pyridine 
structural motif displays photophysical properties, resulting in its application in 
the field of material sciences [17-18]. They have also found application in the 
field of inorganic chemistry. Abnormal (N-heterocyclic carbene) NHC ligands 
bearing the phenylimidazo[1,2-a]pyridine moiety are used as carbene ligands for 
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Palladium, Iridium and Rhodium complexes [19-22]. With these examples, the 
potential of application of  these 3-phenylimidazo[1,2-a]pyridines and 2,3 
diphenylimidazo[1,2-a]pyridines to diverse areas of chemistry, make them 
attractive targets to synthesize.  
   The majority of protocols for the synthesis of derivatives of 
phenylimidazo[1,2-a]pyridines has been targeted towards 2-phenylimidazo[1,2-
a]pyridines. These reactions employ 2-aminopyridine as a dinucleophile, 
reacting with a dielectrophile partner, and futher cyclization of the intermediate 
forms the desired product. Various dielectrophiles have been employed (Figure 
4.1), ranging from α-haloacetophenones [23-24], α-diazoacetophenones [25], α-
tosylacetophenones [26-27], acetophenones with in situ halogenations [18, 28-
33], terminal alkynes [34], propargylic alcohols [35], ketone oxime ester [36], 
cinnamaldehydes [37], nitroolefins [38] and α-β unsaturated ketones [39-40].  
 

























Figure 4.1: Examples of various dielectrophiles reacting with 2-aminopyridine 
to form 2-phenylimidazo[1,2-a]pyridines. 
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   3-component reactions have also been employed to synthesize 2-
phenylimidazo[1,2-a]pyridines using 2-aminopyridines, benzaldehyde with a 
third coupling partner of either nitromethane [41-42], cyanide [43], isocyanide 
[44-45], alkyne [46-49] or cyclic 1,3-dicarbonyl [50]. 
   On the other hand, synthesis of 3-phenylimidazo[1,2-a]pyridines is 
comparatively less abundant in literature. These syntheses are generally more 
challenging and the substrate usually needs to be activated with a leaving group 
for the reaction to proceed with good yields. In 1996, Wegner et al. were the first 
to synthesize 3-phenylimidazo[1,2-a]pyridines using 2-aminopyridines and α-
bromophenylacetaldehyde, which was prefunctionalized in a separate step using 
Br2 [51]. This reaction suffers from long reaction time of 60 h and moderate 
yields of 54 %. In 2011, Zhou synthesize 2-Bromo-3-phenylimidazo[1,2-
a]pyridines using an NaHCO3 mediated reaction between 2-aminopyridines and 
(bromoethynyl)benzene in DMF solvent [52]. However, high reaction 
temperature of 120 °C and long reaction times of 24 h is needed. A protocol 
using the same substrate was also introduced by Jiang et al, albeit at a much 
lower temperature of 60 °C using Cu(OTf)2 as a catalyst [53]. On the other hand, 
Clegy’s group used an alkynyliodonium salt as the coupling partner, in a K2CO3 
mediated reaction, using fluorobenzene as solvent [54].  Liu et al. also develop a 
similar protocol with an alkyne activated by an ester group, using a co-catalytic 
system of Cu(II) and Fe(III) with pivalic acid additives, DMF/DMSO mixed 
solvent at 130 °C [55]. A common shortcoming of all these reactions is the need 
to prefunctionalize the activated acetylene, which requires additional steps. Other 
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drawbacks include high reaction temperatures, the need for transition-metal 
catalysts, high boiling point solvents like DMF and DMSO and also low to 
moderate yields of up to 80 %. 
   In view of these limitations, there was a need for a transition-metal free 
synthesis of 3-phenylimidazo[1,2-a]pyridines which will proceed under milder 
reaction conditions. Meshram pioneered this by employing DABCO as the 
catalyst using α-bromoacetophenones as the coupling partner of 2-
aminopyridines in aqeous media [56]. While this reaction occurs in a short 
reaction time of 1 h and has excellent yields of 93 %, the requirement of 
additional steps to α-brominate the aetophenone is still a step back. Park’s group 
then developed a protocol for a one-pot transition-metal free synthesis of 3-
phenylimidazo[1,2-a]pyridines using phenylacetaldehyde and 2-aminopyridines 
[57]. N-Iodosuccinimide (NIS) was used to α-iodinate in situ and NaHCO3 was 
added into the reaction mixture after 1 h. This reaction proceeds at room 
temperature and gives yields of 36 - 88 % after 1.5 to 5h reaction time. However 
due to choice of substrate phenylacetaldehyde, the reaction is restricted to the 
synthesis of only 3-phenylimidazo[1,2-a]pyridines, with no substituents at the 2-
position. Hence we decided to complete the picture and expand this methodology 
further to include synthesis of 2,3-disubstituted 3-phenylimidazo[1,2-
a]pyridines.  
   In Chapter 3, we reported a one-pot, transition-metal-free synthesis of 
imidazo[1,2-a]pyridines from 2-aminopyridines and 1,3-dicarbonyls using 2-
aminopyridine as an α-bromination shuttle. The Br atom is transferred from the 
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CBrCl3 to the α-carbon of 1,3-dicarbonyls, before initiating a domino reaction 
which ultimately forms the cyclized product. We decided to test if this protocol 
can be extended to other derivatives of 1,3-dicarbonyls as well. Phenylacetones 
and phenylacetophenones were good dielectrophiles under similar protocols to 
form 3-phenylimidazo[1,2-a]pyridines and 2,3-diphenylimidazo[1,2-a]pyridines 
(Scheme 4.1).  
 
 
Scheme 4.1: Retrosynthesis of 3-phenylimidazo[1,2-a]pyridines and 2,3-
diphenylimidazo[1,2-a]pyridines. 
 
   Herein, we report the successful use of this methodology for the synthesis of 
polysubstituted 3-phenylimidazo[1,2-a]pyridines and 2,3-diphenylimidazo[1,2-
a]pyridines (Figure 4.2). To the best of our knowledge, this is the first example 
of a one-pot synthesis of disubstituted 3-phenylimidazo[1,2-a]pyridines with 
alkyl substituents at the 2-position and the first efficient one step method of 
synthesizing 2,3-diphenylimidazo[1,2-a]pyridines. Both of these pioneering 
efforts occur in a one-pot transition-metal free synthesis without the requirement 
of oxidants and prefunctionalization of substrates.This method also has an 
expansive scope of reaction and afforded high yields of up to 97%. Also 
relatively low temperature and reaction times are required without the need for 




Figure 4.2: 2-Aminopyridine acting as an α-bromination shuttle, transferring Br 
atom from CBrCl3 to the alpha carbon of phenylacetone structural motif. 
 
ketoesters, phenylacetones and phenylacetophenoes as the coupling partner of 2-
aminopyridines in this reaction. This was then related to their structure and 
stability for a structure-activity relationship. 
   In this study, we aim to develop a novel and convenient methodology to 
provide new phenylimidazo[1,2-a]pyridine compounds with biological activity 
potential as an extension to those that are already synthesized, so that these 
protocals can be applied in biological assays and industry. 
 
4.2   Experimental 
4.2.1 General Information 





The following chemicals were obtained from Alfa-Aesar, Sigma-Aldrich, GCE 
chemicals and TCI and used as received: CBrCl3, KHCO3, MeCN, 
phenylacetones, phenyl acetophenones and their derivatives, 2-aminopyridine 
and their derivatives.  
 
4.2.3 General Procedure for Synthesis of 3-Phenylimidazo[1,2-a]pyridines. 
A 10 mL round-bottomed flask was charged with 4-methoxyphenylacetone 4-1 
(107.9 µL, 1 mmol), 2-aminopyridine 4-2 (104 mg, 1.1 mmol) and KHCO3 (100 
mg, 1.0 mmol and 2 mL of CBrCl3/MeCN solvent mixture (1/9 v/v). The 
reaction mixture was stirred at 80 °C for 5 h. Thereafter, the reaction was diluted 
with H2O and extracted with EtOAc (15 mL ×5). The combined organic layers 
were washed with brine and dried with anhydrous Na2SO4. After filtration, the 
solvent was removed by rotary evaporation and the residue was cleaned up by 
column chromatography using ethyl acetate and hexane (v/v = 4/1) as eluent to 
afford 4-3aa in 92 % yield. 
 
4.2.4 Procedure for Scaled-up Synthesis of 3-Phenylimidazo[1,2-a]pyridines. 
Procedure is similar to that of Chapter 4.2.3 but at a 15 mmol scale, using 2-
phenylacetophenone instead of 4-methoxylphenylacetone 4-1, in a 100 mL 
round-bottomed and reacted for 5 h. Column chromatography was performed 
using hexane and ethyl acetate (v/v = 4/1) as eluent and further recrystallization 
with ethanol, affording 4-3ha in 88 % yield as yellow crystals. 
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4.3   Results and Discussion 
4.3.1   Optimization 
In Chapter 4.3.1, an optimization study was conducted to obtain an optimized 
condition for scope of reaction. Initial studies were carried out using the 
conditions described in Chapter 3, but with 1 equivalent of KHCO3. 
 
4.3.1.1 Solvent Effect 
To investigate the solvent effect, various solvent mixtures, containing 10% v/v of 
CBrCl3 (2 equivalents wrt 4-1) were tested for the reaction between 4-
methoxyphenylacetone 4-1 and 1 equivalent of 4-2 (Table 4.1, entries 1 - 9). In 
all these cases, the reaction temperature was 80 °C and the reaction time 5 h. 
Besides the desired product 4-3aa, only traces of the N-acylated product 4-4 and 
4-methoxybenzyl bromide are formed. These trace amounts of side product 
could be formed by C-C cleavage of the bromo-hemiaminal intermediate C as in 
Figure 5.5. In general, conversion of 4-1 to form 4-3aa is generally lower than 
that for 3-1 and 3-3aa as described in Chapter 3, which suggests that 
phenylacetones are less reactive substrates than their 1,3-dicarbonyl counterparts. 
Good to moderate conversion of 4-1 and yields of 4-3aa were obtained in aprotic 
solvents like DMF and DMAc (Table 4.1, entries 1 - 4). DMSO was again not 
suitable for the reaction due to its radical quenching ability [58] (Table 4.1, entry 
5). Non-polar solvents like dioxane, DCE, Cyclopentyl methyl ether (CPME) 
and toluene are not suitable for this reaction (Table 4.1, entries 6 - 9), due to their 
inability to dissolve the KHCO3 salt.  
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1 MeCN KHCO3 79 78 (72) 
2 NO2Me KHCO3 55 55 (44) 
3 DMF KHCO3 71 69 (58) 
4 DMAc KHCO3 71 70 (57) 
5 DMSO KHCO3 0 0 
6 dioxane KHCO3 0 0 
7 CPME KHCO3 10 10 
8 DCE KHCO3 12 12 
9 toluene KHCO3 0 0 
10 MeCN - 45 45 (29) 
11 MeCN NaHCO3 66 65 (60) 
12 MeCN K2CO3 49 49 (33) 
13 MeCN KOtBu 0 0 
14[d] MeCN KHCO3 68 67 (54) 
15[e] MeCN KHCO3 93 93 (91) 
16[f] MeCN KHCO3 94 94 (91) 
17[e], [g] MeCN KHCO3 80 80 (77) 
18[e], [h] MeCN KHCO3 94 94 (90) 
[a] Reaction conditions: 4-1 (1.0 mmol), 4-2 (1.0 mmol) and additives (1.0 mmol) in 2 mL of 1:9  
(v/v) CBrCl3/solvent mixture (2.0 mmol wrt CBrCl3) at 80 °C for 5 h. [b] Yield (from GC) with 
respect to 4-1. [c] Isolated yields in parenthesis. [d] 1.25 equiv. of 4-1 was used [e] 1.1 equiv. of 4-2 
was used. [f] 1.25 equiv. of 4-2 was used. [g] Ratio of CBrCl3/MeCN inceased to 1:18 (v/v) (1.0 





4.3.1.2 Effect of Base Additives 
Without KHCO3, both conversion and yield of 4-3aa dropped significantly 
(Table 4.1, entry 10), exemplifying the role of the bicarbonate salt in driving the 
reaction towards forming 4-3aa by extrusion of CO2 and H2O. 
  Next, a few bases were screened for the reaction (Table 4.1, entries 11 - 13). 
Again, NaHCO3 gave slightly lower yields than KHCO3, similar to the 
observations in chapter 3. There was a significant decrease in yield as well when 
K2CO3 was used as a base. Potassium tert-butoxide was not suitable as a base, 
with no observable yield of 4-3aa. This could be due to the fact that its conjugate 
acid tert-butanol is a radical scavenger as well, thus quenching radicals in the 
reaction [59].  
 
4.3.1.3 Fine-tuning of Reaction Conditions  
As the yield of 4-3aa is still moderate, the concentration of either 4-1 or 4-2 was 
varied to over-stoichiometric amounts in the hope that higher yields could be 
achieved (Table 4.1, entries 14 - 16). Increasing the number of equivalents of 4-
methoxyphenylacetone 4-1 to 1.25 times causes a slight drop in yield. On the 
other hand, there was a significant increase in both conversion and yield of 4-3aa 
when the concentration of 2-aminopyridine 4-2 was increased to over-
stoichiometric amounts of 1.1 and 1.25 (Table 4.1, entries 15 and 16). However, 
since there were essentially no differences in yield between these two results, 
subsequent reactions employed 1.1 equivalents of 4-2 instead. Last but not least, 
the amount of CBrCl3 was also investigated (Table 4.1, entries 17 and 18). While 
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decreasing the amount of CBrCl3 to 1 equivalent causes a significant drop in 
yield, an increase to 3 equivalents did not increase the yield any further. Thus, 
the optimized condition used for the next part of the investigation was 1 mmol of 
4-1 together with 1.1 equivalents of 4-2, 1 equivalent of KHCO3 as a base, at 80 
°C for 5h. 
 
4.3.2   Scope of reaction 
The scope of reaction was next tested to see if various types of phenylacetones 
and phenylacetophenones were suitable for the reaction, when using the 
optimized conditions (Table 4.2). The reaction is tolerant to 
methoxyphenylacetones with OMe substituents at para, meta, ortho and even a 
disubstituted derivatives (Table 4.2 4-3aa ‒ 4-3da). Good yields were achieved 
with phenylacetones, and its p-Cl and p-Br derivatives (Table 4.2, 4-3ea ‒ 4-
3ga). Phenylacetophenones are more reactive substrates and generally reacted 
more readily than their phenylacetone counterparts with shorter reaction times 
and higher isolated yields. Phenylacetophenone and 4-methylbenzyl phenyl 
ketone gave excellent yields of 95 % of 4-3ha and 97 % of 4-3ia respectively. 
The reaction also proceeded smoothly with substituents at the other phenyl ring, 
as evident by reaction using 4‘-chloro-2-phenylacetophenones and 4‘-bromo-2-
phenylacetphenones forming excellent yields of 4-3ja and 4-3ka with 91 % and 
93 % respectively. It was also interesting to observe that the cyclic derivative of 
phenylacetone, β-tetralone reacting smoothly with 4-2 to form multiply-fused 
ring 4-3la with 89 % isolated yield.  
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88 % 4-3ba 90 % 4-3ca 86 % 4-3da
85 % 4-3ea 81 % 4-3fa 85 % 4-3ga 95 % 4-3ha
[b]
97 % 4-3ia[b] 91 % 4-3ja[b] 92 % 4-3ka[b] 89 % 4-3la




























traces 4-3af 92 % 4-3ag[b] 94 % 4-3ah[b]
92 % 4-3ai 75 % 4-3aj 79 % 4-3ak
79 % 4-3al 85 % 4-3am 92 % 4-3an
[a] Reaction conditions: 4-1 (1.0 mmol), 4-2 (1.1 equiv) and KHCO3 (1.0 equiv) mmol) in 2 mL 
of 1:9 (v/v) CBrCl3/MeCN mixture (2.0 mmol wrt CBrCl3) at 80 °C for 5 h. Percentage isolated 
yields. [b] Reaction time of 4 h. 
 
   Various substituted aminopyridines were also screened in the reaction, using 
the optimized conditions. The reaction is tolerant to methyl substituents at C-3, 
C-4, C-5 of the 2-aminopyridine structural motif, proceeding with excellent 
yields of 89 - 94 % yields (Table 4.2, 5-3ab - 4-3ad). However, only trace 
amounts of the desired product were formed with a methyl group at the C-6 
position (Table 4.2, 4-3ae). This implies that the reaction is sensitive to the 
presence of a methyl group at the carbon adjacent to the N-atom of the pyridine 
ring. This was further verified when a similar reaction employing dimethyl-2-
aminopyridine with a Me substituent at the C-4 and C-6 position also proceeded 
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with traces amount of desired product (Table 4.2, 4-3af). The observation that 
Me at C-6 position reacts sluggishly compared to the other 3 positions have been 
observed and reported before [28, 52-53]. Both electron-donating and electron-
withdrawing substituents, including Et, OMe, Cl, Br, and CO2Me were well 
tolerated for this reaction, proceeding with good to excellent yields (Table 4.2, 4-
3ag - 4-3ak). Various heteroaromatic derivatives of  2-aminopyridines including 
2-aminothiazole, 2-aminoquinoline and 1-aminoisoquinolines were suitable for 
this reaction as well with good to excellent yields of 79 %, 85 % and 92 % 
isolated yields of 4-3al, 4-3am and 4-3an respectively. 
 
4.3.3   Mechanistic Studies 
The synthesis of 3-phenylimidazo[1,2-a]pyridines from 2-aminopyridines and 
phenylacetones or phenylacetophenones is very similar to the synthesis of 
imidazo[1,2-a]pyridines from 2-aminopyridines and β-ketoesters of β-diketones 
described in Chapter 3. Therefore, the results of the mechanistic studies in 
Chapter 3 could be applied here as well. 
 
4.3.3.1   Comparison Between Reactivity of 3-1 and 4-1 With 6-Methyl-2 
aminopyridine 
 
One main difference between the two reactions that has to be addressed is the 
stark difference in reactivity of 4-methoxy-phenylacetone compared to 
methylacetoacetate, when reacting with 6-methyl-2-aminopyridine, under the 
optimized conditions. While the latter reacts smoothly with 6-methyl-2-
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aminopyridine to form an excellent yield of 92 % of 3-3ab, the former only 
formed traces of 4-3ae under similar reaction conditions.  
   It was proposed in Chapter 3.3.4 that during the formation of 3-3aa, the 
pyridine N atom of intermediate D is involved in an SN2 type ring-closing 
nucleophilic attack on the α-carbon, thus causing the Br- to leave as a leaving 
group. SN2 reactions are concerted such that the attack of the nucleophile and the 
leaving group detaching from the electrophilic carbon occur simultaneously, 
forming a 5-membered transition state (Scheme 4.2). Thus, for this concerted 
reaction to take place, it is required that the attack of the nucleophile occurs from 
the backside to facilitate the leaving of Br. The reaction proceeds through 
intermediate E with inversion of the stereochemistry.  
 
Scheme 4.2: Intermediate D undergoing SN2 backside attack from pyridine N 
atom to α-carbon, showing the transition state and also inversion of 
stereochemistry of intermediate E, towards formation of 3-3ab. 
 
Figure 4.3 compares the intermediates D for formation of 4-3ae and 3-3ab and 
highlights the differences between them. In the 3-3ab, a 4-methoxyphenyl 




Figure 4.3: Working model of Intermediate D of 4-3ae (left) and intermediate D 
of 3-3ab (right). For the left intermediate, steric hindrance occurs between 
phenyl H and CH3 group of 6-methyl-2-aminopyridine. Steric clash is minimal, 
if not none, from the lone pair of electrons on O atom of the CO2Me moiety of 
the right intermediate. 
 
-CH3 group of the 6-methyl-2-aminopyridine moiety. On the other hand, in the 
former, the steric clashes are absent between the lone pair of electrons of O of 
the CO2Me moiety and the -CH3 group. SN2 reactions are known to be sterically 
sensitive and the rate of rection decreases with increasing steric hindrance [60]. 
Thus, for the intermediate D of 4-3ae, due to these steric clashes, the formation 
of transition state and thus intermediate E, is less probable and this accounts for 
the sluggishness of the reaction of forming 4-3ae, as compared to that of 
formation of 3-3ab.  
 
4.3.4   Proposed Mechanism 
Based on our optimization studies, the scope of reaction and the mechanistic 
studies, the following plausible mechanism for the synthesis of 4-3aa is proposed 
(Figure 4.4). Initial heat induced homolytic fission of C-Br bond of CBrCl3 
forms CCl3•.and Br•. The C-Br bond in CBrCl3 undergoes homolytic fission 














































Figure 4.4: Proposed mechanism for the formation of 4-3aa. 
 
mechanism ensues forming of N-brominated 2-aminopyridine intermediate A at 
the propagation step. A then rearranges to form intermediate B. On the other 
hand, 4-1 undergoes keto-enol tautomerisation to the enol form. The enol form of 
4-1 undergoes an addition reaction with B, via a concerted pathway which 
proceeds via a six-membered transition state to form the bromo-hemiaminal 
intermediate C, with simultaneous C-N and C-Br bond formations. This 
intermediate has been proposed by Lee et al. in the one-pot synthesis of 3-aryl 
imidazo[1,2-a]pyridines and proved using NMR studies [40]. As postulated in 
Chapter 3, the 2-aminopyrdine 4-2 will act as a shuttle for the α-bromination part 
of the reaction, transfering Br from CBrCl3 to the enol tautomer of 4-1, carrying 
the Br along through a series of reversible steps. Dehydration of C results in the 
α-bromo imine intermediate D. A ring-closing SN2-type of nucleophilic attack at 
the α-carbon then forms E. Deprotonation of the most acidic proton by HCO3- 
would then yield 4-3aa with release of CO2 gas, H2O and KBr. 
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4.3.5   Scaled up synthesis 
Again, a scaled up synthesis was conducted at a g-scale to demonstrate the 
synthetic usefulness of this reaction. For the scaled up synthesis of 4-3ha, 
15 mmol of phenylacetophenone and 16.5 mmol of 2-aminopyridine 4-2 were 
dissolved in 30 mL of 1/9 (v/v) CBrCl3/CD3CN solvent mixture stirred with 
1 equivalent of KHCO3 for 5 hours at 80 °C (Scheme 4.3). An isolated yield of 
88 % of yellow crystals of 4-3ha was obtained after work-up, purification via 
column chromatography and recrystallization with ethanol. 
 
 
Scheme 4.3: Scaled up synthesis of 4-3ha. 
 
4.4   Conclusion 
In this chapter we have demonstrated that the α-bromination system involving 
CBrCl3/2-aminopyridine is not restricted to just β-ketoesters and β-diketones as 
shown in Chapter 3, but can also be used with phenylacetones, 
phenylacetophenones and β-tetralone as well. The reaction is transition-metal 
free and proceeds in one pot when employing the CBrCl3/MeCN solvent system 
and KHCO3 as a base. This allows synthesis of 3-phenylmidazo[1,2-a]pyridines 
via a direct C-N/C-N coupling of 2-aminopyridines and phenylacetones, 
phenylacetophenones and β-tetralone. 2-Aminopyridine is not only a substrate 
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for this reaction but is also essential as an α-bromination shuttle, transferring the 
Br atom from CBrCl3 to the enol form of the coupling partner via a series of 
reversible steps, involving a bromo-hemiaminal intermediate. This is followed 
by a series of tandem reactions, including dehydration and ring-closing 
nucleophilic attack, giving the product in isolated yields of 75 - 97 %.  
   Comparisons were also being made between the reactions described in Chapter 
3 and in this chapter. The sluggishness in forming 4-3ae as compared to the 
structurally similar 3-3ab, which is readily formed in excellent yields, was 
attributed to steric clashes between the CH3 group in the 6-methyl-2-
aminopyridine moiety and the phenyl protons in intermediate D.    
   To the best of our knowledge, this is the first example where phenylacetones 
were used as substrates for the synthesis of 3-phenylimidazo[1,2-a]pyridines. 
Phenylacetophenones are also used to synthesize 2,3-diphenylimidazo[1,2-
a]pyridine. This reaction has an extensive scope of reaction, uses cheap and 
commercially available starting materials and reagents, proceeds under mild 
reaction conditions and requires only short reaction times. It was also shown that 
the procedure can be scaled up for large-scale synthesis. Thus, we achieved our 
aim to develop a simple and easy synthetic route to a wide variety of 
polysubstituted 3-phenylimidazo[1,2-a]pyridines and 2,3-diphenylimidazo[1,2-
a]pyridines using minimal reagents and cheap and commercially available 
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A Novel Metal-free Multicomponent Synthesis of Polysubstituted Pyrroles 
Promoted by Recyclable 4Å Molecular Sieves. 
 
5.1     Introduction 
Polysubstituted pyrroles are an important class of compounds prevalent in many 
natural products [1]. These include various marine alkaloids, with anti-tumour 
properties like lamellarins [2-3], lukianols [4-5], storniamide [6] and ningalins 
[7]. A substituted pyrrole ring is also found in antibiotics such as batrachotoxin 
[8] and marinopyrrole [9], and also in porphobilinogen [10], which is responsible 
for the biosynthesis of heme and chlorophyll. This structural motif can also be 
found in many pharmaceuticals and biologically active compounds exhibiting 
anti-bacterial [11], anti-tumour [12], antitubucular [13] and anti-inflammatory 
[14] properties. More examples includes HIV-fusion inhibitors [15] and 
Atorvastatin [16], used for prevention of cardiovascular diseases.  
   Polysubstituted pyrroles can be used as synthetic intermediates for more 
complex natural products [17-18] and have also been used in solar batteries, 
solar cells, organic semiconductors and chemosensors [19-21]. Thus, it is not 
surprising that over the past decade, various methods for synthesizing 
polysubstituted pyrroles have been developed.  
Polysubstituted pyrroles are typically constructed via the Knorr [22-24], Paal-
Knorr [25-29] or Hantzsch [30-32] synthesis. However, these routes suffer from 
harsh reaction conditions, functional group incompability, regiospecificity, 
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availability and high cost of starting materials. Some of these starting materials 
require multiple steps synthesis, thus limits the practicality and scope of reaction.  
One creative protocol developed to overcome these limitations is via MCR 
[33]. Many groups have employed MCR for synthesis of polysubstituted pyrroles 
over the past decade or so [34-40]. One of most popular 4-component reaction 
employed by many for the synthesis of polysubstituted pyrroles is the use of 
anilines, benzaldehydes, 1,3-dicarbonyls and nitromethane as reaction substrates, 
as all four substrates are commercially available and cheap. Jana et al. pioneered 
this reaction by using 10 mol% FeCl3 as the catalyst in a one-pot reaction 
consisting of nitromethane as the solvent and substrate, 4-chlorobenzaldehyde, p-
anisidine and acetylacetone at reflux conditions for 7 to 16 h [41]. 1.5 
equivalents of p-anisidine were required for reaction to proceed with low to good 
yields of 38 to 85 %. On the other hand, Khan et al. employed 10 mol % 
NiCl2·6H2O as the catalyst and β-ketoesters as the 1,3-dicarbonyl partner, under 
similar reaction conditions, with the exception of not requiring excess aniline 
moiety [42]. In 2012, Pal’s group was the first to employ a metal-free synthesis, 
using 10 mol% iodine, at a lower temperature of 90 - 95 °C with good yields [43]. 
Zhang et al. were the first to employ a recyclable gluconic acid solution as a 
solvent cum promoter for this reaction [44]. This was followed by Singh et al 
using 20 mol% [bmim][HSO4] ionic liquid as a recyclable catalyst, with 
significantly faster reaction times of 2 - 6h with moderate to good yields [45]. 
Recently, Zhang’s group developed recyclable nano CoFe2O4 supported 
molybdenum as a magnetic heterogeneous catalyst [46]. The last three steps, 
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while have their advantages in terms of their recyclability, do have drawbacks as 
well, including using corrosive catalysts, employing catalysts that are not 
commercially available and requires multiple steps to make, requires addtional 
work-up steps due to usage of aqueous solution and so on.  
With those drawbacks in mind, we would like to report a protocol for the 
synthesis of polysubstituted pyrroles via a novel and recyclable metal-free one-
pot 4-component reaction promoted by 4 Å molecular sieves with short reaction 
times, mild reaction conditions and a very wide scope of reaction of good to 
excellent yields (Scheme 5.1). The reaction is suitable for both aromatic and aliphatic 
aldehydes. β-Ketoamides, β-ketothiosters and 1,3-cyclohexandione are also suitable 
substrates under this protocol. The molecular sieves employed are cheap and 
commercially available and they can be regenerated by overnight drying in the oven and 
reused for subsequent runs. 
 
 
Scheme 5.1: Retrosynthesis of polysubstituted pyrroles. 
 
   A kinetic study employed in the study also ascertain that the formation of the 
N-phenylpyrrole is hindered by formation of a side product (E)-N-benzylidene-4-
methoxyaniline from p-ansidine and benzaldehyde. This prevents p-anisidine 
from reacting with its intended coupling partner 1,3-dicarbonyl towards forming 
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N-phenylpyrrole, thus lowering the selectivity and yield of the desired product. 
The presence of 4 Å molecular sieves, in the presence of water, converts this side 
product back into benzaldehyde and p-anisidine, and by reversing this process 
assists in increasing the selectivity and yield of formation of N-phenylpyrroles. 
 
5.2     Experimental 
5.2.1 General Information 
The instrumental methods were the same as described in Chapter 2.2.1. 
 
5.2.2 Materials 
The following chemicals were obtained from Alfa-Aesar, Sigma-Aldrich, Merck 
and TCI and used as received: Nitromethane and other nitroalkane derivatives, 
methyl acetoacetate and other 1,3-dicarbonyl derivatives, p-anisidine and other 
aliphatic and aromatic amine derivatives, benzaldehyde and other aliphatic and 
aromatic aldehyde derivatives. 4 Å molecular sieves beads 8 - 12 mesh 
(composition 1 Na2O: 1 Al2O3: 2±0.1 SiO2: x H2O) were obtained from Sigma 
Aldrich and activated at the furnace at 210 °C for 2 h prior to usage. 3 Å 
molecular sieves beads 4 - 8 mesh (composition 0.6 K2O: 0.4 Na2O: 1 Al2O3: 
2±0.1 SiO2: x H2O) were also obtained from Sigma Aldrich.  
 
5.2.3 General Procedure for Synthesis of Polysubstituted Pyrroles. 
A 10 mL round-bottomed flask was charged with benzaldehyde 5-1 (102.0 µL, 1 
mmol), p-anisidine 5-2 (123.2 mg, 1 mmol), methyl acetoacetate 5-3 (107.9 µL, 
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1 mmol), 4 Å molecular sieves (159.2 mg, 1.5 wt. equiv wrt 5-1) in 0.5 mL of 
NO2Me. The reaction mixture was stirred at 90 °C for 1 h. The mixture was 
diluted with minimal EtOAc and subject to filtration to separate the molecular 
sieves from the reaction mixture. The filtrate is collected and the solvent was 
removed by rotary evaporation and was subjected to column chromatography 
using hexane and ethyl acetate (v/v = 5/1) as eluent to afford 5-6a in 95 % yield. 
 
5.2.4: Procedure for Scaled-up Synthesis of polysubstituted pyrroles. 
Procedure is similar to that of Chapter 5.2.3 except that a 25 mL round-bottomed 
flask is used instead and the reaction is stirred for 2 h. After separation and 
purification, a yellow viscous liquid 5-6a in 92 % yield. 
 
5.25: Procedure for Synthesis of Polysubstituted Pyrroles from 
Dimethylacetylene Dicarboxylate (DMAD). 
 
A 10 mL round-bottomed flask was charged with benzaldehyde 5-1 (102.0 µL, 1 
mmol), p-anisidine 5-2 (123.2 mg, 1 mmol), DMAD 5-10 (122.5 µL, 1 mmol), 4 
Å molecular sieves (159.2 mg, 1.5 wt. equiv wrt 5-1) in 0.5 mL of NO2Me. The 
reaction mixture was stirred at 90 °C for 2 h. The mixture was diluted with 
minimal EtOAc and subject to filtration to separate the molecular sieves from the 
reaction mixture. The filtrate is collected and the solvent was removed by rotary 
evaporation and was subjected to column chromatography using hexane and 





5.3     Results and Discussion 
5.3.1   Initial Studies 
The initial intention of this project was to device a synthethic route to construct 
polysubstituted quinolines from aldimine 5-4 and methyl acetoacetate 5-3 in a 
Bi(III)-catalyzed reaction. This work was an extension to a previous unpublished 
work on Bi(III)-catayzed synthesis of polysubstituted naphthalene from 
phenylacetaldehyde and methylacetoacete in NO2Me (Scheme 5.2).  
 
 
Scheme 5.2: Reaction equations of previous work, intended reaction based on 
previous work, actual reaction and test reaction respectively.  
Reaction conditions: [a] 1 mmol 2-phenylpropionaldehyde, 2 equiv. methylacetoacetate, 0.02 
mmol Bi(OTf)3 catalyst in 2mL NO2Me at 100 °C for 1 h. [b]1 mmol (E)-N-benzylidene-4-
methoxyaniline, 2 equiv. methylacetoacetate, 0.05 mmol Bi(OTf)3, 5 wt. equiv. 4Å MS in 2mL 
NO2Me at 100 °C for 1 h. [c] 5 wt. equiv. 4Å MS but no Bi(OTf)3 catalyst. [d] 1 mmol 
benzaldehyde, 1 equiv. p-anisidine, 1.5 equiv. methylacetoacetate, 5 wt. equiv. 4Å MS in 2mL 
NO2Me at 90 °C for 1 h. (PMP = p-methoxyphenyl). 
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   Surprisingly polysubstituted N-phenylpyrrole 5-6a was formed instead. A 
similar reaction conducted without the Bi(III) catalyst also proceeded well with 
high yields of 5-6a, signifying that Bi(III) does not play an active role in the 
reaction and is thus not required (Scheme 5.2). A search on the literature reveals 
that the synthesis of 5-6a was possible from the precursor of the aldimine 
moiety; benzaldehyde and p-anisidine. Thus, a test reaction was done using these 
precursors, together with methyl acetoacatete, in NO2Me at 90 °C for 1 h and N-
phenylpyrrole was indeed formed. What was intriguing is that the proposed 
mechanism [46] for the synthesis of 5-6a proceeds via formation of β-enamino 
ester intermediate (Z)-methyl 3-(4-methoxyphenylamino)but-2-enoate from 
methyl acetoacetate and p-anisidine, and nitrostyrene intermediate (E)-(2-
nitrovinyl)benzene from nitromethane and benzaldehyde (Figure 5.1). The 
proposed mechanism suggest that aldimine 5-4 was not involved in the formation 
of 5-6a and could in fact hinder the product formation to a large extent. Another 
quick look at the formation of β-enamino ester and aldimine in the literature 
shows that while both compounds can be synthesized with high yields at room 
temperature, only the latter can be formed without a metal catalyst. Thus in this 
reaction where no metal catalyst is used, while both β-enamino ester and 
aldimine could be formed, it is expected that the latter forms at a faster rate. 
Thus, it could possibily be that the latter would slow down the formation of 5-6a, 


























































Figure 5.1: Proposed mechanism for the formation of 5-6a in the literature. 
 
 
Scheme 5.3: Equations for formations of β-enamino ester (Z)-methyl 3-(4-
methoxyphenylamino)but-2-enoate [47-51] and aldimine (E)-N-benzylidene-4-
methoxyaniline [52]. 
 
signify that the 4Å MS promotes the formation of 5-6a, by converting aldimine 
5-4 formed, back into p-anisidine and nitrostyrene 5-5, towards formation of 5-
6a. 4Å MS have been known to act as dessicants in promoting reversible 
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reactions, including formation of aldimine from aldehydes and amines [53-56], 
by shifting equilibrium to prefer product formation. However, there are 
numerous examples of 4Å MS promoting reactions in the literature, including 
Prins cyclization, glyoxalate-ene reaction, cyclocondensation reaction and a 3-
component reaction of anilines,4-oxo-enoates and diazo compounds [57-61]. 
   To have a better understanding of what is happening in the reaction and the 
role of 4Å MS in the reaction, two sets of kinetic studies were conducted at 90 
°C for 2 h: one with 4Å MS and one without. Samples were taken in between 
and their selectivities and conversion with respcct to benzaldehyde 5-1 were 
measured and plotted against time (Figure 5.2). 
   In the presence of the 4Å molecular sieves, the reaction was very rapid and 
aldehyde 5-1 was completely consumed within 5 minutes (Figure 5.2, top). At 
the beginning of the reaction, majority of 5-1 is converted to Aldimine 5.4 which 
then slowly transformed to product 5-6a over the next hour. The concentration of 
nitrostyrene intermediate 5-5 reached its peak at around 10 minutes. It is then 
also slowly transformed to 5-6a over the next 2 hours. 
   On the other hand, reaction without 4Å MS proceeded much slower, with full 
conversion only at 1 h (Figure 5.2, bottom). Similarly, at the beginning of the 
reaction, majority of 5-1 is converted to Aldimine 5.4. However, selectivity of 
aldimine 5-4 decreases very slowly and this coincides with a slow increase in 
selectivity of both desired product 5-6a and intermediate 5-5. 






Figure 5.2: Kinetic studies for reaction between 1 mmol 5-1, 1 equiv. 5-2, 1.5 
equiv. 5-3 with 5 wt. equiv. 4Å MS (top) or without 4Å MS (bottom) with 2 mL 
NO2Me at 90 °C for 2 h, with samples taken in between. Samples are 
quantitatively analyzed using GC-FID. Conversion is with respect to limiting 
reagent 5-1 and selectivity of 5-4, 5-5 and 5-6a plotted against reaction time. 



































Figure 5.3: Reaction mechanism showing competing reactions side product 5-4 
and desired product 5-6a. Because 5-4 formation is reversable, it can be 
converted back to its starting reagents towards formation of product 5-6a. This 
reaction can be promoted by 4Å MS which drives the reaction towards product 
formation via condensation reaction.  
 
   From the results of both kinetic studies, it can be implied that 4Å MS promotes 
the formation of 5-6a. This is illustrated in Figure 5.3, whereby there is a 
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competing reaction between formation of aldimine side product 5-4 and desired 
product 5-6a. However, being an equilibrium reaction, 5-4 can be converted back 
into ints starting reagents nitrostyrene 5-5 and p-anisidine. These substrates are 
now available to couple with nitromethane and methyl acetoacetate respectively, 
to form nitrostyrene intermediate 5-5 and β-enamino ester intermediate (Z)-
methyl 3-(4-methoxyphenylamino)but-2-enoate. Thesetwo intermediates then 
couple together, releasing HNO and H2O, forming 5-6a product in the process. 4 
Å molecular sieves thus promotes formation of 5-6a by providing a driving force 
by absorbing H2O and HNO. This ensures allows the equilibrium to shift towards 
hydrolysis of aldimine 5-4, thus maximizing the amount of substrates 5-1 and 5-
2 available to form 5-6a.  
 
5.3.2   Optimization 
5.3.2.1 Effect of Various Dehyderating Reagents 
Various dehydrating agents were screened for this reaction (Table 5.1, entries 2 - 
6). Both 3Å and 4Å MS beads gave somewhat similar selectivity and yield of the 
desired product 5-6a. Around 40 % of 5-4 was still not converted at 30 minutes. 
Silica gel 60 (0.040 - 0.063 mm) gave slighty higher yields and selectivity. 
However, both anhydrous Na2SO4 and MgSO4 gave a significantly lower 
selectivity and yield of 5-6a. Comparing the results of the two anhydrous 
sulphates with the three silica compounds, (Table 5.1, entries 2 - 5), the former 






















































1 - 98 1 1 0 traces 
2 3Å MS 42 2 56 0 56 (53) 
3 4Å MS 40 2 58 0 58 (54) 
4 Silica gel 60 35 4 61 0 61 (55) 
5 Anhydrous 
Na2SO4 
68 4 28 0 28 (17) 
6 Anhydrous 
MgSO4 
65 4 31 0 31 (23) 
7[c] 4Å MS 57 1 42 0 42 (36) 
8[d] 4Å MS 23 4 72 1 72 (70) 
9[d], [e] 4Å MS 0 0 82 18 82 (75) 
10[d], [f] 4Å MS 0 0 92 8 92 (86) 
11[d], [g] 4Å MS 0 0 97 3 97 (95) 
12[d], [h] 4Å MS 0 0 99 1 99 (98) 
13[d], [i] 4Å MS 0 0 100 0 100 (98) 
14[d], [j] 4Å MS 0 0 100 0 100 (97) 
15[d], [k] 4Å MS 3 0 97 0 97 (95) 
[a] Reaction conditions: 5-1 (1.0 mmol), 5-2 (1.0 equiv.), 5-3 (1.5 equiv.), promoter (5 wt equiv. 
for 3 Å MS and 4 Å MS, 2.0 equiv. for the rest), 2 mL NO2Me at 90 °C for 30 min. [b] Yield 
determined by GC analysis. Isolated yields in parentheses. [c] Reaction with 4 mL NO2Me. [d] 
Reaction with 0.5 mL NO2Me [e] Reaction with 3 equiv. 5-3 at a time of 1 h. [f] Reaction with 2 
equiv. 5-3 at a time of 1 h. [g] Reaction with 1.5 equiv. 5-3 at a time of 1 h.[h] Reaction with 1.25 
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equiv. 5-3 at a time of 1 h. [i] Reaction with 1.0 equiv. 5-3 at a time of 1 h. [j] Reaction with 3.0 wt 
equiv. of 4 Å MS. [k] Reaction with 1.5 wt. equiv. of 4 Å MS. 
 
 
   It can be implied that removal of water could drive the equilibrium to convert 
back to substrates 5-1 and 5-2 towards forming 5-6a but porosity allows 
absorption of both H2O and HNO gas. Even though the result using silica gel 60 
was slighty better than the rest, 4Å MS was chosen as the choice of promoter for 
subsequent optimization reactions, based on their ease of separation from 
reaction mixture and work-up, their recyclability potential and their cost.  
 
5.3.2.2 Fine-tuning of Reaction Conditions  
We next investigate the effect of dilution on selectivity and yield of 5-6a (Table 
5.1, entries 3,7 and 8). With increasing dilution, selectivity of aldimine 5-4 
increases, whereas selectivity and yield of 5-6a decreases. Using a more 
concentrated reaction mixture of 0.5 mL NO2Me at the 1 mmol scale, could 
improve the selectivity and yield of product significantly. However, traces of a 
new side product 5-11 are formed.  
   In an attempt to get higher yields of 5-6a, the reaction time was increased to 1 
h. An excellent yield of 97 % 5-6a was obtained. Also at 1 h, the selectivity of 
side product 5-11 increased by a small margin. 
  The effect of equivalence of methyl acetoacetate 5-3 on the reaction was also 
investigated by varying from three to one equivalent (Table 5.1, entries 9-10 and 
12-13). When the equivalents of 5-3 were increased to two, the selectivity of 5-
11 increased significantly. A further increase to three equivalents increased the 
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selectivity of 5-11 even further. In contrast, decreasing the equivalents to 1.25 
and a further decrease to 1 equivalent does not cause a significant change in yield 
of 5-6a. It was delightful to observe that the selectivity of side product 5-11 
decrease to essentially zero at one equivalent of 5-3.  
   Last but not least, we sought to investigate if it is possible to decrease the 
amount of 4Å MS (Table 5.1, entries 14-15). Reducing to 3 weight equivalents 
caused no observable changes in yield of 5-6a. A further reduction to 1.5 
equivalents caused a slightly lower yield but the drop was not significant. Thus, 
the optimized condition employed for the scope of reaction is 1 mmol of 
benzaldehyde 5-1, 1 equiv. of  p-anidisine 5-2 and methyl acetoacetate 5-3, using 
1.5 weight equivalents of 4Å MS in 0.5 mL NO2Me at 90 °C for 1 h. 
 
5.3.3   Scope of reaction 
With the optimized conditions in hand, the scope of reaction was explored by 
varying the substrates of the 4-component reaction 1,3-dicarbonyl, amine, 
aldehyde and nitroakane moiety, one at a time. 
 
5.3.3.1 Scope of β-diketones, β-ketoesters and Their Derivatives 
The scope of the reaction was then investigated using the optimized conditions. 
Firstly, various 1,3-dicarbonyls were screened as substrates for this reaction, 
starting with β-ketoesters (Table 5.2). Various aliphatic acetoacetates including 
allyl, methoxyethyl, benzyl and cyclohexyl moieties were good substrates for the 
reaction, proceeding with good to excellent yields (Table 5.2, 5-6a - 5-6f). The  
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Table 5.2: Scope of reaction of synthesis of polysubstituted pyrroles by varying 




























































[a] Reaction conditions: 5-1 (1.0 mmol), 5-2 (1.0 equiv) and various types of 5-3 (1.0 equiv) with 
4Å MS (1.5 wt. equiv) in 0.5 mL of NO2Me at 90 °C for 1 h. Percentage isolated yields. [b] 
Reaction time of 2 h. [c] Reaction time of 4 h. 
 
 
R2 positions of β-ketoesters were also varied with n-butyl, i-Pr, trifluoromethyl 
and phenyl groups (Table 5.2, 5-6g - 5-6j). Good yields were obtained but longer 
reaction times were needed for substrates bearing electronwithdrawing 
trifluoromethyl and phenyl R2 substituents. β-ketoamide and β-ketothioesters 
were also suitable as substrates for this reaction with excellent yields of 5-6k and 
good yields of 5-6l respectively. β-diketones were good substrates for this 
reaction, with acetylacetone, benzoylmethane and dibenzoylmethane proceeding 
with good to excellent yields of 5-6m, 5-6n and 5-6o respectively. The cyclic β-
diketone 1,3-cyclohexanedione were also active, but the reaction proceeded more 
slowly and gave only moderate yields of 71 % of 5-6p. 
 
5.3.3.2 Scope of Amines 
Next, various types of amines were screened as suitable substrates for this 4- 




Table 5.3: Scope of reaction of synthesis of polysubstituted pyrroles by varying 


































85% 5-7b 94% 5-7c[c] 89% 5-7d

























[a] Reaction conditions: 5-1 (1.0 mmol), various types of 5-2 (1.0 equiv) and 5-3 (1.0 equiv) with 
4Å MS (1.5 wt. equiv) in 0.5 mL of NO2Me at 90 °C for 2 h. Percentage isolated yields. [b] 
Reaction time of 1 h. [c] Reaction time of 3 h. [d] Reaction time of 5 h. [e] Reaction time of 24 h. 
 
in the reaction. Aniline was a good substrate for the reaction proceeding with 93 
% yield of 5-7a. The reaction tolerated also p-substituted moieties including 
methyl, fluoro, chloro, bromo and iodoanilines, with good to excellent yields 
(Table 5.3, 5-7b - 5-7f). Benzocaine, with p-CO2Et ester functionality was also a 
good substrate proceeding with 91 % yield of 5-7i. However, with a strong 
electron-withdrawing trifluoromethyl group, a longer reaction was needed to 
form 5-7g in 78 % yield. Interestingly, the strongest electron-withdrawing p-NO2 
group was significantly more sluggish, needing a much longer time of 24 h to 
have a significant conversion with respect to 5-1 and only 56 % isolated yield of 
5-7h was obtained after 24 h. This trend was also observed by Zhang et al. in two 
separate studies of a similar reaction catalyzed by aqueous solutions of gluconic 
acid or by a nano-CoFe2O4 supported molybdenum [44, 46]. It seems that a 
strongly electron-withdrawing group can significantly pull electron density away 
from the nucleophilic N atom of the aniline moiety, thereby reducing its 
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susecptibilty for a nucleophilic attack during the reaction. Other aromatic amines 
like 4-aminobiphenyl and 2-naphthylamine were also good substrates and 
reacted with good to excellent yields (Table 5.2, 5-7j and 5-7k). 
   Aliphatic amines like benzylamine and phenethylamine were very reactive 
substrates, needing short reaction times to proceed with excellent yields of 5-7l 
and 5-7m respectively. Other aliphatic amines, incuding cyclohexylamine and n-
octylamine were also tolerated under the optimized conditions procceding with 
excellent yields of 5-7n and 5-7o within 1 h. Aliphatic amines was obviously the 
more reactive amine substrate than most of their aromatic moieties. This could 
be due to the electron donating ability of the alkyl groups attached to the N-atom, 
including n-octyl and cyclohexyl functionalities, thus increasing its 
nucleophilicity. This is even true for benzyl and phenethyl moieties, whereby the 
electron withdrawing ability of the phenyl group was diminished by the presence 
of 1 or 2 Csp3 carbons separating the phenyl group from the N atom.  
 
5.3.3.3 Scope of Aldehydes 
Next, the scope of reaction for various aldehydes was investigated. Various p-
substituted benzaldehydes were tested as substrate for the 4 component reaction 
(Table 5.4, 5-8a - 5-8g). The reaction was tolerant to electron-donating groups 
such as Me and OMe. Electron-withdrawing groups like nitro, trifluoro- methyl 
and fluoro were well tolerated for this reaction as well. 4-chloro and 4-
bromobenzaldehydes were also good substrates for this reaction. Other aromatic 
aldehydes including biphenyl-4-carboxaldehyde, 2-naphthaldehyde, 9-  
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Table 5.4: Scope of reaction of synthesis of polysubstituted pyrroles by varying 









[a] Reaction conditions: Various types of 5-1 (1.0 mmol), 5-2 (1.0 equiv.) and 5-3 (1.0 equiv.) 
with 4Å MS (1.5 wt. equiv.) in 0.5 mL of NO2Me at 90 °C for 1 h. Percentage isolated yields. [b] 
Reaction time of 2 h. [c] Reaction time of 4 h. [d] Reaction time of 8 h. 
 
anthracenecarboxaldehyde and 1-pyrenecarboxaldehyde were also suitable 
substrates, proceeding with good to excellent yields, albeit at longer reaction 
times (Table 5.4, 5-8h - 5-8k). The heteroromatic derivative 2-thiophene 
carboxaldehyde also react smoothly to give 5-8l in 80 % isolated yield. 
   Various aliphatic aldehydes were tested as substrate for this reaction. 
Cyclohexanecarboxaldehyde surprisingly proceeded with 89 % yield of 5-8m 
after an extended reaction time of 4 h. On the other hand, octanal reacted 
sluggishly with 59 % yield of 5-8n achieved only after an extended reaction time 
of 8 h. From the results in Table 5.4, it can be implied that aliphatic aldehydes 
are generally weaker substrates for this reaction as compared to than 
benzaldehyde and its p-substituted derivatives. This is because one of the two 
intermediates towards forming the pyrrole, nitrostyrene, would favourably be 
formed with aromatic aldehydes, as they are driven by formation of an 
intermediate stabilized by conjugation with π-electrons of the phenyl moiety. On 
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the other hand, aliphatic aldehydes do not have this stabilization effect. Bulky 
aromatic aldehydes like naphthaldehyde, anthraldehyde and 
pyrenecarboxaldehyde were also less reactive than benzaldehydes and their p-
substituted derivatives. These bulky fused aromatic rings could hinder 
nucleophilic attack due to steric clashes. 
 
5.3.3.4 Scope of Nitroalkanes 
Last but not least, other nitroalkanes were also tested for their compatibility in 
this reaction (Table 5.5). Nitroethane proceed well with high yield of 93 %  
Table 5.5: Scope of reaction of synthesis of polysubstituted pyrroles by varying 












[a] Reaction conditions: 5-1 (1.0 mmol), 5-2 (1.0 equiv) and 5-3 (1.0 equiv) with 4Å MS (1.5 wt. 
equiv) in 0.5 mL of various nitroalkane solvents at 90 °C for 1 h. Percentage isolated yields. [b] 





















pentasubstituted N-pyrrole 5-9a after 1 h. However, other nitroalkane derivatives 
like 1-nitropropane and 1-nitrohexane formed multiple products in their reaction 
mixture that could not be separated after column chromatography. Thus, under 
this protocol, the reaction is restricted to nitromethane and nitroethane only as 
substrate cum solvent. 
 
5.3.4   Proposed Mechanism 
The proposed mechanism for the formation of polysubstituted pyrroles has 
already been shown in Figure 5.3. Thus, the proposed mechanism for the 
formation of side product 5-11 is shown here (Figure 5.4). Nucleophilic addition 
of NH2 to the ketone moiety of methyl acetoacetate and subsequent dehydration 
forms the β-enamino ester intermediate. This intermediate, via its α-carbon, then 
attacks another equivalent of methyl acetoacetate to form a bis-β-enamino ester.  
 
 
Figure 5.4: Proposed mechanism of formation of side product 5-11 from over-




This intermediate then undergoes nucleophilic addition twice with the same 
molecule of benzaldehyde, forming a cyclized product 5-11 and releasing 
another equivalent of water. 
 
5.3.5   Scaled-up synthesis 
With the expansive scope of reaction, ease of separation of 4Å from the reaction 
mixture, and the use of cheap and commercially available substrates for this 
reaction, we further sought to increase the utility of this reaction by 
demonstrating that it is amenable to synthesis at the gram scale. The scaled-up 
synthesis of 5-6a uses 15 mmol of benzaldehyde, 15 mmol of p-anisidine, 15 
mmol of methyl acetoacetate  with 1.5 weight equivalents of 4Å MS in 7.5 mL 
NO2Me at 90 °C for 2 h (Scheme 5.4). An isolated yield of 92 % of viscous 









5.3.6   Recyclability test 
The recyclability of the molecular sieve was tested to demonstrate the 
sustainability of this reaction (Figure 5.5). After a typical reaction using the 
optimized condition was completed (run 1), the 4Å MS were separated from the 
reaction mixture through filtration. The 4Å MS was washed repeatedly with 
water and acetone to remove any adsorbed and absorbed residual organic 
substrates. The molecular sieve was dried in the oven overnight at 180 °C before 
Its use in the subsequent run. This is repeated for four times with a total of five 
runs (incuding one fresh reaction).  
   After five runs, there is essentially no loss in isolated yields of desired product 
5-6a. Thus, it shows that the 4Å MS can be recycled after every reaction, further 
demonstrating the utility of this method for the 4-component reaction synthesis 
of polysubstituted pyrroles.  
 
 
Figure 5.5: Graph of subsequent runs using recycled 4Å molecular sieves and 
their respective isolated yields of 5-6a.  
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5.3.7   Expanding Scope to Similar Reactions 
To further enhance the novelty of this method, we sought to extend our method 
to similar 4-component reactions using similar optimized conditions. From the 
literature, polysubstituted N-phenylpyrroles could also be synthesized by a 4-
component reaction of aromatic aldehydes, amines, nitromethane and internal 
alkynes [62-63].  We thus employed our optimized conditions on this reaction by 
reacting 1 mmol of 5-1, 1 equiv of p-anisidine, 1 equiv of dimethyl 
acetylenedicarboxylate (DMAD) with 1.5 weight equiv of 4Å MS in 0.5mL 
NO2Me at 90 °C for 1 h (Scheme 5.5). An isolated yield of 91 % 5-10a was 
achieved. Thus, this reactions show that the method can also be applied to a 
similar 4-component reaction as well. 
Scheme 5.5: Utilization of optimized method to synthesize 5-10a. 
 
5.4     Conclusion 
In summary, the use of 4 Å molecular sieves promotes the four-component 
synthesis of polysubstitued pyrroles from aldehydes, amines, 1,3-dicarbonyls and 
nitroalkanes. It was discovered from a series of kinetic runs that formation of the 
pyrrole is hindered by formation of an aldimine side product from p-ansidine and 
benzaldehyde. This prevents p-anisidine from reacting with its 1,3-dicarbonyl 
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coupling partner, towards forming the desired product 5-6a, thus lowering the 
selectivity and yield of 5-6a. The presence of 4Å molecular sieves, in the 
presence of water, converts this side product back into benzaldehyde and p-
anisidine, and by reversing this process increases the selectivity and yield of 
formation of 5-6a. 
   This reaction has a wide scope of reaction, incuding aromatic and aliphatic 
amines and aldehydes, various kinds of 1,3-dicarbonyls, including β-ketoesters, 
β-ketoamides, β-ketothioesters, β-diketones and cyclic β-diketones as substrates. 
However, only nitromethane and nitroethane are suitable substrates cum solvents 
for this reaction.  
   The novelty of this reaction was further manifested with a succesful scaled-up 
synthesis of 5-6a in 15 mmol scale. Also, the 4Å MS could be recycled for 4 
subsequent runs with essentially no significant decrease in isolated yield. Last 
but not least, this method is extended to a similar 4-component reaction of 
synthesizing polysubstituted N-phenylpyrroles from benzaldehydes, aniline, 
nitromethane and dimethyl acetylenedicarbonxylate with excellent yields.  
      Thus, we achieved our aim to develop an easy synthetic route to a wide 
variety of polysubstituted N-phenylpyrroles for applications in biological assays 
and applications in the industry.  
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Cobalt(II)-Catalyzed Electrophilic Alkynylation in the Synthesis of 
Polysubstituted Furans via π-π Activation.* 
 
6.1     Introduction 
Polysubstituted furans are an important class of 5-membered heterocycles that 
are found in many natural products, pharmaceuticals and agrochemicals [1-5]. 
Many naturally occurring furans have medicinal properties such as antiallergic 
[6], antiasthmatic [7], antispasmodic [8], antitumor [9] and antidiabetic activities 
[10] (Figure 7.1).  
 
 
Figure 6.1: Furan as versatile synthons for further functionalization. 
* This chapter is based on a publication: Adv.Synth. Catal. 2015, 357, 719-726. 
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   Such substituted furans are versatile synthons that can undergo many types of 
reactions to convert to other functionalities (Figure 6.2) [11].  This ability allows 
furan to be an important intermediate in the total synthesis of various complex 
natural products [12-17]. Furthermore, furans can also be transformed to 
biofuels, polymers with electrochemical properties and macrocycles with 
selective binding for biomolecules [18 - 22].  
 
Figure 6.2: Examples of furan-containing compounds (top) and furan as a useful 
intermediate in the total synthesis of Spiculisporic Acid (bottom). 
 
Polysubstituted furans are traditionally synthesized from 1,4-diketones via the 
Paal-Knorr reaction [23] but the required high reaction temperatures and harsh 
acidic conditions are a major shortcoming. Therefore, many alternative methods 
to obtain polysubstituted furans from a variety of substrates have been developed 
[24 - 38]. Most of these syntheses are indeed more effective and require milder 
reaction conditions, but a limited scope of reaction or difficulties with acquiring 
substrates, which frequently are only accessible via multiple-step syntheses, is 
the main drawback. A significant step forward was made in 2012 when Lei et al. 
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showed that arylacetylenes and 1,3-dicarbonyls can be transformed into 
substituted furans via a Ag(I)-mediated dehydrogenative cross-coupling reaction 
[39]. However, this reaction was restricted to aromatic terminal alkynes and 
required long reaction times and also an inert atmosphere.  
   We envisioned that by adding a Br group to the terminal alkyne, the scope of 
the reaction could be extended.  Employing an electrophilic alkynylating reagent 
such as brominated acetylenes increases the flexibility and versatility of the 
acetylene chemistry and extends the scope of the reaction [40 - 41]. This is due 
to its umpolung nature, whereby the terminal Csp is electrophilic, instead of the 
usual nucleophilic nature of Csp of terminal acetylenes. It should also lead to 
shorter reaction times and higher yields. The Csp-Csp2 electrophilic alkynylation 
of aryl and heteroaromatic compounds catalyzed by group 10 – 13 metals such as 
Cu, Au, Ni, Pd and Ga has been extensively studied [42 - 53]. In contrast, only a 
few studies have been conducted on the Csp-Csp3 electrophilic alkynylation of 
aliphatic compounds. One of the first reports was by Ano et al. on the 
alkynylation of carboxylic acid derivatives using brominated acetylenes [54]. 
Huang’s group also employed electrophilic alkynylation to form various 
aromatic H-pyrazolo[5,1-a]isoquinolines from (bromoethynyl)benzene and N’-
(2-alkynyl benzylidene) hydrazide [55]. Wipf and Venkatraman utilized 
electrophilic alkynylation to synthesize thiazoles using alkynyliodonium salts 
and thioamides [56]. More recently, Jiang et al. reacted (bromoethynyl)benzene 
with ethyl 2-pyridylacetate to form 2,3,4-trisubstituted furans via a silver-
catalyzed sequential nucleophilic addition and cyclization reaction [57]. 20 
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mol%  of  AgNO3 was used as a catalyst, with 2 equivalents of the strong organic 
base, 1,4-diazabicyclo[2.2.2]octane (DABCO), to form the desired product.  
 
Scheme 6.1: Retrosynthesis of polysubstituted furans. 
 
   With these works in mind, the possibility of a Csp-Csp3 electrophilic 
alkynylation to form polysubstituted furans from (bromoethynyl)benzene 
derivatives and 1,3- dicarbonyls was investigated (Scheme 6.1). This approach is 
advantageous as (bromoethynyl)benzene derivatives are easily prepared with 
short reaction times and easy work-up while 1,3-dicarbonyls are both cheap and 
commercially available. Also, shorter reaction times, milder conditions without 
the need for strong bases and inert conditions are advantageous as well. 
 
6.2     Experimental 
6.2.1 General information 
The instrumental methods were the same as described in Chapter 2.2.1 except for 
Infra-red spectra (IR) were obtained on a BIO-RAD Excalibur Series FT-IR and 
data conversion was carried out using Varian Resolution. Also, UV 
measurements are recorded on dual-beam UV-vis spectrophotometer UV-1601 
from Shimadzu was employed, scanning from 260 nm - 800 nm. DMAc was 
used as reference and quartz cell are used for measurements. Each sample is 
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diluted until their λmax absorbance is below 1.0 arbrtitary units (a.u), whereby the 
Beer-Lambert-Bouguer law applies. 
 
6.2.2 Materials 
The following chemicals were obtained from Alfa-Aesar, Sigma-Aldrich Merck 
and TCI and used as received: toluene, N,N-dimethylacetamide (DMAc), 
CBrCl3, KOH pellets, dimethyldioctyl-ammonium chloride (DDAC), Ag2CO3, 
PCy3, aromatic and aliphatic alkynes and their derivatives and 1,3-dicarbonyls 
and their derivatives. Anhydrous CoCl2 was obtained by heating CoCl2.6H2O 
(GCE Chemicals) in an oven at 130 °C overnight. 
 
6.2.3 General Procedure for Bromination of Terminal Alkynes [58]. 
A 25 ml round-bottomed flask, cooled in an ice bath, was charged with 
phenylacetylene (1.02 g, 10 mmol), ground KOH (0.056 g, 1 mmol) and 
dimethyldioctylammonium chloride (DDAC) (0.12 g, 0.3 mmol) as phase 
transfer catalyst. This reaction mixture was stirred for 10 min before adding 
CBrCl3 dropwise (4 ml, 20 mmol) over a period of 10 min. The mixture was 
stirred for another 5 minutes. For work up, 10 ml distilled water was added and 
the organic phase was collected and washed twice with distilled water. After 
drying with magnesium sulfate, the solvent was removed using a rotary 
evaporator. For chlorine and iodine derivatives, the halogen sources were 
tetrachloromethane and 1-iodoperfluorohexane, respectively.   
   Aliphatic terminal alkynes were brominated by AgNO3-catalyzed bromination 
of methyl propiolate, octyne and cyclohexylacetylene with N-bromosuccinimide 
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(NBS), to afford 6-2w, 6-2x and 6-2y respectively [59], For iodine derivatives, 
iodination of octyne with KI and TBHP afforded 6-2x’ [60]. 
 
6.2.4 General Procedure for Synthesis of Polysubtituted Furans 
A 25 mL round-bottomed flask was charged with methyl acetoacetate 6-1 (134.8 
µL, 1.25 mmol), (bromoethynyl)benzene 6-2 (59.8 µL, 0.5 mmol), anhydrous 
CoCl2 (6.5 mg, 0.05 mmol), Ag2CO3 (179 mg, 0.65 mmol) in a mixed solvent of 
DMAc and toluene (v/v = 1/1) (8.0 mL). The reaction mixture was stirred at 80 
˚C for 5 h, quenched with 2 M HCl (2 mL) and extracted with ethyl acetate (3 x 
5 mL). After removing the solvent on a rotary evaporator, the crude product was 
subjected to column chromatography using hexane and ethyl acetate (v/v = 10/1) 
as eluent, to afford 6-3aa in 95 % yield. 
 
6.2.5 Procedure for Synthesis of Silver Phenylacetylide [39]. 
A 100 mL round-bottomed flask was charged with a solution of 1-trimethylsilyl-
2-phenylacetylene (872 mg, 5 mmol) in H2O and MeOH (v/v = 1/3) (20.0 mL) 
and AgNO3 (849 mg, 5 mmol) at room temperature for 15 minutes. The white 
solid formed was recovered by filtration, washed with cold MeOH and dried.  
 
6.2.6 Procedure for Electrophilic Alkynylation of Cyclic β-Ketoester. 
Procedure is similar to Chapter 6.2.4 except that 6-1 is replaced with ethyl 2-
oxocyclopentanecarboxylate 6-6 (185.2 µL, 1.25 mmol) and the reaction is 
conducted at 80 °C for 12 h. Column chromatography was performed using 
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hexane and ethyl acetate (v/v = 20/1) instead, to afford 6-7 with an isolated yield 
of 80 %. 
 
6.3     Results and Discussion 
6.3.1   Optimization 
A series of optimization studies were conducted to obtain an optimized condition 
that can be employed for scope of reaction and mechanistic studies (Table 6.1). 
 
6.3.1.1   Effect of Metal Catalyst 
Various metals were screened as suitable catalysts for the electrophilic 
alkynylation reaction between methyl acetoacetate 6-1 and 
(bromoethynyl)benzene 6-2, in the presence of  Ag2CO3 as an additive, at 110 °C 
for 12 h, using dimethyl formamide (DMF) as solvent. In addition to the desired 
polysubstituted furan 6-3aa, the debrominated alkyne, phenylacetylene 6-4, and 
the homocoupling product, 1,4-diphenyldiacetylene 6-5, were also formed in 
varying amounts (Table 6.1). Cu(I) or Pd(II) salts (Table 6.1, entries 1 and 2) 
gave mainly the homocoupling product 6-5. However, when Co(II), Ni(II) or 
Zn(II) chlorides were used as catalyst, the reaction proceeded with good to 
moderate yields to 6-3aa (Table 6.1, entries 3 - 5). Over bromide and iodide salts 
of Co(II), the yield was lower compared to CoCl2, which was the most effective 
































1 CuI DMF 2 110 - 12 4 
2 PdCl2 DMF 2 110 - 12 12 
3 ZnCl2 DMF 2 110 - 12 68 (61) 
4 NiCl2 DMF 2 110 - 12 86 (82) 
5 CoCl2 DMF 2 110 - 12 93 (90) 
6 CoBr2 DMF 2 110 - 12 70 (65) 
7 CoI2 DMF 2 110 - 12 61 (53) 
8 - DMF 2 110 - 12 Traces 
9[c] CoCl2 DMF 2 110 - 12 Traces 
10 CoCl2 DMF 2 80 - 8 47 (42) 
11 CoCl2 DMF 5 80 - 8 60 (53) 
12 CoCl2 DMF 8 80 - 8 95 (92) 
13 CoCl2 Toluene 8 80 - 8 4 
14 CoCl2 DCE 8 80 - 8 26 (10) 
15 CoCl2 Dioxane 8 80 - 8 51 (44) 
16 CoCl2 DMAc 8 80 - 8 86 (82) 
17 CoCl2 Toluene/DMAc 8 80 - 8 99 (94) 
18[d] CoCl2 Toluene/DMAc 8 80 - 8 75 (67) 
19[e] CoCl2 Toluene/DMAc 8 80 - 8 23 (10) 
20[f] CoCl2 Toluene/DMAc 8 80 - 8 4 
21 CoCl2 Toluene/DMAc 8 80 - 5 81 (76) 
22 CoCl2 Toluene/DMAc 8 80 PCy3 5 99 (92) 
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24 CoCl2 Toluene/DMAc 8 80 P(o-tol)3 5 87 (78) 
25 CoCl2 Toluene/DMAc 8 80 PPh3 5 60 (49) 
26[g] CoCl2 Toluene/DMAc 8 80 - 5 95 (92) 
27[h] CoCl2 Toluene/DMAc 8 80 - 5 95 (90) 
28[i] CoCl2 Toluene/DMAc 8 80 - 5 65 (59) 
29[j] CoCl2 Toluene/DMAc 8 80 - 5 67 
[a] Reaction conditions: 6-2 (0.5 mmol), 6-1 (2.0 equiv), catalyst (10 mol %), ligand (20 mol %), 
Ag2CO3 (2 equiv). [b] Yield determined by GC analysis. Isolated yields in parentheses. [c] 
Reaction with no Ag2CO3. [d] Reaction with 3/1 DMAc/Toluene (v/v). [e] Reaction with 1/3 
DMAc/Toluene (v/v). [f] Reaction with 1/9 DMAc/Toluene (v/v)  [g] Reaction with 2.5 equiv of 6-
1.[h] Reaction with 2.5 equiv. of 6-1 and 1.3 equiv of Ag2CO3. [i] Reaction with 2.5 equiv. of 6-1 
and 1.0 equiv of Ag2CO3. [j] Reaction with 1 equiv. of TEMPO and 1.3 eqv of Ag2CO3. 
 
Conversion with respect to 6-2 was low in the absence of CoCl2, with only small 
amounts of 6-4 and traces of 6-3aa (Table 6.1, entry 8). Similarly, in the absence 
of Ag2CO3, only traces of 6-3aa were formed (Table 6.1, entry 9). These results 
show that both CoCl2 and Ag2CO3 are critical for the reaction to proceed with 
high yield.  
   The use of Co(II) as a catalyst for the regioselective synthesis of 
polysubstituted furans has been reported before. A Co(II) porphyrin complex 
initiated the metalloradical cyclization of alkynes with α-diazocarbonyls. A total 
of 28 examples of polysubstituted furans were shown to form with up to 98 % 
isolated yield [61]. A number of Co(II)-catalyzed coupling reactions of 
bromoalkynes with organozinc halides and Grignard reagents have also been 
described in the literature [62-64]. Reducing the reaction temperature to 80 C 
and the reaction time to 8 h causes a significant decrease in yield (Table 6.1, 





6.3.1.2   Effect of Solvent 
The effect of dilution on the reaction activity was investigated. Interestingly, 
increasing the volume of solvent from 2 to 8 mL resulted in an increase in yield 
of 6-3aa from 47 to 95 % after 8 h (Table 6.1, entries 10-12). It was also 
observed that the formation of the unwanted homodimer 6-5 decreases with 
dilution. This implies that the increase in yield of 6-3aa with dilution is the result 
of a slowing down of the dimerisation reaction of (bromoethynyl)benzene 6-2 
(second order reaction), so that more 6-2 will react with the ketoester to form the 
desired product. 
   The effect of type of solvents on yield of 6-3aa was also investigated. Non-
polar solvents like toluene and dichloroethane (DCE) gave low yields of 6-3aa 
whereas polar aprotic solvents like DMAc and DMF resulted in excellent yields 
(Table 6.1, entries 12-16). This could be due to the higher solubility of CoCl2 
and Ag2CO3 in these solvents as compared to the non-polar solvents. Various 
polar aprotic solvents like N-methyl-2-pyrrolidone (NMP), DMSO, DMF and 
DMAc have been employed as the solvents of choice for reactions catalyzed or 
mediated by Ag2CO3 [65-73]. To optimize the solubility of the organic 
substrates, the products and the metal salts, various ratios of DMAc/Toluene 
were tested. The best yield of 6-3aa, 99 % after 8 h, was obtained with a 
DMAc/toluene (v/v = 1/1) mixture, whereas increasing the amount of toluene to 
3/1 and further to 9/1 (v/v) decreased the yield of 6-3aa siginificantly (Table 6.1, 




6.3.1.3   Effect of Ligands 
   Acetylacetonate can act as a bidentate ligand and coordinates with the metal 
cation. The effect of additional ligands was therefore also considered (Table 6.1, 
entries 22-25). The addition of phosphines (Figure 6.3) with electron-
withdrawing phenyl substituent had a negative effect as there was a significant 
decrease in yield of 6-3aa to only 60 %. On the other hand, phosphines with 
electron-donating cyclohexyl and o-tolyl substituents yielded 91 – 99 % of 6-3aa 
after a reaction time of only 5 h. However, the reduction in reaction time to 
obtain high yields of 6-3aa does not justify the extra costs and increased work-up 
required with the addition of the ligands. In fact, by increasing the amounts of 6-
1 to 2.5 equivalents, a fully satisfactory yield of 91 % within 5 h could be 




PCy3 PPh3P(o-tol)3PPh2(o-tol)  
Figure 6.3: Examples of phosphine ligands employed in the optimization study, 
 
6.3.1.4   Fine-tuning of Reaction Conditions 
Firstly, the effect of amount of silver salts was investigated. Reducing the 
amount of Ag2CO3 from 2 to 1.3 equivalents did not affect the reaction. 
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However, a further decrease to 1 equivalent resulted in a significant drop in the 
yield of 6-3aa to 65 % (Table 6.1, entries 26 - 28). Hence, the optimized 
condition employed for subsequent reactions is 10 mol % CoCl2 as catalyst, 1.3 
equivalvents Ag2CO3 as base and bromide acceptor, and a mixed solvent system 
of 8 mL 1:1 DMA/toluene (v/v) at 80 C for 5 h. 
 
 6.3.2   Scope of Reaction 
Using the optimized conditions, the scope of reaction was next investigated 
(Table 6.2). Good to excellent yields of 74 – 95 % were obtained for various β-
ketoesters with 6-2 (Table 6.2, 6-3aa – 6-3ai). However, the reaction was less 
suitable for β-keto esters with a bulky tert-butyl substituent, where at only 47 % 
the yield was significantly lower (Table 6.2, 6-3aj). Reactions employing 
(chloroethynyl)benzene produced similar yield as compared to reaction with 6-2 
but interestingly, the reaction with (iodoethynyl)benzene proceeded at a much 
lower yield (Table 6.2, 6-3aa’, 6-3aa’’). This trend was also observed in a 
similar work done by Jiang et al [57]. No reaction was observed when 
(iodoethynyl)benzene was combined with a sterically hindered tert-butyl 
acetoacetate (Table 6.2, 6-3aj’). These results suggest that the reaction is very 
sensitive to steric constraints and that iodo(ethynyl)benzene, usually thought to 
perform better than its bromo derivatives, due to weaker C-halogen bond 
strengths, was actually less reactive due to these steric factors. Other than β-



















































































































[a] Isolated yields. Reaction conditions: 6-2 (0.5 mmol), 6-1 (2.50 equiv.), CoCl2 (10 mol %), 
Ag2CO3 (1.3 equiv.), DMAc/Toluene (v/v = 1/1) (8.0 mL), 80 °C, 5 h. [b] Reaction with 0.5 mmol 
of (chloroethynyl)benzene. [c] Reaction with 0.5 mmol of (iodoethynyl)benzene. [d] Reaction with 
2.5 equiv of  1-tert-butyl-4-(iodoethynyl)benzene. [e] Reaction with 0.5 mmol of 1-iodooct-1-yne. 
 
β-keto amides and acetylacetone with moderate to good yields (Table 6.2, 6-3ak 
- 6-3am). However, cyclic β-diketone 1,3-cyclohexadione was not suitable for 
the reaction (Table 6.2, 6-3an). This could be due to the inability of the cyclic 
diketone to form a chelate after deprotonation of α proton. Other 1,3-dicarbonyls 
derivatives including benzoylnitromethane and 4,4-dimethyl-3-oxopentanenitrile 













































   Various derivatives of (bromoethynyl)benzene were tested in this reaction. 
High yields were observed for both p-tolyl and m-tolyl derivatives (Table 6.2, 6-
3ba - 6-3ca). However, with the mesityl derivative, only traces of product were 
formed suggesting the effect of steric hindrance at the ortho position (Table 6.2, 
6-3da). Both electron-withdrawing and electron-donating substituting groups at 
the para position including Et, n-Bu, OMe, F were suitable under the reaction 
conditions and this includes other halides like Cl and Br (Table 6.2, 6-3ea, 6-3fa, 
6-3ha – 6-3ka). However, steric effects also affect the reaction yield when 1-
tert-butyl-4-(bromoethynyl)benzene and 1-tert-butyl-4-(iodoethynyl)benzene, 
were reacted with 6-1, resulting in low yields of 47% and 30 % respectively 
(Table 6.2, 6-3ga and 6-3ga’). Reactions emplying other aromatic and 
heteroaromatic derivatives including thiophene and naphthalene proceeded to 
form 6-3la and 6-3ma with good yields of 90 % and 76 %, respectively. Methyl 
3-bromopropiolate was also suitable for this reaction, forming 6-3na with an 
excellent yield of 95 %. This example shows that the reaction is not limited to 
aromatic alkynes but also proceeds well with a propiolate moiety. However, both 
brominated and iodinated aliphatic acetylenes were unsuitable for the reaction, 
with only traces of the desired products formed (Table 6.2, 6-3oa - 6-3pa).  
 
6.3.3   Mechanistic studies 
To gain some insight into the reaction mechanism of this reaction, a series of 




7.3.3.1 Mechanistic Studies on Alkyne Moiety 
. In the first study, 6-2 was replaced with phenylacetylene 6-4 under the 
optimized reaction condition. No desired product 6-3aa were formed, ruling out 
the possibility that dehalogenation at the Csp initiated the reaction (Table 6.3, 
entry 1).   In another set of mechanistic studies, silver phenylacetylide was used 
instead of 6-2, together with 1 or 2 equivalents of Ag2CO3. 6-3aa was formed 
albeit in low yields. Instead, more of the side products 6-4 and 6-5 were formed 
(Table 6.3, entries 2 and 3), showing that the reaction did not proceed via the  
 












6-3aa 6-4 6-5 
1 Ph−≡−H 2 eqv Ag2CO3 - - - 
2 Ph−≡−Ag 1 eqv Ag2CO3 1 43 56 
3 Ph−≡−Ag 2 eqv Ag2CO3 12 55 33 
4[c] Ph−≡−H 2 eqv Ag2CO3 - - 18 
5[d] Ph−≡−Br 1 eqv. Zn, 2 eqv.  
Ag2CO3 
5 - 4 
6 Ph−≡−Br 2 eqv AgOAc 87 - 7 
7 Ph−≡−Br 2 eqv Ag2O 92 2 5 
8 Ph−≡−Br 2 eqv AgOTf 46 43 11 
      
[a] Reaction conditions: 6-1 (2.5 equiv.), 6-2 (0.5 mmol), 10 mol% CoCl2 in DMA/toluene 
(v/v=1/1) (8.0 mL), 80 °C, for 5 h. [b] Yield determined by GC analysis. [c] 1.25 equiv. of methyl 
2-bromoacetoacetate and 1.25 equiv. of methyl acetoacetate were used. [d] Zn and CoCl2 were 




initial formation of the silver phenylacetalide species. To disprove the possibility 
that bromination of methyl acetoacetate occurs by reaction with 6-2, a typical 
reaction using optimized condition was carried out with 1 equivalent of methyl 
2-bromoacetoacetate, 6-1 and phenylacetylene 6-4 (Table 6.3, entry 4). No 6-3aa 
was detected and 6-4 reacted exclusively to form the homodimer product 6-5. 
Thus, it is unlikely that the reaction proceeds via the formation of methyl 2-
bromoacetoacetate intermediate. 
 
6.3.3.2 Elucidating the Cobalt-catalyzed Reaction Pathway 
   Co(II) salts catalyzing various coupling reactions of bromoalkynes with 
organozinc halides and Grignard reagents have been described before, but the 
mechanism involved free radicals [62-64]. Similarly, a Co(II) porphyrin complex 
for the regioselective synthesis of polysubstituted furans initiated the 
metalloradical cyclization of alkynes with a-diazocarbonyl compounds [61]. 
Thus, to determine if this reaction was initiated by radicals, one equivalent of 
2,2,6,6-tetramethylpiperidinyl 1-oxyl (TEMPO) was introduced as radical 
scavenger to the reaction mixture. 67 % of 6-3aa was formed, which is only 
moderately lower than in the absence of TEMPO (Table 6.1, entry 29). The 
observation of a silver mirror on the inside walls of the round-bottomed flask 
shows that some Ag(I) had been reduced to silver metal, lowering the Ag+ 
concentration to below optimum. This result is indeed comparable, in terms of 
yield, to that obtained when only 1 equivalent of Ag2CO3 was used (Table 6.1, 
entry 28).  
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   To elucidate if the catalyst operates via an oxidative mechanism involving 
Co(I)/Co(III) or a π-activation mechanism involving Co(II), zinc was used to 
reduce Co(II) to the Co(I) species in situ prior to the reaction (Table 6.3, entry 5) 
[74-78]. An excess of zinc was employed to ensure the complete reduction of 
Co(II) to Co(I). It was noted that the presence of zinc could also lead to the 
reduction of some Ag2CO3 to metallic silver. Trace amounts of 6-3aa were 
formed under these conditions, implying that the reaction does not proceed via a 
Co(I)/Co(III) mechanism but rather via π-activation.  
 
6.3.3.3 Effect of Various Ag salts 
   Different Ag salts were also tested as additives for this electrophilic 
alkynylation reaction. While AgOAc or Ag2O were suitable for this reaction, 
albeit at a lower yield than Ag2CO3, reaction with AgOTf proceeded poorly 
(Table 6.3, entries 6–8). This suggests that in addition to increasing the 
electrophilicity of the brominated alkyne and to precipitate out the Br anion, 
Ag(I) could also function as a base in abstracting α-proton from 6-1 to form the 
methyl acetoacetanoate anion.  
 
6.3.3.4   Reaction of Substrate with One α-Proton 
To prove that the reaction proceeds via an alk-3-yn-1-one intermediate before 
subsequent cycloisomerization forms the desired furan product, a typical reaction 
employing the optimized condition was conducted, substituting 6-1 with ethyl 2-








Scheme 6.2: Reaction scheme for the electrophilic alkynylation of 6-6 to form 6-
7. 
 
   This substrate lacks an additional α-proton, and once formed, the product 
formed should not be able to undergo cyclization. Alkynylated product 6-7 was 
indeed formed and could be isolated with 80% isolated yield, lending further 
support that a cycloisomerization of alk-3-yn-1-one intermediate is formed 
before cycloisomerization forms the furan product. Cycloizomerization of alk-3-
yn-1-one and its derivatives is well documented in literature, catalyzed by PdCl2 
[79], ZnCl2 [80], CuCl [81], AgBF4 [82], [(Ph3P)Au]OTf [83] and even NBS and 
NIS [84].  
 
6.3.4   Proposed Mechanism 
Based on our optimization studies, an analysis of the substituent influence and 
the mechanistic studies, two different plausible reaction mechanisms are 
proposed (Figure 6.4). We postulate that reaction begins with Ag2CO3 acting as a 
base to deprotonate methyl acetoacetate 6-1 at the α-position. This forms the 


































































































Figure 6.4: Proposed mechanisms for the Co(II)-catalyzed electrophilic 
alkynylation reaction based on initial C-C (left) or C-O (right) bond formation 
with the alkyne moiety. 
 
Co(II) complex A, Two plausible pathways to form desired furan product is 
proposed, depending on initial C-O bond formation (Figure 6.4, right) or initial 
C-C bond formation (Figure 6.4, left) with the alkyne moiety. This is due to the 
nature of the methyl acetoacetanoate anion whereby the negative charge is 
delocalized, allowing it to be at either of the O atoms or α-carbon at any one 
time.  
   The pathway on the right of Figure 6.4 will be explained first. When alkyne 7-
2 enters the catalytic cycle, its triple bond will π-coordinate to the cobalt metal 
center, forming complex B’. The Ag salt could also π-coordinated as well, to 
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increase the electrophilicity of the 6-2 towards impending attack. Next, a 
migratory insertion of the alkynyl substrate forms intermediate C’, via C-O bond 
formation between the keto O atom of complex B’ and the Csp of the alkyne. β-
halo elimination then affords the CoBr complex D’ and releases intermediate E’. 
Reaction of D with another molecule of methyl acetoacetate 6-1 under 
elimination of the bromide by precipitation of AgBr regenerates the Co(II) 
complex A, thus completing the catalytic cycle. Intermediate E’ undergoes a 
rearrangement reaction to form the alk-3-yn-1-one intermediate F’, with 
alkynylation at the α-carbon. Cycloisomerization of F’ then forms the desired 
polysubstituted furan 6-3aa.  
   Next, the pathway on the left of Figure 6.4 is explained. Complex B is formed 
when alkyne substrate 6-2 enters the catalytic cycle (Figure 6.5). In complex B, 
the π electron clouds of the methyl acetoacetanoate anion interacts with that of 
the phenyl group, via π-π interaction. π–π interaction, also known as π–π 
stacking, is defined as a non covalent interaction between a π-donor and a π-
acceptor. It involves orbital interaction between low energy empty orbital 
(LUMO) of the acceptor and the high energy filled orbital (HOMO) of the donor 
[85]. In this case, the phenyl moiety of 6-2 would be the π-donor whereas the 
Co(II)-methylacetoacetanoate complex would be the π-acceptor.  As a result of 
this π–π interaction, both molecules are brought close together to form complex 
B. The Ag salt being soft according to HSAB theory, which states qualitatively 
that soft nucleophile preferentially binds to soft electrophiles, would π-




Figure 6.5: Proposed alignment of (bromoethynyl)benzene and the Co-methyl 
acetoacetanoate complex A for π– π interaction in Complex B. (Blue: Cobalt, 
Red: oxygen, Brown: Bromine, Black: Carbon, White: Hydrogen). 
 
moiety. This increases the electrophilicity of the 6-2 towards impending attack. 
The two molecules are now suitably arranged so that the C−C bond formation 
between the soft α-C of methyl acetoacetanoate anion and the soft electrophilic 
carbon of 6-2 is facilitated via a concerted mechanism. This proceeds through a 6 
membered transition state (Figure 6.4), forming intermediate C. β-halo 
elimination then affords the CoBr complex D and releases intermediate E. D 
reacts with another molecule of methyl acetoacetate 6-1 under elimination of the 
bromide by precipitation of AgBr regenerates the Co(II) complex A, thus 
completing the catalytic cycle, whereas alk-3-yn-1-one intermediate E undergoes 
cycloisomerization reaction to form the desired polysubstituted furan 6-3aa with 
C-O bond formation. 
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   With both plausible pathways explained, we believe that the left pathway is 
more likely. Firstly, a C-C bond formation is more probable than C-O bond 
formation with soft alkyne moiety of 6-2 on the basis of HSAB theory since the 
α-carbon atom in complex B is soft whereas the keto O anion in B’ is hard. 
Secondly, we feel that for the proposed mechanism on the right, the 
rearrangement of E’ to form alk-3-yn-1-one intermediate F’ is less probable as it 
requires additional bond forming and bond breaking, which would have required 
more energy. This is in contrast to just a C-O bond formation between 
intermediate E to form 6-3aa as in the proposed mechanism on the left. Thirdly, 
a six membered ring transition state for formation of intermediate C from 
complex B, would definitely be advantageous. Thus, more investigation into the 
π–π interactions between the complex A and 6-2 is conducted. 
 
6.3.4.1 π– π Interactions 
   The π–π interaction between the phenyl group of 6-2 and the methyl 
acetoacetanoate anion appears to be important for the reaction. A bulky tert-butyl 
group in the β-keto ester or at the p-position of the (bromoethynyl)benzene 
interferes with this alignment, and indeed results in low yields of 6-3aj and 6-
3ga respectively. If these bulky substrates are reacted with the larger and more 
sterically hindered iodide instead of the bromide, a further reduction in the yields 
of 6-3aa’’, 6-3aj’ and 6-3ga’ (Figure 6.6) occur. Similarly, because an ortho 
methyl-substituent at the phenyl group of the (bromoethynyl)benzene derivative 




Figure 6.6: Representative working models for steric clashes occurring during 
Intermediate B for formation of 6-3aa’’, 6-3aj and 6-3ga. I is elaborately drawn 
bigger for size comparison with Br.  
   
acetoacetanoate complex, only trace amounts of 6-3da were formed with this 
substrate. 
   In contrast, brominated methyl priopolate is suitable for the reaction, forming 
excellent yields of 6-3na. This may be due to the formation of a η3 allyl π–π 
interaction with the Co(II)-methyl acetoacetanoate complex. Brominated 
aliphatic alkynes are not suitable substrates as they are unable to form π–π 
interactions with the complex. The formation of a square planar complex 
between the metal and 6-1 facilitates the reaction by allowing favorable π–π 
interactions between the methyl acetoacetanoate anion and the phenyl group of 
6-2. Whereas Co(II) and Ni(II) are known to form square planar complexes [86], 
and thus can catalyze the reaction effectively, Zn(II) is less likely to adopt such a 




6.3.5   Further Proofs 
Last but not least a UV-Vis study was conducted to qualitatively show the π-π 
interaction (Figure 6.7). Based on the UV-Vis spectrum, t(0) has a charge 
transfer band at 261 nm and a d-d transition band at 661 nm. Upon addition of  
 
 
Figure 6.7: UV-Vis spectra of time series of kinetic studies at 50 °C (left) and 
that of various substrate in room temperature (right). (Left image): UV-Vis 
spectra of a typical reaction mixture CoCl2 - t(45), during progress of reaction in 
DMAc at 50 °C. An expanded part of the spectrum at 500 - 800 nm (bottom) and 
a UV-Vis spectrum of 6-3aa (top, right image). CoCl2: CoCl2 in DMAc. t(0): 
Addition of substrates and Ag2CO3. t(15): Reaction time of 15 minutes. t(30): 
Reaction time of 30 minutes. t(45): Reaction time of 45 minutes. (Right image): 
UV-Vis spectrum of various reaction substrates in DMA with and without CoCl2.  
 
 
substrates and Ag2CO3 there is a significant increase in intensity of the charge 
transfer band, together with a shift to 268 nm, As the reaction progress, there is a 
further increase in intensity of the peak at 268 nm. Furthermore, there is a 
bathochromic shift from peaks t(15) to t(45). This implies that the HOMO-
LUMO gap gets narrower as the reaction proceeds and there is an increase in π-π 
activity with time, lending further support to our hypothesis. 
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6.4     Conclusion 
In summary, an efficient π–π activated electrophilic alkynylation reaction has 
been developed to form polysubstituted furans using Co(II) as the catalyst. This 
reaction proceeds via a Csp-Csp3 coupling between 1,3-dicarbonyls and 
bromoethynyl moieties. Ag2CO3 serves as a base for abstracting the α-hydrogen 
from 1,3-dicarbonyl, increases the electrophilicity of the alkyne moiety, and is a 
sacrificial acceptor for the bromide anion. Using this methodology, 
polysubstituted furans can be synthesized under mild conditions with short 
reaction times. Furthermore, the method has a wide scope of reaction and does 
not require an inert atmosphere. A series of experiments and measurements were 
used to prove the hypothesis, including optimization studies, mechanistic studies 
and UV-Vis spectroscopy. To the best of our knowledge, this is a first example 
of a cobalt-catalyzed catalyzed electrophilic alkynylation reaction and pioneers 
its application in the formation of polysubstituted furans via cyclization. 
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In conclusion, five new and simple protocols of synthesizing polysubstituted 4H-
pyrido[1,2-a]pyrimidin-4ones, imidazo[1,2-a]pyridines, phenylimidazo[1,2-
a]pyridines, pyrroles and furans have been developed, by employing 1,3-
dicarbonyls and their derivatives phenylacetone and phenylacetophenones in a 
one-pot reaction. These protocols involves a tandem process that begins with an 
initial cleavage of Csp3-H at the α-carbon, followed by C-X/C-X (X = C, N, O) 
bond formations and lastly, forming of the cyclic product via cycloisomerization 
or ring-closing condensation.  
   The main aim of this project is for these protocols to be viable methods for 
scaled-up synthesis in the fragrance, food and pharmaceutical industry and also 
for applications in the development of biological assays. Thus, there is a focus on 
the minimalistic approach of utilizing inexpensive and commercially available 
reagents and substrates, including their multisubstituted ones, mild reactions 
conditions and short reaction times, using as little reagents as possible, and 
eliminating the need for metals and oxidants, whenever possible, so that a wide 
scope of molecules can be synthesized using these one-pot protocols with 
minimum cost and time expanded. This is especially important in the industry 
and in the development of biological assays, as cost and time must be kept at the 
minimum to save money.  
   In Chapter 2, BiCl3 was employed as the catalyst for the 32 examples of the 
synthesis of 4H-pyrido[1,2-a]pyrimidin-4-ones by coupling of cheap and 
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commercially available 2-aminopyridines with β-ketoesters via C-N/C-N bond 
formation. 2-aminopyridine also acts as a Lewis base, increasing the 
electrophilicity of the Bi(III) metal center and nucloephilicity of the counteranion 
via the spillover effect. This protocol was also possible in a scaled-up synthesis 
at 15 mmol scale.  
   In Chapter 3, a 2-aminopyrdine and CBrCl3 system was employed for the 
synthesis of 29 different types imidazo[1,2-a]pyridines by coupling of 2-
aminopyridines wth 1,3-dicarbonyls via C-N/C-N bond formation. 2-
aminopyridine also acts as an α-brominating reagent to activate the α-carbon in 
situ. This protocol was scaled-up synthesis at 15 mmol scale and proceeded with 
excellent yields.  
   In Chapter 4, a 2-aminopyrdine and CBrCl3 system was for the synthesis of 9 
different types 3-phenylimidazo[1,2-a]pyridines, 13 types of 2,3-
diphenylimidazo[1,2-a]pyridines and 1 type of multiple fused-ring 
phenylimidazo[1,2-a]pyridine by coupling of 2-aminopyridines with 
phenylacetones, phenylacetophenones and β-tetralone respectively, proceeding 
via C-N/C-N bond formation. 2-aminopyridine also acts as an α-brominating 
reagent to activate the α-carbon in situ. This protocol was also possible to be 
scaled-up at 15 mmol scale. 
   In Chapter 5, a 4Å MS promoted 4-component reaction was employed for the 
synthesis of 47 types of polysubstituted pyrroles from amines, aldehydes, 1,3-
dicarbonyls and nitroalkanes via C-C/C-N coupling. 4Å MS addresses a big 
problem in this MCR reaction, which is formation of aldimine side product. It 
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promotes the reaction by converting the unwanted aldimine side product back 
benzaldehyde and p-anisidine. 4Å MS was also shown to be recyclable for 
subsequent runs by heating in the oven or furnace before each new reaction. This 
method have been extended to a similar 4-component reaction of synthesis of 
pyrroles by employing DMAD instead of 1,3-dicarbonyls. This protocol also 
procceded well with high yelds in a scaled-up synthesis at 15 mmol scale. 
   In Chapter 6, CoCl2 was employed as the catalyst for the synthesis of 27 
different types of furans from bromoinated phenylacetylenes and 1,3-
dicarboynls. This method proceeded via a π-π activaton of the aromatic π-system 
of the ring and the Co(II) methyl acetoacetanoate complex.  
   These five protocols are stepping stones for further exploration in the field of 
heterocycle synthesis. Particularly, the newly conceived CBrCl3-aminopyridine 
system can be employed as a simple, greener and oxidant-free alternative to the 
ubiquitous iodinating agents like NIS, PhI(OAc)2 and TBAI, which usually 
requires overstoichiometric amounts of oxidants. This is towards redox economy 
protocols. The system could also be explored further to react with other 
dielectrophiles as well, including brominated acetylenes, α-β unsaturated ketones 
and malonitrile etc. The system could also be expanded further, to replace 
aminopyridine with other dinucleophiles. This is currently done in our group, 
which shows that thiourea-CBrCl3 and thiobenzamide-CBrCl3 system are 
possible as well. Furthermore, it was recently discovered that the coupling 
reaction between 2-aminopyridines and phenylacetophenones using 2-
aminopyridine and CBrCl3 system can be done in room temperature when being 
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exposed to UV light irradiation (30W, UVC). An optimized protocol is currently 
underway. This is a stepping stone towards utilizing energy from the sun for both 
bromination reactions and tandem reactions employing a brominating step as per 
Chapters 3 and 4, instead of conventional heating. 
   Also, the field of Lewis base enhanced Lewis acidity is relatively new and 
could be expanded further. This allows the opportunity to open up the field of 
main-group metal catalysis further, as activation of this main group metal center, 
allows it to be as reactive, if not stronger, than transition and f-group metal 
catalyst for various reactions. Currently, in our group, we are exploring 2-
methylpyridine as a Lewis base activation of Indium and Bismuth triflates for the 
synthesis of indolizines by coupling with 1,3-dicarbonyls. Other N-heterocycles 
















I. Chapter 2: Proposed mechanisms for products for reactions A and B in 
Scheme 2.4. 
 


























































































































































Chapter 3 compound characterization data 
 
2-Methyl-4H-pyrido[1,2-a]pyrimidin-4-one (3-3aa) 
1H NMR (300 MHz, CDCl3) δ 8.93 (d, J = 7.2 Hz, 1H), 7.64 (t, J = 7.4 Hz, 1H), 
7.50 (d, J = 8.7 Hz, 1H), 7.03 (t, J = 6.6 Hz, 1H), 6.24 (s, 1H), 2.37 (s, 3H); 13C 
NMR (300 MHz, CDCl3) δ 165.1, 157.6, 150.5, 136.1, 127.0, 125.6, 114.9, 




1H NMR (300 MHz, CDCl3) δ 8.94 (d, J = 6.9 Hz, 1H), 7.63 (t, J = 7.7 Hz, 1H), 
7.54 (d, J = 9.0 Hz, 1H), 7.02 (t, J = 6.9 Hz, 1H), 6.30 (s, 1H), 2.92-2.77 (m, 
1H), 1.24 (s, 3H), 1.22 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 173.9, 158.4, 
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150.7, 135.7, 126.9, 125.9, 114.8, 100.4, 36.2, 21.5. HRMS (ESI) calcd for 
C11H13N2O [M-H]+: 189.1022; found 189.1025. 
 
2-Propyl-4H-pyrido[1,2-a]pyrimidin-4-one (3-3ca) 
1H NMR (300 MHz, CDCl3) δ 8.87 (d, J = 6.9 Hz, 1H), 7.57 (t, J = 7.8 Hz, 1H), 
7.45 (d, J = 8.7 Hz, 1H), 6.96 (t, J = 6.9 Hz, 1H), 6.19 (s, 1H), 2.50 (t, J = 7.7 
Hz, 2H),  1.70-1.55 (m, 2H), 0.84 (t, J = 7.4 Hz 3H); 13C NMR (300 MHz, 
CDCl3) δ 168.5, 157.7, 150.5, 135.7, 126.8, 125.6, 114.7, 102.4, 40.0, 21.6, 
13.5. HRMS (ESI) calcd for C11H13N2O [M-H]+: 189.1022; found 189.1021. 
 
2-Butyl-4H-pyrido[1,2-a]pyrimidin-4-one (3-3da) 
1H NMR (300 MHz, CDCl3) δ 8.90 (d, J = 7.2 Hz, 1H), 7.61 (t, J = 7.8 Hz, 1H), 
7.49 (d, J = 9.0 Hz, 1H), 6.99 (t, J = 6.9 Hz, 1H), 6.22 (s, 1H), 2.56 (t, J = 7.7 
Hz, 2H),  1.67-1.55 (m, 2H), 1.36-1.22 (m, 2H) 0.83 (t, J = 7.4 Hz 3H); 13C 
NMR (300 MHz, CDCl3) δ 168.9, 157.8, 150.6, 135.8, 126.9, 125.7, 114.7, 
102.4, 37.8, 30.5, 22.2, 13.6. HRMS (ESI) calcd for C12H15N2O [M-H]+: 
203.1179; found 203.1186. 
 
2-Phenyl-4H-pyrido[1,2-a]pyrimidin-4-one (3-3ea) 
1H NMR (300 MHz, CDCl3) δ 9.05 (d, J = 7.2 Hz, 1H), 8.10-8.05 (m, 2H), 7.72 
(d, J = 3.6 Hz, 2H), 7.48 (t, J = 3.0 Hz, 3H), 7.14-7.06 (m, 1H) 6.90 (s, 1H); 13C 
NMR (300 MHz, CDCl3) δ 162.0, 158.6, 150.9, 137.2, 136.1, 130.6, 128.7, 
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127.4, 127.2, 126.7, 115.1, 100.0. HRMS (ESI) calcd for C14H11N2O [M-H]+: 
223.0866; found 223.0860. 
 
Ethyl 3-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidine-2-carboxylate (3-3fa) 
1H NMR (300 MHz, CDCl3) δ 8.92 (d, J = 7.5 Hz, 1H), 7.67-7.60 (m, 2H), 7.09 
(t, J = 7.7 Hz, 1H), 4.41 (q, J = 7.2 Hz, 2H), 2.31 (s, 3H), 4.41 (t, J = 7.2 Hz, 
3H); 13C NMR (300 MHz, CDCl3) δ 165.8, 159.0, 151.4, 148.8, 135.1, 126.7, 
126.6, 115.8, 113.6, 62.0, 14.0, 12.2. HRMS (ESI) calcd for C12H13N2O3 [M-H]+: 
223.0921; found 223.0918. 
 
Ethyl 2-(4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)acetate (3-3ga) 
1H NMR (300 MHz, CDCl3) δ 9.03 (d, J = 6.9 Hz, 1H), 7.73 (t, J = 7.8 Hz, 1H), 
7.63 (d, J = 9.0 Hz, 1H), 7.14 (t, J = 6.8 Hz, 1H) 6.43 (s, 1H), 4.20 (q, J = 7.2 
Hz, 2H), 3.71 (s, 2H) 1.26 (t, J = 7.2 Hz, 3H); 13C NMR (300 MHz, CDCl3) δ 
169.4, 160.7, 157.8, 150.9, 136.4, 127.2, 126.2, 115.5, 104.2, 61.3, 43.9, 14.1. 
HRMS (ESI) calcd for C12H13N2O3 [M-H]+: 223.0921; found 223.0920. 
 
2-(Chloromethyl)- 4H-pyrido[1,2-a]pyrimidin-4-one (3-3ha) 
1H NMR (300 MHz, DMSO) δ 8.96 (d, J = 6.9 Hz, 1H), 8.00 (t, J = 7.8 Hz, 1H), 
7.71 (d, J = 8.7 Hz, 1H), 7.39 (t, J = 6.9 Hz, 1H) 6.56 (s, 1H), 4.67 (s, 2H); 13C 
NMR (300 MHz, CDCl3) δ 162.0, 157.3, 150.8, 138.0, 127.0, 125.7, 116.6, 





1H NMR (300 MHz, CDCl3) δ 9.05 (d, J = 6.9 Hz, 1H), 7.86 (t, J = 7.2 Hz, 1H), 
7.78 (d, J = 8.7 Hz, 1H), 7.26 (t, J = 7.2 Hz, 1H), 6.75 (s, 1H); 13C NMR (300 
MHz, CDCl3) δ 157.8, 153.1, 152.6, 151.8, 137.7, 127.5, 127.0, 122.4, 118.8, 
116.9, 115.1, 101.2, 101.1. HRMS (ESI) calcd for C9H6F3N2O [M-H]+: 
215.0427; found 215.0428. 
 
2,3-Dimethyl-4H-pyrido[1,2-a]pyrimidin-4-one (3-3ja) 
1H NMR (300 MHz, CDCl3) δ 8.78 (d, J = 7.5 Hz, 1H), 7.45 (t, J = 7.8 Hz, 1H), 
7.34 (d, J = 9.0 Hz, 1H), 6.89 (t, J = 6.8 Hz, 1H), 2.31 (s, 3H), 2.08 (s, 3H); 13C 
NMR (300 MHz, CDCl3) δ 160.9, 157.6, 147.7, 134.1, 126.6, 125.3, 114.3, 




1H NMR (300 MHz, CDCl3) δ 8.72 (d, J = 7.2 Hz, 1H), 7.39 (t, J = 7.8 Hz, 1H), 
7.27 (d, J = 9.0 Hz, 1H), 6.82 (t, J = 6.9 Hz, 1H), 2.49 (q, J = 7.5 Hz, 2H), 2.26, 
(s, 3H), 0.94 (t, J = 7.5 Hz, 3H); 13C NMR (300 MHz, CDCl3) δ 160.3, 157.2, 
147.7, 134.2, 126.5, 125.2, 117.0, 114.2, 21.7, 19.6, 12.3. HRMS (ESI) calcd for 







1H NMR (300 MHz, CDCl3) δ 8.99 (d, J = 6.9 Hz, 1H), 7.64(t, J = 7.5 Hz, 1H), 
7.55 (d, J = 8.7 Hz, 1H), 7.41 (t, J = 7.4 Hz, 2H), 7.33 (q, J = 6.9 Hz, 3H), 7.04 
(t, J = 6.5 Hz, 1H), 2.34, (s, 3H),; 13C NMR (300 MHz, CDCl3) δ 161.7, 157.1, 
149.0, 135.6, 134.8, 130.1, 128.2, 127.4, 127.3, 125.6, 116.7, 114.9, 23.6. HRMS 
(ESI) calcd for C15H13N2O [M-H]+: 237.1022; found 237.1015. 
 
3-Benzyl-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one (3-3ma) 
1H NMR (300 MHz, CDCl3) δ 8.82 (d, J = 4.5 Hz, 1H), 7.35(s, 2H), 7.24-6.96 
(m, 5H), 6.82 (s, 1H), 3.97 (s, 2H), 2.36, (s, 3H); 13C NMR (300 MHz, CDCl3) δ 
161.6, 157.5, 148.0, 139.3, 134.5, 127.8, 127.8, 126.6, 125.6, 125.1, 114.3, 




1H NMR (300 MHz, CDCl3) δ 9.02 (d, J = 6.9 Hz, 1H), 7.63 (t, J = 7.5 Hz, 1H), 
7.54 (d, J = 8.7 Hz, 1H), 7.05 (t, J = 6.6 Hz, 1H), 2.96 (q, J = 7.5 Hz, 4H), 2.17-
2.04(m, 2H); 13C NMR (300 MHz, CDCl3) δ 170.6, 155.5, 151.0, 135.0, 127.2, 
125.8, 115.2, 114.7, 35.5, 27.9, 21.6. HRMS (ESI) calcd for C11H11N2O [M-H]+: 







1H NMR (300 MHz, CDCl3) δ 8.90 (d, J = 7.2 Hz, 1H), 7.60 (t, J = 7.7 Hz, 1H), 
7.52 (d, J = 8.7 Hz, 1H), 7.02 (t, J = 6.8 Hz, 1H), 2.79 (t, J = 5.7 Hz, 2H), 2.70 (t, 
J = 5.7 Hz, 2H) 1.90-1.77 (m, 4H); 13C NMR (300 MHz, CDCl3) δ 161.7, 157.7, 
148.2, 134.7, 126.7, 125.3, 114.5, 113.4, 32.3, 23.0, 22.2, 21.9. HRMS (ESI) 
calcd for C12H13N2O [M-H]+: 201.1022; found 201.1020. 
 
7,8,9,10-Tetrahydrocyclohepta[d]pyrido[1,2-a]pyrimidin-11(6H)-one (3-3pa) 
1H NMR (300 MHz, CDCl3) δ 8.90 (d, J = 7.2 Hz, 1H), 7.53 (t, J = 7.7 Hz, 1H), 
7.43 (d, J = 9.0 Hz, 1H), 6.98 (t, J = 6.8 Hz, 1H), 2.85 (t, J = 5.3 Hz, 4H) 1.83-
1.73 (m, 2H), 1.67-1.49 (m, 4H); 13C NMR (300 MHz, CDCl3) δ 167.9, 157.6, 
148.1, 134.4, 127.2, 125.7, 117.2, 114.7, 39.1, 32.2, 26.9, 25.6, 25.2. HRMS 
(ESI) calcd for C13H15N2O [M-H]+: 215.1179; found 215.1170. 
 
2,6-Dimethyl-4H-pyrido[1,2-a]pyrimidin-4-one (3-3ab) 
1H NMR (300 MHz, CDCl3) δ 8.82 (d, J = 7.2 Hz, 1H), 7.26 (s, 1H), 6.85 (d, J = 
7.5 Hz, 1H), 6.17 (s, 1H), 2.39 (s, 3H), 2.35 (s, 3H); 13C NMR (300 MHz, 
CDCl3) δ 165.3, 157.7, 150.6, 148.2, 126.3, 123.7, 117.5, 102.2, 24.6, 21.3. 
HRMS (ESI) calcd for C10H11N2O [M-H]+: 175.0866; found 175.0870. 
 
2,7-Dimethyl-4H-pyrido[1,2-a]pyrimidin-4-one (3-3ac) 
1H NMR (300 MHz, CDCl3) δ 8.65 (s, 1H), 7.43 (d, J = 9 Hz, 1H), 7.33 (d, J = 
9.0 Hz, 1H), 6.14 (s, 1H), 2.29 (s, 3H), 2.26 (s, 3H); 13C NMR (300 MHz, 
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CDCl3) δ 164.3, 157.3, 149.3, 138.8, 124.9, 124.3, 102.7, 24.3, 18.0. HRMS 
(ESI) calcd for C10H11N2O [M-H]+: 175.0866; found 175.0872. 
 
2,8-Dimethyl-4H-pyrido[1,2-a]pyrimidin-4-one (3-3ad) 
1H NMR (300 MHz, CDCl3) δ 8.87 (d, J = 7.2 Hz, 1H), 7.32 (s, 1H), 6.90 (d, J = 
7.5 Hz, 1H), 6.22 (s, 1H), 2.43 (s, 3H), 2.40 (s, 3H); 13C NMR (300 MHz, 
CDCl3) δ 165.3, 157.8, 150.6, 148.3, 126.4, 123.8, 117.6, 107.3, 24.6, 21.4. 
HRMS (ESI) calcd for C10H11N2O [M-H]+: 175.0866; found 175.0868. 
 
2,9-Dimethyl-4H-pyrido[1,2-a]pyrimidin-4-one (3-3ae) 
1H NMR (300 MHz, CDCl3) δ 8.92 (d, J = 6.9 Hz, 1H), 7.54 (d, J = 6.9 Hz, 1H), 
6.98 (t, J = 7.1 Hz, 1H), 6.32 (s, 1H), 2.57 (s, 3H), 2.46 (s, 3H); 13C NMR (300 
MHz, CDCl3) δ 164.5, 158.4, 150.3, 134.7, 134.4, 125.3, 114.4, 103.1, 24.9, 
18.2. HRMS (ESI) calcd for C10H11N2O [M-H]+: 175.0866; found 175.0866. 
 
8-Ethyl-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one (3-3af) 
1H NMR (300 MHz, CDCl3) δ 8.63 (d, J = 6.0 Hz, 1H), 7.06 (s, 1H), 6.70 (d, J = 
4.8 Hz, 1H), 5.97 (s, 1H), 2.51 (q, J = 6.1 Hz, 2H), 2.17 (s, 3H), 1.06 (t, J = 6.1 
Hz, 3H); 13C NMR (300 MHz, CDCl3) δ 164.7, 157.3, 153.3, 150.3, 126.0, 
121.7, 116.1, 101.8, 27.7, 24.1, 12.6. HRMS (ESI) calcd for C11H13N2O [M-H]+: 






1H NMR (300 MHz, CDCl3) δ 8.94-8.90 (m, 1H), 7.64-7.60 (m, 2H), 6.35 (s, 
1H), 2.46 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 165.2, 156.8, 149.0, 137.3, 
126.8, 125.0, 123.6, 103.8, 24.6. HRMS (ESI) calcd for C9H8FN2O [M-H]+: 
179.0615; found 175.0619. 
 
7-Chloro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one (3ah) 
1H NMR (300 MHz, CDCl3) δ 9.04 (d, J = 2.1 Hz, 1H), 7.64 (d, J = 9.5 Hz, 1H), 
7.53 (d, J = 9.3 Hz, 1H), 6.35 (s, 1H), 2.46 (s, 3H); 13C NMR (300 MHz, CDCl3) 
δ 165.2, 156.8, 149.0, 137.4, 126.8, 125.0, 123.6, 103.8, 24.6. HRMS (ESI) calcd 
for C9H8ClN2O [M-H]+: 195.0320; found 195.0317. 
 
7-Bromo-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one (3-3ai) 
1H NMR (300 MHz, CDCl3) δ 9.14 (d, J = 2.4 Hz, 1H), 7.73 (d, J = 9.3 Hz, 1H), 
7.46 (d, J = 9.3 Hz, 1H), 6.35 (s, 1H), 2.45 (s, 3H); 13C NMR (300 MHz, CDCl3) 
δ 165.2, 156.8, 149.1, 139.5, 127.4, 126.8, 110.2, 103.9, 24.6. HRMS (ESI) calcd 
for C9H8BrN2O [M-H]+: 238.9815; found 238.9804. 
 
7-Iodo-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one (3-3aj) 
1H NMR (300 MHz, CDCl3) δ 9.24 (d, J = 1.5 Hz, 1H), 7.83 (d, J = 9.3 Hz, 1H), 
7.31 (d, J = 9.3 Hz, 1H), 6.34 (s, 1H), 2.44 (s, 3H); 13C NMR (300 MHz, CDCl3) 
δ 165.3, 156.6, 149.2, 143.9, 132.4, 126.8, 103.9, 78.5, 24.7. HRMS (ESI) calcd 




1H NMR (300 MHz, CDCl3) δ 8.49 (d, J = 6.9 Hz, 1H), 7.15-6.96 (m, 3H), 6.29 
(s, 1H), 2.43 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 163.1, 157.8, 148.3, 144.1, 
117.8, 115.1, 113.1, 103.6, 24.1. HRMS (ESI) calcd for C9H9N2O2 [M-H]+: 
177.0659; found 177.0660. 
 
2-Methyl-7-nitro-4H-pyrido[1,2-a]pyrimidin-4-one (3-3al) 
1H NMR (300 MHz, CDCl3) δ 9.96 (d, J = 2.1 Hz, 1H), 8.32 (d, J = 9.6 Hz, 1H), 
7.60 (d, J = 9.6 Hz, 1H), 6.43 (s, 1H), 2.49 (s, 3H); 13C NMR (300 MHz, CDCl3) 
δ 166.6, 157.0, 150.2, 144.5, 128.9, 127.7, 126.9, 105.0, 24.8. HRMS (ESI) calcd 
for C9H8N3O3 [M-H]+: 206.0557; found 206.0559. 
 
Ethyl 2-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidine-9-carboxylate (3-3am)  
1H NMR (300 MHz, CDCl3) δ 9.09 (d, J = 7.2 Hz, 1H), 7.96 (d, J = 6.9 Hz, 1H), 
7.08(t, J = 7.1 Hz, 1H), 6.36 (s, 1H), 4.47 (q, J = 7.2 Hz, 2H) 2.46 (s, 3H), 1.42 
(t, J = 7.2 Hz, 1H); 13C NMR (300 MHz, CDCl3) δ 165.7, 164.9, 157.5, 147.8, 
136.6, 129.5, 113.4, 104.0, 98.1, 62.2, 24.9, 14.1. HRMS (ESI) calcd for 
C12H13N2O3 [M-H]+: 233.0921; found 233.0920. 
 
7-Methyl-5H-thiazolo[3,2-a]pyrimidin-5-one (3-3an) 
1H NMR (300 MHz, CDCl3) δ 7.88 (d, J = 5.1 Hz, 1H), 6.94 (d, J = 4.8 Hz, 1H), 
6.08 (s, 1H), 2.30 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 164.1, 162.3, 158.3, 
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1H NMR (300 MHz, CDCl3) δ 9.91 (s, 1H), 8.30-8.12 (m, 2H), 7.66 (t, J = 7.8 
Hz, 1H), 6.98 (t, J = 6.3 Hz, 1H), 2.15 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 
169.1, 151.9, 147.1, 138.4, 119.4, 114.6, 24.3. HRMS (ESI) calcd for C7H9N2O 
[M-H]+: 185.0709; found 185.0708. 
 
II. Chapter 4 compound characterization data 
Methyl 2-methylimidazo[1,2-a]pyridine-3-carboxylate (4-3aa) 
1H NMR (300 MHz, CDCl3) δ 9.02 (d, J = 6.9 Hz, 1H), 7.38 (d, J = 8.7 Hz, 1H), 
7.17 (t, J = 7.8 Hz, 1H), 6.73 (t, J = 6.9 Hz, 1H), 3.75 (s, 3H), 2.49 (s, 3H); 13C 
NMR (300 MHz, CDCl3) δ 161.2, 152.3, 146.4, 127.4, 127.2, 116.1, 113.2, 
112.0, 50.9, 16.1. HRMS (ESI) calcd for C10H11N2O2 [M-H]+: 191.0815; found 
191.0814. 
 
Ethyl 2-methylimidazo[1,2-a]pyridine-3-carboxylate (4-3ba) 
1H NMR (300 MHz, CDCl3) δ 8.91 (d, J = 6.6 Hz, 1H), 7.24 (d, J = 9.0 Hz, 1H), 
7.00 (t, J = 7.8 Hz, 1H), 6.58 (t, J = 6.9 Hz, 1H), 4.09 (q, J = 7.1 Hz, 2H), 2.38 
(s, 3H), 1.12 (t, J = 7.1 Hz, 3H); 13C NMR (300 MHz, CDCl3) δ 160.6, 152.0, 
146.1, 127.2, 126.7, 115.9, 112.8, 111.8, 59.5, 16.0, 13.8. HRMS (ESI) calcd for 
C11H13N2O2 [M-H]+: 205.0972; found 205.0977. 
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Isopropyl 2-methylimidazo[1,2-a]pyridine-3-carboxylate (4-3ca) 
1H NMR (300 MHz, CDCl3) δ 9.02 (d, J = 6.9 Hz, 1H), 7.33 (d, J = 9.0 Hz, 1H), 
7.08 (t, J = 7.8 Hz, 1H), 6.68 (t, J = 6.9 Hz, 1H), 5.14-5.00 (m, 1H), 2.47 (s, 3H), 
1.18 (d, J = 6.3 Hz, 6H); 13C NMR (300 MHz, CDCl3) δ 160.4, 151.9, 146.2, 
127.3, 126.9, 116.0, 113.0, 112.2, 67.4, 21.7, 16.2. HRMS (ESI) calcd for 
C12H15N2O2 [M-H]+: 219.1128; found 219.1129. 
 
tert-Butyl 2-methylimidazo[1,2-a]pyridine-3-carboxylate (4-3da) 
1H NMR (300 MHz, CDCl3) δ 9.02 (d, J = 6.9 Hz, 1H), 7.38 (d, J = 8.7 Hz, 1H), 
7.17 (t, J = 7.8 Hz, 1H), 6.73 (t, J = 6.9 Hz, 1H), 3.75 (s, 3H), 2.49 (s, 3H); 13C 
NMR (300 MHz, CDCl3) δ 160.1, 151.3, 145.8, 127.2, 126.5, 115.8, 112.7, 
112.7, 80.8, 27.9, 16.1. HRMS (ESI) calcd for C13H17N2O2 [M-H]+: 233.1284; 
found 233.1286. 
 
Pentyl 2-methylimidazo[1,2-a]pyridine-3-carboxylate (4-3ea) 
1H NMR (300 MHz, CDCl3) δ 9.11 (d, J = 6.0 Hz, 1H), 7.42 (d, J = 8.1 Hz, 1H), 
7.18 (t, J = 7.8 Hz, 1H), 6.77 (t, J = 6.8 Hz, 1H), 4.19 (t, J = 6.3 Hz, 2H), 2.55 (s, 
3H), 1.70-1.57 (m, 2H), 1.34-1.19 (m, 4H), 0.77 (t, J = 6.6 Hz, 3H); 13C NMR 
(300 MHz, CDCl3) δ 161.1, 152.2, 146.4, 127.5, 127.2, 116.2, 113.2, 112.2, 64.0, 
28.2, 27.9, 22.0, 16.3, 13.1. HRMS (ESI) calcd for C14H19N2O2 [M-H]+: 





Cyclohexyl 2-methylimidazo[1,2-a]pyridine-3-carboxylate (4-3fa) 
1H NMR (300 MHz, CDCl3) δ 8.89 (d, J = 6.9 Hz, 1H), 7.19 (d, J = 9.0 Hz, 1H), 
6.93 (t, J = 7.8 Hz, 1H), 6.53 (t, J = 6.8 Hz, 1H), 4.78-4.69 (m, 1H), 2.36 (s, 3H), 
1.65-1.57 (m, 2H), 1.45-1.40 (m, 2H), 1.30-0.98 (m, 6H); 13C NMR (300 MHz, 
CDCl3) δ 160.0, 151.5, 145.9, 127.0, 126.5, 115.7, 112.7, 112.0, 71.7, 31.0, 24.7, 
22.9, 16.0. HRMS (ESI) calcd for C15H19N2O2 [M-H]+: 259.1440; found 
259.1443. 
 
2-Methoxyethyl 2-methylimidazo[1,2-a]pyridine-3-carboxylate (4-3ga) 
1H NMR (300 MHz, CDCl3) δ 9.06 (d, J = 6.6 Hz, 1H), 7.41 (d, J = 8.7 Hz, 1H), 
7.18 (t, J = 8.0 Hz, 1H), 6.77 (t, J = 6.8 Hz, 1H), 4.34 (t, J = 4.7 Hz, 2H), 3.58 (t, 
J = 4.8 Hz, 2H), 3.26 (s, 3H), 2.55 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 
160.5, 152.6, 146.4, 127.4, 127.1, 116.1, 113.1, 111.8, 70.1, 62.5, 58.4, 16.2. 
HRMS (ESI) calcd for C12H15N2O3 [M-H]+: 235.1077; found 235.1083. 
 
N,N-Diethyl-2-methylimidazo[1,2-a]pyridine-3-carboxmide (4-3ha) 
1H NMR (300 MHz, CDCl3) δ 8.15 (d, J = 6.9 Hz, 1H), 7.39 (d, J = 9.0 Hz, 1H), 
7.07 (t, J = 8.0 Hz, 1H), 6.68 (t, J = 6.8 Hz, 1H), 3.41 (q, J = 7.1 Hz, 4H), 2.32 
(s, 3H), 1.05 (t, J = 7.1 Hz, 6H); 13C NMR (300 MHz, CDCl3) δ 162.5, 145.3, 
142.5, 125.4, 125.4, 116.3, 116.0, 112.3, 40.7, 14.4, 13.6. HRMS (ESI) calcd for 






1H NMR (300 MHz, CDCl3) δ 8.37 (d, J = 6.9 Hz, 1H), 7.46 (d, J = 9.0 Hz, 1H), 
7.16 (t, J = 7.8 Hz, 1H), 6.75 (t, J = 6.8 Hz, 1H), 3.53 (s, 4H), 2.40 (s, 3H), 1.62-
1.55 (m, 6H); 13C NMR (300 MHz, CDCl3) δ 161.6, 145.3, 143.2, 125.8, 125.3, 
115.8, 115.2, 111.9, 45.5, 25.7, 23.9, 14.4. HRMS (ESI) calcd for C14H18N3O 
[M-H]+: 244.1444; found 244.1447. 
 
2-Methylimidazo[1,2-a]pyridine-3-carboxamide (4-3ja) 
1H NMR (300 MHz, CDCl3) δ 9.42 (d, J = 6.6 Hz, 1H), 7.56 (d, J = 8.7 Hz, 1H), 
7.32 (t, J = 7.8 Hz, 1H), 6.90 (t, J = 6.8 Hz, 1H), 6.88 (s, 2H), 6.06 (broad, 2H),  
2.71 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 163.3, 146.8, 146.3, 128.3, 127.3, 
116.4, 114.6, 113.4, 16.7. HRMS (ESI) calcd for C9H10N3O [M-H]+: 176.0820; 
found 176.0824. 
 
Ethyl 2-propylimidazo[1,2-a]pyridine-3-carboxylate (4-3ka) 
1H NMR (300 MHz, CDCl3) δ 8.86 (d, J = 7.2 Hz, 1H), 7.19 (d, J = 9.0 Hz, 1H), 
6.90 (t, J = 8.0 Hz, 1H), 6.49 (t, J = 6.9 Hz, 1H), 4.00 (q, J = 7.2 Hz, 2H), 2.65 (t, 
J = 7.8 Hz, 2H), 1.46-1.32 (m, 2H), 1.01 (t, J = 7.2 Hz, 3H), 0.60 (t, J = 7.4 Hz, 
3H); 13C NMR (300 MHz, CDCl3) δ 160.8, 156.2, 146.4, 127.5, 127.0, 116.2, 
113.0, 111.7, 59.7, 31.6, 22.4, 13.9, 13.7. HRMS (ESI) calcd for C13H17N2O2 





Methyl 2-butylimidazo[1,2-a]pyridine-3-carboxylate (4-3la) 
1H NMR (300 MHz, CDCl3) δ 9.07 (d, J = 7.2 Hz, 1H), 7.41 (d, J = 9.0 Hz, 1H), 
7.14 (t, J = 8.0 Hz, 1H), 6.73 (t, J = 6.9 Hz, 1H), 3.76 (s, 3H), 2.89 (t, J = 7.8 Hz, 
2H), 1.63-1.51 (m, 2H), 1.31-1.20 (m, 2H), 0.77 (t, J = 7.3 Hz, 3H); 13C NMR 
(300 MHz, CDCl3) δ 161.2, 156.7, 146.6, 127.6, 127.1, 116.3, 113.1, 111.6, 50.8, 
31.2, 29.3, 22.3, 13.5. HRMS (ESI) calcd for C13H17N2O2 [M-H]+: 233.1284; 
found 233.1289. 
 
Methyl 2-isopropylimidazo[1,2-a]pyridine-3-carboxylate (4-3ma) 
1H NMR (300 MHz, CDCl3) δ 9.11 (d, J = 6.9 Hz, 1H), 7.49 (d, J = 9.0 Hz, 1H), 
7.16 (t, J = 8.0 Hz, 1H), 6.75 (t, J = 6.9 Hz, 1H), 3.79 (s, 3H), 3.72-3.62 (m, 1H), 
1.22 (d, J = 6.9 Hz, 6H); 13C NMR (300 MHz, CDCl3) δ 161.7, 161.4, 146.8, 
127.7, 127.1, 116.5, 113.2, 110.7, 50.9, 27.5, 21.8. HRMS (ESI) calcd for 
C12H14N2O2 [M-H]+: 219.1128; found 219.1131. 
 
Ethyl 2-tert-butylimidazo[1,2-a]pyridine-3-carboxylate (4-3na) 
1H NMR (300 MHz, CDCl3) δ 9.15 (d, J = 6.9 Hz, 1H), 7.51 (d, J = 9.0 Hz, 1H), 
7.14 (t, J = 7.8 Hz, 1H), 6.74 (t, J = 6.9 Hz, 1H), 4.32 (q, J = 7.2 Hz, 2H), 1.40 
(s, 9H), 1.30 (t, J = 7.1 Hz, 3H); 13C NMR (300 MHz, CDCl3) δ 163.0, 160.7, 
145.0, 127.8, 126.6, 116.8, 113.3, 111.9, 60.2, 34.3, 29.2, 14.0. HRMS (ESI) 





Ethyl 2-phenylimidazo[1,2-a]pyridine-3-carboxylate (4-3oa) 
1H NMR (300 MHz, CDCl3) δ 9.39 (d, J = 6.9 Hz, 1H), 7.77-7.68 (m, 3H), 7.44-
7.38 (m, 4H), 7.00 (t, J = 6.9 Hz, 1H), 4.28 (q, J = 7.1 Hz, 2H), 1.20 (t, J = 7.1 
Hz, 3H) ); 13C NMR (300 MHz, CDCl3) δ 161.0, 153.5, 147.0, 134.4, 130.1, 
128.6, 128.2, 127.8, 127.4, 117.4, 114.0, 111.9, 60.3, 13.9. HRMS (ESI) calcd 
for C16H15N2O2 [M-H]+: 267.1134; found 267.1137. 
 
1-(2-Methylimidazo[1,2-a]pyridin-3-yl)ethanone (4-3pa) 
1H NMR (300 MHz, CDCl3) δ 9.20 (d, J = 6.9 Hz, 1H), 7.16 (d, J = 8.7 Hz, 1H), 
7.01 (t, J = 7.8 Hz, 1H), 6.54 (t, J = 6.6 Hz, 1H), 2.33 (s, 3H), 2.16 (s, 3H); 13C 
NMR (300 MHz, CDCl3) δ 186.5, 151.8, 145.8, 128.1, 128.0, 120.8, 115.5, 




1H NMR (300 MHz, CDCl3) δ 9.02 (d, J = 6.9 Hz, 1H), 7.38 (d, J = 8.7 Hz, 1H), 
7.17 (t, J = 7.8 Hz, 1H), 6.73 (t, J = 6.9 Hz, 1H), 3.75 (s, 3H), 2.49 (s, 3H); 13C 
NMR (300 MHz, CDCl3) δ 161.2, 152.3, 146.4, 127.4, 127.2, 116.1, 113.2, 







Methyl 2,5-dimethylimidazo[1,2-a]pyridine-3-carboxylate (4-3ab) 
1H NMR (300 MHz, CDCl3) 7.44 (d, J = 8.7 Hz, 1H), 7.25 (t, J = 7.8 Hz, 1H), 
6.68 (d, J = 6.9 Hz, 1H), 3.89 (s, 3H), 2.58 (s, 3H); 13C NMR (300 MHz, 
CDCl3) δ 161.2, 151.9, 148.1, 138.3, 127.6, 114.8, 114.0, 51.4, 21.5, 15.8. 
HRMS (ESI) calcd for C11H13N2O2 [M-H]+: 205.0972; found 205.00973. 
 
Methyl 2,6-dimethylimidazo[1,2-a]pyridine-3-carboxylate (4-3ac) 
1H NMR (300 MHz, CDCl3) δ 8.47 (s, 1H), 6.95 (d, J = 9.0 Hz, 1H), 6.67 (d, J = 
9.0 Hz, 1H), 3.50 (s, 3H), 2.21 (s, 3H), 1.86 (s, 3H); 13C NMR (300 MHz, 
CDCl3) δ 160.6, 151.4, 144.9, 129.3, 124.8, 122.4, 114.8, 111.1, 50.2, 17.4, 15.7. 
HRMS (ESI) calcd for C11H13N2O2 [M-H]+: 205.0972; found 205.0974. 
 
Methyl 2,7-dimethylimidazo[1,2-a]pyridine-3-carboxylate (4-3ad) 
1H NMR (300 MHz, CDCl3) δ 7.10 (d, J = 6.9 Hz, 1H), 6.89 (s, 1H), 6.29 (d, J = 
6.9 Hz, 1H), 3.55 (s, 3H), 2.27 (s, 3H), 2.00 (s, 3H); 13C NMR (300 MHz, 
CDCl3) δ 160.7, 151.9, 146.5, 138.0, 126.2, 115.1, 114.4, 111.1, 50.3, 20.5, 15.8. 
HRMS (ESI) calcd for C11H13N2O2 [M-H]+: 205.0972; found 205.0975. 
 
Methyl 2,8-dimethylimidazo[1,2-a]pyridine-3-carboxylate (4-3ae) 
1H NMR (300 MHz, CDCl3) δ 9.02 (d, J = 6.9 Hz, 1H), 7.04 (t, J = 6.9 Hz, 1H), 
6.75 (t, J = 6.9 Hz, 1H), 3.86 (s, 3H), 2.62 (s, 3H), 2.51 (s, 3H); 13C NMR (300 
MHz, CDCl3) δ 161.5, 151.8, 146.7, 126.4, 126.1, 125.4, 113.3, 112.4, 50.9, 
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16.7, 16.3. HRMS (ESI) calcd for C11H13N2O2 [M-H]+: 205.0972; found 
205.0975. 
 
Methyl 7-ethyl-2-methylimidazo[1,2-a]pyridine-3-carboxylate (4-3af) 
1H NMR (300 MHz, CDCl3) δ 9.01 (d, J = 7.2 Hz, 1H), 7.24 (s, 1H), 6.68 (d, J = 
6.9 Hz, 1H), 3.82 (s, 3H), 2.64-2.55 (m, 5H), 1.16 (t, J = 7.7 Hz, 3H); 13C NMR 
(300 MHz, CDCl3) δ 161.5, 152.6, 147.3, 144.8, 127.0, 114.8, 113.6, 111.7, 50.9, 
28.1, 16.3, 14.0. HRMS (ESI) calcd for C12H15N2O2 [M-H]+: 219.1128; found 
219.1132. 
 
Methyl 2,5,7-trimethylimidazo[1,2-a]pyridine-3-carboxylate (4-3ag) 
1H NMR (300 MHz, CDCl3) δ 7.23 (s, 1H), 6.56 (s, 1H), 3.91 (s, 3H), 2.61-2.57 
(m, 6H), 2.37 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 161.5, 152.6, 149.0, 
139.2, 137.8, 117.6, 113.1, 111.3, 51.5, 21.7, 21.0, 16.1. HRMS (ESI) calcd for 
C12H15N2O2 [M-H]+: 219.1128; found 219.1131. 
 
Methyl 7-methoxy-2-methylimidazo[1,2-a]pyridine-3-carboxylate (4-3ah) 
1H NMR (300 MHz, CDCl3) δ 8.89 (d, J = 7.5 Hz, 1H), 6.70 (s, 1H), 6.46 (d, J = 
7.5 Hz, 1H), 3.79-3.72 (m, 6H), 2.50 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 
161.4, 159.5, 152.8, 148.6, 128.0, 111.3, 107.2, 94.4, 55.3, 50.8, 16.2. HRMS 





Methyl 6-chloro-2-methylimidazo[1,2-a]pyridine-3-carboxylate (4-3ai) 
1H NMR (300 MHz, CDCl3) δ 9.35 (s, 1H), 7.53 (d, J = 9.3 Hz, 1H), 7.33 (d, J = 
9.6 Hz, 1H),  3.95 (s, 3H), 2.68 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 161.5, 
153.3, 146.3, 128.8, 125.9, 122.0, 116.8, 114.5, 51.5, 16.5. HRMS (ESI) calcd 
for C10H10 ClN2O2 [M-H]+: 225.0425; found 225.0424. 
 
Methyl 6-bromo-2-methylimidazo[1,2-a]pyridine-3-carboxylate (4-3aj) 
1H NMR (300 MHz, CDCl3) δ 9.37 (s, 1H), 7.44-7.34 (m, 2H), 3.91 (s, 3H), 2.62 
(s, 3H); 13C NMR (300 MHz, CDCl3) δ 161.3, 153.0, 145.1, 130.8, 127.9, 117.0, 
112.6, 108.4, 51.4, 16.4. HRMS (ESI) calcd for C10H10BrN2O2 [M-H]+: 
268.9921; found 268.9925. 
 
Dimethyl 2-methylimidazo[1,2-a]pyridine-3,7-dicarboxylate (4-3ak) 
1H NMR (300 MHz, CDCl3) δ 9.04 (d, J = 5.7 Hz, 1H), 8.03 (s, 1H), 7.30 (d, J = 
5.4 Hz, 1H), 3.82 (s, 6H), 2.54 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 164.7, 
161.0, 153.8, 145.4, 128.2, 127.1, 118.2, 113.3, 112.3, 52.4, 51.2, 16.3. HRMS 
(ESI) calcd for C12H13N2O4 [M-H]+: 249.0870; found 249.0868. 
 
Methyl 2-methylimidazo[1,2-a]quinoline-1-carboxylate (4-3al) 
1H NMR (300 MHz, CDCl3) δ 8.20 (d, J = 8.7 Hz, 1H), 7.69 (d, J = 7.5 Hz, 1H), 
7.59-7.49 (m, 2H), 7.45-7.34 (m, 2H), 3.96 (s, 3H), 2.62 (s, 3H); 13C NMR (300 
MHz, CDCl3) δ 162.4, 152.0, 146.5, 133.1, 129.9, 128.8, 128.3, 124.8, 124.2, 
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118.9, 116.4, 116.0, 51.7, 16.1. HRMS (ESI) calcd for C14H13N2O2 [M-H]+: 
241.0972; found 241.0974. 
 
Methyl 2-methylimidazo[2,1-a]isoquinoline-3-carboxylate (4-3am) 
1H NMR (300 MHz, CDCl3) δ 8.79 (d, J = 7.5 Hz, 1H), 8.49 (d, J = 8.9 Hz, 1H), 
7.52-7.44 (m, 3H), 6.94 (d, J = 7.5 Hz, 1H), 3.84 (s, 3H), 2.62 (s, 3H); 13C NMR 
(300 MHz, CDCl3) δ 161.1, 150.3, 144.0, 129.7, 128.7, 127.5, 126.1, 123.5, 
121.9, 113.5, 113.0, 50.8, 16.0. HRMS (ESI) calcd for C14H13N2O2 [M-H]+: 
241.0972; found 241.0973. 
 
III. Chapter 5 compound characterization data 
3-(4-Methoxyphenyl)-2-methylimidazo[1,2-a]pyridine (5-3aa) 
1H NMR (300 MHz, CDCl3) δ 8.00 (d, J = 6.9 Hz, 1H), 7.53 (d, J = 9.0 Hz, 1H), 
7.35 (d, J = 8.7 Hz, 2H), 7.10 (t, J = 8.0 Hz, 1H), 7.05 (d, J = 8.7 Hz, 2H), 6.68 
(t, J = 6.8 Hz, 1H),  3.87 (s, 3H), 2.43 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 
159.4, 144.2, 140.5, 130.9, 123.8, 123.0, 121.5, 121.1, 116.8, 114.6, 111.7, 55.3, 
13.7. HRMS (ESI) calcd for C15H15N2O [M-H]+: 239.1179; found 239.1181. 
 
3-(3-Methoxyphenyl)-2-methylimidazo[1,2-a]pyridine (5-3ba) 
1H NMR (300 MHz, CDCl3) δ 8.07 (d, J = 6.9 Hz, 1H), 7.51 (d, J = 9.0 Hz, 1H), 
7.39 (t, J = 7.8 Hz, 1H), 7.09 (t, J = 7.8 Hz, 1H), 7.00 (d, J = 7.5 Hz, 1H), 6.96-
6.89 (m, 2H), 6.65 (t, J = 6.8 Hz, 1H),  3.81 (s, 3H), 2.45 (s, 3H); 13C NMR (300 
MHz, CDCl3) δ 160.0, 144.3, 140.8, 130.6, 130.1, 123.9, 123.0, 121.5, 121.1, 
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116.8, 115.0, 113.2, 111.7, 55.2, 13.8. HRMS (ESI) calcd for C15H13N2O [M-
H]+: 239.1179; found 239.1182. 
 
3-(2-Methoxyphenyl)-2-methylimidazo[1,2-a]pyridine (5-3ca) 
1H NMR (300 MHz, CDCl3) δ 7.62 (d, J = 6.6 Hz, 1H), 7.53 (d, J = 9.0 Hz, 1H), 
7.41 (t, J = 7.8 Hz, 1H), 7.30 (t, J = 7.2 Hz, 1H), 7.12-6.99 (m, 3H), 6.63 (t, J = 
6.8 Hz, 1H),  3.72 (s, 3H), 2.40 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 157.4, 
144.5, 141.2, 132.3, 130.0, 124.5, 123.5, 120.8, 118.6, 117.8, 116.4, 111.1, 




1H NMR (300 MHz, CDCl3) δ 8.03 (d, J = 6.9 Hz, 1H), 7.53 (d, J = 9.0 Hz, 1H), 
7.13 (t, J = 7.8 Hz, 2H), 7.00 (s, 2H), 7.00 (s, 2H), 6.92 (s, 1H), 6.70 (t, J = 6.8 
Hz, 1H), 3.94 (s, 3H), 3.89 (s, 3H), 2.45 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 
149.4, 149.0, 144.0, 140.3, 124.0, 123.0, 122.4, 121.6, 121.3, 116.7, 112.6, 
111.9, 111.7, 56.0, 55.9, 13.7. HRMS (ESI) calcd for C16H17N2O2 [M-H]+: 
269.1285; found 269.1286. 
 
2-Methyl-3-phenylimidazo[1,2-a]pyridine (5-3ea) 
1H NMR (300 MHz, CDCl3) δ 8.07 (d, J = 6.9 Hz, 1H), 7.57-7.47 (m, 3H), 7.46-
7.36 (m, 3H), 7.12 (t, J = 7.8 Hz, 1H), 6.68 (t, J = 6.9 Hz, 1H), 2.46 (s, 3H); 13C 
NMR (300 MHz, CDCl3) δ 144.3, 140.8, 129.4, 129.1, 128.0, 124.0, 122.9, 
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1H NMR (300 MHz, CDCl3) δ 8.03 (d, J = 6.9 Hz, 1H), 7.58 (d, J = 9.0 Hz, 1H), 
7.51 (d, J = 8.4 Hz, 2H), 7.39 (d, J = 8.4 Hz, 2H), 7.17 (t, J = 7.2 Hz, 1H), 6.74 
(t, J = 6.9 Hz, 1H), 2.46 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 144.5, 141.1, 
134.1, 130.7, 129.5, 127.8, 124.5, 122.8, 120.3, 117.0, 112.2, 13.8. HRMS (ESI) 
calcd for C14H12ClN2 [M-H]+: 243.0684; found 243.0682. 
 
3-(4-Bromophenyl)-2-methylimidazo[1,2-a]pyridine (5-3ga) 
1H NMR (300 MHz, CDCl3) δ 7.99 (d, J = 6.9 Hz, 1H), 7.60 (d, J = 8.4 Hz, 2H), 
7.51 (d, J = 9.3 Hz, 1H), 7.27 (d, J = 8.4 Hz, 2H), 7.10 (t, J = 7.8 Hz, 1H), 6.68 
(t, J = 6.8 Hz, 1H), 2.41 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 144.5, 141.1, 
132.3, 130.8, 128.2, 124.2, 122.7, 122.0, 120.1, 116.9, 112.0, 13.7. HRMS (ESI) 
calcd for C14H12ClN2 [M-H]+: 243.0684; found 243.0682. 
 
2,3-Diphenylimidazo[1,2-a]pyridine (5-3ha) 
1H NMR (300 MHz, CDCl3) δ 7.83 (d, J = 6.3 Hz, 1H), 7.71-7.57 (m, 3H), 7.43-
7.29 (m, 5H), 7.25-7.13 (m, 3H), 7.06 (t, J = 7.8 Hz, 1H), 6.57 (t, J = 6.5 Hz, 
1H); 13C NMR (300 MHz, CDCl3) δ 144.4, 142.0, 133.9, 130.2, 129.4, 129.1, 
128.5, 127.9, 127.7, 127.1, 124.2, 122.8, 120.6, 117.0, 111.8. HRMS (ESI) calcd 




1H NMR (300 MHz, CDCl3) δ 7.87 (d, J = 6.9 Hz, 1H), 7.70 (d, J = 6.9 Hz, 2H), 
7.64 (d, J = 9.0 Hz, 1H), 7.30-7.18 (m, 7H), 7.10 (t, J = 7.8 Hz, 1H), 6.61 (t, J = 
6.9 Hz, 1H)  2.40 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 144.4, 141.9, 138.5, 
134.1, 130.3, 130.0, 128.0, 127.8, 127.1, 126.5, 124.2, 123.0, 120.9, 117.2, 




1H NMR (300 MHz, CDCl3) δ 7.65 (d, J = 6.6 Hz, 1H), 7.47-7.39 (m, 3H), 7.30-
7.11 (m, 5H), 7.01 (d, J = 8.1 Hz, 2H), 6.90 (t, J = 7.7 Hz, 1H), 6.40 (t, J = 6.5 
Hz, 1H); 13C NMR (300 MHz, CDCl3) δ 144.1, 140.5, 132.6, 132.3, 129.9, 
129.0, 128.8, 128.6, 128.4, 127.8, 124.2, 122.5, 120.5, 116.7, 111.7. HRMS 
(ESI) calcd for C19H14Cl N2 [M-H]+: 305.0840; found 305.0844. 
 
2-(4-Bromophenyl)-3-phenylimidazo[1,2-a]pyridine (5-3ka) 
1H NMR (300 MHz, CDCl3) δ 7.91 (d, J = 6.9 Hz, 1H), 7.65 (d, J = 9.0 Hz, 1H), 
7.55-7.46 (m, 5H), 7.43-7.35 (m, 4H), 7.18 (t, J = 7.4 Hz, 1H), 6.71 (t, J = 6.8 
Hz, 1H); 13C NMR (300 MHz, CDCl3) δ 144.1, 141.0, 133.1, 131.3, 130.5, 
129.6, 129.5, 129.4, 129.0, 128.7, 124.9, 123.2, 121.5, 117.4, 112.4. HRMS 






1H NMR (300 MHz, CDCl3) δ 8.55 (d, J = 6.9 Hz, 1H), 7.62 (d, J = 9.0 Hz, 2H), 
7.29 (t, J = 7.5 Hz, 2H), 7.15 (q, J = 6.6 Hz, 2H), 6.87 (t, J = 6.9 Hz, 1H), 3.05 
(s, 4H); 13C NMR (300 MHz, CDCl3) δ 146.6, 145.9, 135.3, 128.8, 128.1, 126.7, 
124.0, 123.5, 119.5, 118.6, 117.6, 112.7, 30.1, 23.9. HRMS (ESI) calcd for 
C15H13N2 [M-H]+: 221.1073; found 221.1077. 
 
3-(4-Methoxyphenyl)-2,8-dimethylimidazo[1,2-a]pyridine (5-3ab) 
1H NMR (300 MHz, CDCl3) 7.81 (d, J = 6.6 Hz, 1H), 7.28 (d, J = 8.4 Hz, 2H), 
6.98 (d, J = 8.4 Hz, 2H), 6.85 (d, J = 6.6 Hz, 1H), 6.53 (t, J = 6.8 Hz, 1H), 3.79 
(s, 3H), 2.56 (s, 3H), 2.41 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 159.2, 144.3, 
139.4, 130.7, 129.4, 126.2, 122.7, 121.5, 120.7, 114.4, 111.6, 55.1, 16.9, 13.5. 
HRMS (ESI) calcd for C16H17N2O [M-H]+: 253.1335; found 253.1337. 
 
7-Methyl-2-phenyl-3-p-tolylimidazo[1,2-a]pyridine (5-3ac) 
1H NMR (300 MHz, CDCl3) δ 7.74 (d, J = 6.9 Hz, 1H), 7.68 (d, J = 6.9 Hz, 2H), 
7.39 (s, 1H),  7.27-7.15 (m, 7H), 6.44 (d, J = 6.9 Hz, 1H), 2.38 (s, 3H), 2.32 (s, 
3H); 13C NMR (300 MHz, CDCl3) δ 144.9, 141.5, 138.3, 135.2, 134.2, 130.2, 
129.9, 127.9, 127.7, 126.9, 126.7, 122.2, 120.3, 115.5, 114.5, 21.1, 21.0. HRMS 







1H NMR (300 MHz, CDCl3) δ 7.89 (d, J = 6.9 Hz, 1H), 7.37-7.27 (m, 3H), 7.04 
(d, J = 9.0 Hz, 2H), 6.52 (d, J = 6.9 Hz, 1H), 3.87 (s, 3H), 2.41 (s, 3H), 2.37 (s, 
3H); 13C NMR (300 MHz, CDCl3) δ 159.3, 144.4, 139.6, 135.1, 130.8, 122.3, 
121.6, 120.6, 115.1, 114.6,  114.5, 55.3, 21.2, 13.6. HRMS (ESI) calcd for 
C16H17N2O [M-H]+: 253.1335; found 253.1333. 
 
7-Ethyl-2-phenyl-3-p-tolylimidazo[1,2-a]pyridine (5-3ae) 
1H NMR (300 MHz, CDCl3) δ 7.78 (d, J = 6.9 Hz, 1H), 7.69 (d, J = 6.9 Hz, 2H), 
7.44 (s, 1H), 7.28-7.17 (m, 7H), 6.51 (d, J = 7.2 Hz, 1H), 2.64 (q, J = 7.5 Hz, 
2H), 2.39 (s, 3H), 1.24 (t, J = 7.5 Hz, 3H); 13C NMR (300 MHz, CDCl3) δ 
145.2, 141.8, 141.5, 138.5, 134.4, 130.5, 130.1, 128.1, 127.9, 127.1, 126.9, 
122.6, 120.5, 114.3, 113.7, 28.3, 21.4, 14.4. HRMS (ESI) calcd for C22H21N2[M-
H]+: 313.1699; found 313.1703. 
 
7-Methoxy-2-phenyl-3-p-tolylimidazo[1,2-a]pyridine (5-3af) 
1H NMR (300 MHz, CDCl3) δ 7.67-7.59 (m, 3H), 7.23-7.10 (m, 7H), 6.86 (s, 
1H), 6.30 (d, J = 7.5 Hz, 1H), 3.74 (s, 3H), 2.33 (s, 3H); 13C NMR (300 MHz, 
CDCl3) δ 157.6, 145.7, 141.0, 138.2, 134.1, 130.2, 129.8, 127.8, 127.4, 126.8, 
126.5, 123.4, 119.7, 106.7, 94.1, 55.0, 21.0. HRMS (ESI) calcd for C21H19N2O 





Methyl 2-phenyl-3-p-tolylimidazo[1,2-a]pyridine-7-carboxylate (5-3ag) 
1H NMR (300 MHz, CDCl3) δ 8.34 (s, 1H), 7.89 (d, J = 7.2 Hz, 1H), 7.64 (d, J = 
6.9 Hz, 2H), 7.29-7.19 (m, 8H), 3.88 (s, 3H), 2.40 (s, 3H); 13C NMR (300 MHz, 
CDCl3) δ 165.4, 144.6, 143.3, 139.1, 133.5, 130.2, 130.1, 128.1, 127.9, 127.6, 
125.8, 125.4, 122.6, 122.5, 119.9, 111.2, 52.2, 21.2. HRMS (ESI) calcd for 
C22H19N2O2 [M-H]+: 343.1441; found 343.1444. 
 
6-Chloro-2-(4-chlorophenyl)-3-phenylimidazo[1,2-a]pyridine (5-3ah) 
1H NMR (300 MHz, CDCl3) δ 7.91 (s, 1H), 7.63-7.50 (m, 6H), 7.42 (d, J = 7.8 
Hz, 2H),  7.24 (d, J = 8.7 Hz, 2H), 7.17 (d, J = 9.6 Hz, 1H); 13C NMR (300 
MHz, CDCl3) δ 143.1, 142.2, 133.6, 132.2, 130.5, 129.8, 129.5, 129.2, 128.9, 
128.5, 126.2, 121.7, 121.1, 120.8, 117.9. HRMS (ESI) calcd for C19H13 Cl2N2 
[M-H]+: 339.0450; found 339.0451. 
 
6-Bromo-2-phenyl-3-p-tolylimidazo[1,2-a]pyridine (5-3ai) 
1H NMR (300 MHz, CDCl3) δ 8.03 (s, 1H), 7.67 (d, J = 7.8 Hz, 2H), 7.55 (d, J = 
9.3 Hz, 1H), 7.33-7.19 (m, 8H), 2.45 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 
142.9, 142.9, 139.2, 133.7, 130.3, 128.2, 127.8, 127.7, 127.6, 126.0, 123.2, 








1H NMR (300 MHz, CDCl3) δ 7.53 (d, J = 8.7 Hz, 2H), 7.45-7.37 (m, 5H), 7.32 
(d, J = 4.5 Hz, 1H), 7.21 (d, J = 8.7 Hz, 2H), 6.78 (d, J = 4.5 Hz, 1H); 13C NMR 
(300 MHz, CDCl3) δ 149.0, 142.1, 132.8, 132.8, 130.0, 129.2, 129.0, 128.6, 
128.5, 128.3, 122.9, 117.3, 112.7. HRMS (ESI) calcd for C17H12ClN2S [M-H]+: 
311.0404; found 311.0410. 
 
2-Phenyl-1-p-tolylimidazo[1,2-a]quinoline (5-3ak) 
1H NMR (300 MHz, CDCl3) δ 8.79 (d, J = 8.4 Hz, 1H), 7.58 (d, J = 6.9 Hz, 2H), 
7.49-7.41 (m, 3H), 7.38-7.26 (m, 5H), 7.23 (t, J = 7.5 Hz, 1H), 7.16 (d, J = 8.1 
Hz, 2H), 6.79 (d, J = 9.6 Hz, 1H), 2.33 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 
181.2, 155.5, 140.1, 138.1, 137.6, 137.0, 134.8, 130.9, 129.3, 129.2, 128.5, 
128.4, 127.8, 127.3, 127.2, 125.3, 122.3, 118.7, 115.8, 21.0. HRMS (ESI) calcd 
for C24H19N2 [M-H]+: 335.1543; found 335.1545. 
 
2-Phenyl-3-p-tolylimidazo[2,1-a]isoquinoline (5-3al) 
1H NMR (300 MHz, CDCl3) δ 8.83 (d, J = 7.5 Hz, 1H), 7.79 (d, J = 6.9 Hz, 2H), 
7.70 (d, J = 7.5 Hz, 1H), 7.65 (t, J = 7.1 Hz, 2H), 7.54 (t, J = 7.4 Hz, 1H), 7.39-
7.25 (m, 7H), 6.93 (d, J = 7.5 Hz, 1H), 2.47 (s, 3H); 13C NMR (300 MHz, 
CDCl3) δ 142.2, 140.2, 138.7, 134.5, 130.6, 130.1, 129.5, 128.2, 128.0, 127.9, 
127.8, 127.0, 126.7, 126.7, 123.8, 123.4, 123.0, 121.0, 112.6, 21.4. HRMS (ESI) 




Chapter 6 compound characterization data 
Methyl 1-(4-methoxyphenyl)-2-methyl-4-phenyl-1H-pyrrole-3-carboxylate 
(6-6a) 
1H NMR (300 MHz, CDCl3) δ 7.42 (d, J = 6.9 Hz, 2H), 7.34 (t, J = 7.2 Hz, 2H), 
7.29-7.22 (m, 3H), 6.99 (d, J = 9.0 Hz, 2H), 6.67 (s, 1H), 3.87 (s, 3H), 3.70 (s, 
3H), 2.42 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 166.3, 159.3, 137.1, 135.6, 
131.8, 129.1, 127.6, 127.6, 126.3, 126.2, 121.2, 114.4, 111.0, 55.6, 50.6, 12.6. 




1H NMR (300 MHz, CDCl3) δ 7.44 (d, J = 6.9 Hz, 2H), 7.34 (t, J = 7.2 Hz, 2H), 
7.29-7.21 (m, 3H), 6.98 (d, J = 9.0 Hz, 2H), 6.68 (s, 1H), 4.20 (q, J = 7.2 Hz, 
2H), 3.85 (s, 3H), 2.44 (s, 3H), 1.16 (t, J = 7.2 Hz, 3H); 13C NMR (300 MHz, 
CDCl3) δ 165.8, 159.2, 136.8, 135.6, 131.7, 129.2, 127.4, 126.2, 126.1, 121.0, 
114.3, 111.2, 59.3, 55.4, 14.0, 12.5. HRMS (ESI) calcd for C21H21NNaO3 [M-




1H NMR (300 MHz, CDCl3) δ 7.49 (d, J = 7.8 Hz, 2H), 7.37 (t, J = 7.4 Hz, 2H), 
7.32-7.22 (m, 3H), 7.00 (d, J = 8.7 Hz, 2H), 6.71 (s, 1H), 5.96-5.82 (m, 1H), 5.17 
(d, J = 6.0 Hz, 1H), 5.12 (s, 1H), 4.70 (d, J = 5.4 Hz, 2H), 3.84 (s, 3H), 2.49 (s, 
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3H); 13C NMR (300 MHz, CDCl3) δ 165.1, 159.1, 136.9, 135.4, 132.4, 131.5, 
129.0, 127.4, 127.3, 126.3, 126.0, 121.0, 117.6, 114.2, 110.8, 64.0, 55.2, 12.4. 




1H NMR (300 MHz, CDCl3) δ 7.47 (d, J = 6.9 Hz, 2H), 7.35 (t, J = 7.2 Hz, 2H), 
7.30-7.19 (m, 3H), 6.98 (d, J = 9.0 Hz, 2H), 6.68 (s, 1H), 4.30 (t, J = 5.0 Hz, 
2H), 3.84 (s, 3H), 3.49 (t, J = 5.0 Hz, 2H), 3.27 (s, 3H), 2.46 (s, 3H); 13C NMR 
(300 MHz, CDCl3) δ 165.4, 159.1, 137.1, 135.5, 131.6, 129.1, 127.4, 127.3, 
126.3, 126.0, 121.0, 114.2, 110.7, 62.3, 58.5, 55.3, 12.4. HRMS (ESI) calcd for 




1H NMR (300 MHz, CDCl3) δ 7.40 (d, J = 8.1 Hz, 2H), 7.32-7.21 (m, 8H), 7.13 
(d, J = 7.2 Hz, 2H), 6.99 (d, J = 9.0 Hz, 2H), 6.67 (s, 1H), 5.20 (s, 2H), 3.86 (s, 
3H), 2.44 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 165.5, 159.3, 137.3, 136.4, 
135.7, 131.8, 129.3, 128.2, 128.0, 127.6, 127.6, 127.5, 126.5, 126.2, 121.2, 
114.4, 111.0, 65.3, 55.5, 12.6. HRMS (ESI) calcd for C26H23NNaO3 [M-Na]+: 






1H NMR (300 MHz, CDCl3) δ 7.43 (d, J = 6.9 Hz, 2H), 7.33 (t, J = 7.2 Hz, 2H), 
7.28-7.21 (m, 3H), 6.98 (d, J = 9.0 Hz, 2H), 6.66 (s, 1H), 4.94-4.84 (m, 1H), 3.86 
(s, 3H), 2.43 (s, 3H), 1.86-1.77 (m, 2H), 1.61-1.53 (m, 2H), 1.35-1.25 (m, 6H); 
13C NMR (300 MHz, CDCl3) δ 165.3, 159.2, 136.7, 135.8, 131.9, 129.4, 127.5, 
127.5, 126.4, 126.1, 121.0, 114.4, 111.8, 71.8, 55.5, 31.6, 25.4, 23.7, 12.6. 




1H NMR (300 MHz, CDCl3) δ 7.41 (d, J = 6.9 Hz, 2H), 7.34 (t, J = 7.2 Hz, 2H), 
7.28-7.22 (m, 3H), 6.98 (d, J = 9.0 Hz, 2H), 6.62(s, 1H), 3.87 (s, 3H), 3.69 (s, 
3H), 2.81 (t, J = 7.8 Hz, 2H), 1.52-1.41 (m, 2H), 1.30-1.19 (m, 2H), 0.80 (t, J = 
7.4 Hz, 3H); 13C NMR (300 MHz, CDCl3) δ 166.1, 159.4, 142.1, 135.7, 131.9, 
129.1, 128.0, 127.6, 126.2, 126.1, 121.5, 114.3, 110.3, 55.5, 50.5, 32.3, 25.4, 





1H NMR (300 MHz, CDCl3) δ 7.43 (d, J = 6.9 Hz, 2H), 7.36 (t, J = 7.5 Hz, 2H), 
7.31-7.22 (m, 3H), 6.99 (d, J = 9.0 Hz, 2H), 6.63(s, 1H), 3.84 (s, 3H), 3.71 (s, 
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3H), 3.34-3.19 (m, 1H), 1.36 (d, J = 7.2 Hz, 6H); 13C NMR (300 MHz, CDCl3) 
δ 166.6, 159.3, 144.6, 135.5, 132.1, 128.3, 128.1, 127.5, 125.8, 125.7, 120.9, 
114.0, 110.2, 55.2, 50.4, 26.3, 21.2. HRMS (ESI) calcd for C22H23NNaO3 [M-




1H NMR (300 MHz, CDCl3) δ 7.44-7.29 (m, 7H), 6.97 (d, J = 9.0 Hz, 2H), 6.88 
(s, 1H), 4.29 (q, J = 7.2 Hz, 2H), 3.86 (s, 3H), 1.24 (t, J = 7.2 Hz, 3H); 13C 
NMR (300 MHz, CDCl3) δ 164.8, 159.9, 133.1, 131.4, 129.0, 128.7, 128.4, 
128.1, 127.6, 127.5, 127.1, 125.0, 122.8, 122.2, 118.6, 118.5, 118.5, 115.1, 
114.4, 114.3, 114.2, 114.2, 61.4, 55.5, 13.8. HRMS (ESI) calcd for 
C21H18F3NNaO3 [M-Na]+: 412.1132; found 412.1139. 
 
Ethyl 1-(4-methoxyphenyl)-2,4-diphenyl-1H-pyrrole-3-carboxylate (6-6j) 
1H NMR (300 MHz, CD2Cl2) δ 7.47 (d, J = 6.9 Hz, 2H), 7.39-7.31 (m, 3H), 
7.30-7.21 (m, 6H), 7.05 (d, J = 9.0 Hz, 2H), 6.91(s, 1H), 6.78 (d, J = 9.0 Hz, 
2H), 3.99 (q, J = 7.1 Hz, 2H), 3.75 (s, 3H), 0.92 (t, J = 7.1 Hz, 3H); 13C NMR 
(300 MHz, CDCl3) δ 165.5, 159.1, 138.2, 135.5, 132.6, 132.2, 131.4, 130.2, 
129.1, 128.2, 128.0, 127.8, 127.7, 126.7, 126.5, 122.5, 114.3, 60.0, 55.7, 13.8. 






1H NMR (300 MHz, CDCl3) δ 7.41 (d, J = 6.9 Hz, 2H), 7.29-7.18 (m, 4H), 7.14 
(t, J = 7.4 Hz, 1H), 6.93 (d, J = 9.0 Hz, 2H), 6.81(s, 1H), 3.83-3.61 (m, 4H), 
3.38-3.16 (m, 2H), 3.04-2.84 (m, 1H), 3.15 (s, 3H), 1.15 (t, J = 7.1 Hz, 3H), 0.75 
(t, J = 7.1 Hz, 3H); 13C NMR (300 MHz, CDCl3) δ 168.4, 158.7, 134.9, 132.2, 
128.4, 128.2, 126.9, 126.5, 125.7, 122.2, 118.4, 116.6, 114.1, 55.3, 42.6, 38.5, 





1H NMR (300 MHz, CDCl3) δ 7.41 (d, J = 6.9 Hz, 2H), 7.34 (t, J = 7.1 Hz, 2H), 
7.31-7.22 (m, 3H), 6.98 (d, J = 9.0 Hz, 2H), 6.65(s, 1H), 3.86 (s, 3H), 2.91 (t, J = 
7.2 Hz, 2H), 2.38 (s, 3H), 1.67-1.54 (m, 2H), 0.94 (t, J = 7.4 Hz, 3H); 13C NMR 
(300 MHz, CDCl3) δ 189.0, 159.2, 135.0, 133.6, 131.7, 129.3, 128.9, 127.8, 
127.4, 126.5, 125.0, 121.1, 114.4, 55.5, 31.0, 23.1, 13.3, 12.7. HRMS (ESI) calcd 
for C22H23NNaO2S [M-Na]+: 388.1342; found 388.1343. 
 
1-(1-(4-Methoxyphenyl)-2-methyl-4-phenyl-1H-pyrrol-3-yl)ethanone (6-6m) 
1H NMR (300 MHz, CDCl3) 7.41-7.27 (m, 5H), 7.23 (d, J = 8.7 Hz, 2H), 6.92 (d, 
J = 9.0 Hz, 2H), 6.62(s, 1H), 3.83 (s, 3H), 2.38 (s, 3H), 2.08 (s, 3H); 13C NMR 
(300 MHz, CDCl3) δ 197.3, 159.1, 136.0, 135.5, 131.4, 129.2, 128.1, 127.3, 
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126.6, 125.9, 120.7, 114.3, 55.4, 30.9, 12.6. HRMS (ESI) calcd for 




1H NMR (300 MHz, CDCl3) δ 7.90 (d, J = 7.2 Hz, 2H), 7.32-7.25 (m, 3H), 7.23-
7.15 (m, 4H),  7.09 (t, J = 7.5 Hz, 2H), 7.04-6.96 (m, 3H), 6.84 (s, 1H), 3.80 (s, 
3H), 2.30 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 193.7, 158.9, 139.2, 135.0, 
134.7, 131.4, 129.5, 128.0, 127.6, 127.4, 127.0, 126.0, 125.4, 120.1, 120.0, 





1H NMR (300 MHz, CDCl3) δ 8.10-7.92 (m, 4H), 7.54-7.31 (m, 11H), 6.76 (d, J 
= 9.0 Hz, 2H), 6.67 (d, J = 9.0 Hz, 2H), 6.05 (s, 1H), 3.73 (s, 3H); 13C NMR 
(300 MHz, CDCl3) δ 189.3, 162.1, 156.5, 140.0, 135.8, 132.4, 132.4, 131.1, 
130.0, 129.9, 129.5, 128.9, 128.9, 128.6, 128.4, 128.3, 127.2, 124.9, 114.3, 








1H NMR (300 MHz, CDCl3) δ 7.67 (d, J = 6.9 Hz, 2H), 7.36 (t, J = 7.4 Hz, 2H), 
7.30-7.25 (m, 3H), 7.00 (d, J = 9.0 Hz, 2H), 6.82 (s, 1H), 3.87 (s, 3H), 2.75 (t, J 
= 6.2 Hz, 2H), 2.55 (t, J = 6.5 Hz, 2H), 2.18-2.08 (m, 3H); 13C NMR (300 MHz, 
CDCl3) δ 194.0, 159.2, 144.7, 134.1, 128.7, 127.9, 126.6, 126.5, 125.1, 121.9, 
117.9, 114.6, 55.6, 39.1, 23.7, 23.4. HRMS (ESI) calcd for C21H19NNaO2[M-
Na]+: 340.1308; found 340.1309. 
 
Methyl-2-methyl-1,4-diphenyl-1H-pyrrole-3-carboxylate (6-7a) 
1H NMR (300 MHz, CDCl3) δ 7.54-7.42 (m, 5H), 7.40-7.25 (m, 5H), 6.73 (s, 
1H), 3.72 (s, 3H), 3.48 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 166.2, 
138.9,136.7, 135.5, 129.4, 129.3, 129.0, 128.1, 127.6, 126.6, 126.3, 120.9, 111.4, 




1H NMR (300 MHz, CDCl3) δ 7.49 (d, J = 7.5 Hz, 2H), 7.41-7.35 (m, 4H), 7.33-
7.23 (m, 3H), 6.62 (s, 1H), 3.75 (s, 3H), 2.33 (s, 3H), 2.12 (s, 3H); 13C NMR 
(300 MHz, CDCl3) δ 166.2, 137.8, 137.2, 135.8, 135.5, 130.8, 129.0, 128.9, 
127.8, 127.5, 126.7, 126.1, 120.5, 110.3, 50.4, 17.1, 12.0. HRMS (ESI) calcd for 






1H NMR (300 MHz, CDCl3) δ 7.49 (d, J = 6.9 Hz, 2H), 7.43-7.33 (m, 5H), 7.12 
(d, J = 6.6 Hz, 2H), 6.64 (s, 1H), 3.74 (s, 3H), 2.54 (s, 3H); 13C NMR (300 
MHz, CDCl3) δ 165.9, 136.5, 136.2, 135.5, 128.8, 128.6, 127.4, 127.3, 126.2, 
125.8, 120.3, 110.4, 50.1, 11.2. HRMS (ESI) calcd for C19H16FNNaO2 [M-Na]+: 




1H NMR (300 MHz, CDCl3) δ 7.49 (m, 4H), 7.38 (d, J = 7.2 Hz, 2H), 7.32-7.5 
(m, 3H), 6.70 (s, 1H), 3.73 (s, 3H), 2.48 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 
165.9, 137.2, 136.4, 135.1, 133.8, 129.4, 128.9, 127.5, 127.4, 126.8, 126.2, 
120.6, 111.6, 50.5, 12.5. HRMS (ESI) calcd for C19H16ClNNaO2 [M-Na]+: 




1H NMR (300 MHz, CDCl3) δ 7.62 (d, J = 8.7 Hz, 2H), 7.44 (d, J = 6.9 Hz, 2H), 
7.37 (t, J = 7.2 Hz, 2H), 7.29 (t, J = 7.1 Hz, 1H), 7.21 (d, J = 8.4 Hz, 2H), 6.69 
(s, 1H), 3.72 (s, 3H), 2.47 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 165.9, 137.8, 
136.4, 135.1, 132.4, 128.9, 127.7, 127.6, 126.8, 126.3, 121.8, 120.5, 111.7, 50.5, 
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12.5. HRMS (ESI) calcd for C19H16BrNNaO2 [M-Na]+: 392.0257; found 
392.0263. 
 
Methyl 1-(4-iodophenyl)-2-methyl-4-phenyl-1H-pyrrole-3-carboxylate (6-7f) 
1H NMR (300 MHz, CDCl3) δ 7.82 (d, J = 8.7 Hz, 2H), 7.42 (d, J = 6.9 Hz, 2H), 
7.36 (t, J = 7.2 Hz, 2H), 7.28 (t, J = 6.9 Hz, 1H), 7.08 (d, J = 8.4 Hz, 2H), 6.68 
(s, 1H), 3.71 (s, 3H), 2.46 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 166.0, 138.5, 
138.5, 136.4, 135.2, 129.0, 128.0, 127.6, 126.9, 126.4, 120.6, 111.8, 93.2, 50.6, 




1H NMR (300 MHz, CDCl3) δ 7.78 (d, J = 8.1 Hz, 2H), 7.48 (d, J = 8.4 Hz, 2H), 
7.43-7.28 (m, 5H), 6.73 (s, 1H), 3.71 (s, 3H), 2.49 (s, 3H); 13C NMR (300 MHz, 
CDCl3) δ 166.0, 141.9, 136.4, 135.1, 129.0, 127.7, 127.3, 126.6, 126.6, 126.5, 
126.5, 126.4, 120.5, 112.4, 50.7, 12.8. HRMS (ESI) calcd for C20H16F3NNaO2 




1H NMR (300 MHz, CDCl3) δ 8.38 (d, J = 8.7 Hz, 2H), 7.53 (d, J = 9.0 Hz, 2H), 
7.42-7.28 (m, 5H), 6.75 (s, 1H), 3.71 (s, 3H), 2.52 (s, 3H); 13C NMR (300 MHz, 
CDCl3) δ 165.8, 146.8, 144.2, 136.2, 134.8, 129.0, 127.9, 127.8, 126.7, 126.6, 
247 
 
125.0, 120.3, 113.2, 50.8, 12.9. . HRMS (ESI) calcd for C19H16N2NaO4 [M-Na]+: 




1H NMR (300 MHz, CDCl3) δ 1H NMR (300 MHz, CDCl3) δ 8.18 (d, J = 8.4 
Hz, 2H), 7.44-7.31 (m, 6H), 7.27 (t, J = 7.1 Hz, 1H), 6.74 (s, 1H), 4.42 (q, J = 
7.2 Hz, 2H), 3.70 (s, 3H), 2.49 (s, 3H) 1.42 (t, J = 7.2 Hz, 3H); 13C NMR (300 
MHz, CDCl3) δ 165.9, 165.5, 142.5, 136.3, 135.1, 130.7, 129.9, 128.9, 127.6, 
127.1, 126.4, 125.8, 120.5, 112.2, 61.7, 50.6, 14.2, 12.7. HRMS (ESI) calcd for 
C22H21NNaO4 [M-Na]+: 386.1363; found 386.1370. 
 
Methyl 1-(biphenyl-4-yl)-2-methyl-4-phenyl-1H-pyrrole-3-carboxylate (6-7j) 
1H NMR (300 MHz, CDCl3) δ 1H NMR (300 MHz, CDCl3) δ 7.72 (d, J = 8.4 
Hz, 2H), 7.65 (d, J = 6.9 Hz, 2H), 7.53-7.45 (m, 4H), 7.44-7.36 (m, 5H), 7.30 (t, 
J = 7.2 Hz, 1H), 6.78 (s, 1H), 3.74 (s, 3H), 2.54 (s, 3H); 13C NMR (300 MHz, 
CDCl3) δ 166.2, 141.0, 139.8, 138.0, 136.7, 135.5, 129.1, 128.9, 127.9, 127.8, 
127.6, 127.1, 127.0, 126.5, 126.3, 120.9, 111.5, 50.6, 12.8. HRMS (ESI) calcd 








1H NMR (300 MHz, CDCl3) δ 8.00-7.89 (m, 3H), 7.81 (s, 1H), , 7.62-7.58 (m, 
2H), 7.54 (d, J = 6.9 Hz, 2H), 7.48-7.40 (m, 3H), 7.34 (t, J = 7.2 Hz, 1H), 6.85 
(s, 1H), 3.78 (s, 3H), 2.57 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 166.1, 136.8, 
136.2, 135.4,133.1, 132.4,129.2, 129.0, 127.8, 127.7, 127.6, 127.0, 126.7, 126.6, 
126.2, 124.6, 124.2, 121.1,111.4, 50.5, 12.7.  HRMS (ESI) calcd for 
C23H19NNaO2 [M-Na]+: 364.1308; found 364.1311. 
 
Methyl 1-benzyl-2-methyl-4-phenyl-1H-pyrrole-3-carboxylate 6-(7l) 
1H NMR (300 MHz, CDCl3) δ 7.51 (d, J = 7.2 Hz, 2H), 7.45-7.36 (m, 6H), 7.13 
(d, J = 6.6 Hz, 2H) 6.65 (s, 1H), 5.05 (s, 2H), 3.75 (s, 3H), 2.55 (s, 3H); 13C 
NMR (300 MHz, CDCl3) δ 165.9, 136.5, 136.2, 135.5, 128.8, 128.6, 127.3, 
126.2, 125.8, 120.3, 110.4, 50.1, 50.1, 11.2. HRMS (ESI) calcd for 
C20H19NNaO2 [M-Na]+: 328.1308; found 328.1309. 
 
Methyl 2-methyl-1-phenethyl-4-phenyl-1H-pyrrole-3-carboxylate (6-7m) 
1H NMR (300 MHz, CDCl3) δ 7.42-7.29 (m, 8H), 7.14 (d, J = 6.9 Hz, 2H) 6.49 
(s, 1H), 4.08 (t, J = 7.2 Hz, 2H) 3.72 (s, 3H), 3.04 (t, J = 7.2 Hz, 2H) 2.46 (s, 
3H); 13C NMR (300 MHz, CDCl3) δ 166.1, 137.5, 1235.9, 135.8, 128.9, 128.6, 
128.5, 127.4, 126.7, 125.9, 125.8, 119.5, 110.0, 50.2, 48.0, 37.3, 11.0. HRMS 




Methyl 1-cyclohexyl-2-methyl-4-phenyl-1H-pyrrole-3-carboxylate (6-7n) 
1H NMR (300 MHz, CDCl3) δ 7.41 (d, J = 6.9 Hz, 2H), 7.35 (t, J = 7.4 Hz, 2H), 
7.26 (t, J = 7.1 Hz, 1H), 6.68 (s, 1H), 3.93 (t, J = 11.7 Hz, 1H), 3.69 (s, 3H), 2.60 
(s, 3H), 2.03 (d, J = 11.4 Hz, 2H), 1.94 (d, J = 11.4 Hz, 2H), 1.79 (d, J = 12.6 
Hz, 1H), 1.65 (q, J = 12.5 Hz, 2H), 1.46 (q, J = 12.8 Hz, 2H), 1.28 (t, J = 12.8 
Hz, 1H) ; 13C NMR (300 MHz, CDCl3) δ 166.2, 136.1, 135.3, 128.8, 127.3, 
125.7, 125.6, 115.8, 109.6, 55.0, 50.1, 33.7, 25.6, 25.1, 11.0. HRMS (ESI) calcd 
for C19H23NNaO2 [M-Na]+: 320.1621; found 320.1626. 
 
Methyl 2-methyl-1-octyl-4-phenyl-1H-pyrrole-3-carboxylate (6-7o) 
1H NMR (300 MHz, CDCl3) δ 7.39 (d, J = 6.6 Hz, 2H), 7.34 (t, J = 7.4 Hz, 2H), 
7.26 (t, J = 6.9 Hz, 1H), 6.55 (s, 1H), 3.83 (t, J = 7.4 Hz, 2H), 3.68 (s, 3H), 2.55 
(s, 3H), 1.79-1.69 (m, 2H), 1.37-1.29 (m, 10H), 0.92 (t, J = 6.6 Hz, 3H) ; 13C 
NMR (300 MHz, CDCl3) δ 166.2, 136.1, 135.3, 128.8, 127.3, 125.7, 125.6, 
115.8, 109.6, 55.0, 50.1, 33.7, 25.6, 25.1, 11.0. HRMS (ESI) calcd for 




1H NMR (300 MHz, CDCl3) δ 7.34 (d, J = 7.8 Hz, 2H), 7.25 (d, J = 8.7 Hz, 2H), 
7.18 (d, J = 7.8 Hz, 2H), 6.99 (d, J = 8.7 Hz, 2H), 6.67 (s, 1H), 3.87 (s, 3H), 3.73 
(s, 3H), 2.44 (s, 3H), 2.39 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 166.3, 159.2, 
136.9, 135.7, 132.5, 131.8, 128.9, 128.4, 127.5, 126.2, 121.0, 114.3, 110.9, 55.5, 
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50.5, 21.1, 12.6. HRMS (ESI) calcd for C21H21NNaO3 [M-Na]+: 358.1414; found 
358.1416. 
 
Methyl 1,4-bis(4-methoxyphenyl)-2-methyl-1H-pyrrole-3-carboxylate (6-8b) 
1H NMR (300 MHz, CDCl3) δ 7.35 (d, J = 7.8 Hz, 2H), 7.23 (d, J = 9.0 Hz, 2H), 
6.98 (d, J = 9.0 Hz, 2H), 6.90 (d, J = 8.7 Hz, 2H), 6.63 (s, 1H), 3.86 (s, 3H), 3.83 
(s, 3H), 3.71 (s, 3H), 2.42 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 166.3, 159.2, 
158.2, 136.9, 131.9, 130.1, 128.0, 127.5, 125.9, 120.9, 114.4, 113.1, 110.9, 55.5, 





1H NMR (300 MHz, CDCl3) δ 7.39 (d, J = 5.4 Hz, 2H), 7.22 (d, J = 8.7 Hz, 2H), 
7.04 (d, J = 9.0 Hz, 2H), 6.98 (d, J = 9.0 Hz, 2H), 6.64 (s, 1H), 3.84 (s, 3H), 3.71 
(s, 3H), 2.43 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 165.9, 163.2, 159.9, 159.2, 
137.0, 131.5, 131.4, 130.5, 130.4, 127.3, 125.2, 121.0, 114.4, 114.3, 114.1, 
110.7, 55.3, 50.3, 12.5. HRMS (ESI) calcd for C20H18FNNaO3 [M-Na]+: 








1H NMR (300 MHz, CDCl3) δ 7.35 (d, J = 8.7 Hz, 2H), 7.29 (d, J = 8.7 Hz, 2H), 
7.21 (d, J = 9.0 Hz, 2H), 6.98 (d, J = 9.0 Hz, 2H), 6.65 (s, 1H), 3.85 (s, 3H), 3.71 
(s, 3H), 2.42 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 165.9, 159.3, 137.2, 134.0, 
131.9, 131.5, 130.3, 127.6, 127.4, 125.1, 121.2, 114.4, 110.7, 55.4, 50.5, 12.5.  




1H NMR (300 MHz, CDCl3) δ 7.46 (d, J = 8.7 Hz, 2H), 7.28 (d, J = 8.7 Hz, 2H), 
7.22 (d, J = 9.0 Hz, 2H), 6.98 (d, J = 9.0 Hz, 2H), 6.65 (s, 1H), 3.86 (s, 3H), 3.71 
(s, 3H), 2.41 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 166.0, 159.4, 137.4, 134.6, 
131.7, 130.8, 130.7, 127.5, 125.2, 121.2, 114.5, 110.8, 55.6, 50.6, 12.6. HRMS 




1H NMR (300 MHz, CDCl3) δ 7.59 (d, J = 8.1 Hz, 2H), 7.52 (d, J = 8.1 Hz, 2H), 
7.23 (d, J = 8.7 Hz, 2H), 6.99 (d, J = 8.7 Hz, 2H), 6.70 (s, 1H), 3.86 (s, 3H), 3.72 
(s, 3H), 2.42 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 165.9, 159.4, 139.4, 137.6, 
131.5, 1129.2, 127.5, 126.8, 125.1, 124.6, 124.5, 124.5, 124.4,121.7, 114.5, 
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114.2, 110.8, 55.5, 50.6, 12.6. HRMS (ESI) calcd for C21H18F3NNaO3 [M-Na]+: 




1H NMR (300 MHz, CDCl3) δ 8.18 (d, J = 9.0 Hz, 2H), 7.55 (d, J = 9.0 Hz, 2H), 
7.23 (d, J = 8.7 Hz, 2H), 6.99 (d, J = 8.7 Hz, 2H), 6.75 (s, 1H), 3.86 (s, 3H), 3.72 
(s, 3H), 2.41 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 165.7, 159.5, 146.1, 142.7, 
138.1, 131.2, 129.5, 127.5, 124.3, 122.9, 122.1, 114.5, 110.7, 55.5, 50.7, 12.6. 




1H NMR (300 MHz, CDCl3) δ 7.67 (d, J = 7.2 Hz, 2H), 7.63 (d, J = 8.4 Hz, 2H), 
7.54 (d, J = 8.4 Hz, 2H), 7.46 (t, J = 7.5 Hz, 2H), 7.35 (t, J = 7.2 Hz, 1H), 7.26 
(d, J = 9.0 Hz, 2H), 7.00 (d, J = 9.0 Hz, 2H), 6.75 (s, 1H), 3.86 (s, 3H), 3.77 (s, 
3H), 2.46 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 166.2, 159.2, 141.0, 138.9, 
137.1, 134.6, 131.7, 129.4, 128.6, 127.5, 126.9, 126.3, 125.8, 121.3, 114.4, 
114.4, 110., 55.4, 50.5, 12.6. HRMS (ESI) calcd for C26H23NNaO3 [M-Na]+: 







1H NMR (300 MHz, CDCl3) δ 7.94 (s, 1H), 7.90-7.84 (m, 3H), 7.66 (d, J = 8.7 
Hz, 1H), 7.51-7.46 (m, 2H), 7.27 (d, J = 8.7 Hz, 2H), 7.00 (d, J = 8.7 Hz, 2H), 
6.82 (s, 1H), 3.84 (s, 3H), 3.74 (s, 3H), 2.52 (s, 3H); 13C NMR (300 MHz, 
CDCl3) δ 166.1, 159.1, 137.1, 133.2, 133.2, 132.1, 131.6, 128.3, 127.7, 
127.4,127.3, 126.6, 126.6, 126.1, 125.6, 125.1, 121.4, 114.3, 110.9, 55.3, 50.4, 




1H NMR (300 MHz, CDCl3) δ 8.45 (s, 1H), 8.02 (d, J = 8.7 Hz, 4H), 7.48-7.34 
(m, 6H), 7.01 (d, J = 8.7 Hz, 2H), 6.76 (s, 1H), 3.86 (s, 3H), 3.17 (s, 3H), 2.65 (s, 
3H); 13C NMR (300 MHz, CDCl3) δ 165.9, 159.2, 136.9, 131.9, 131.6,131.4, 
131.3, 128.2, 127.5, 127.2, 125.8, 124.8, 124.7, 122.9, 121.0, 114.4, 114.0, 55.5, 





1H NMR (300 MHz, CDCl3) δ 8.27 (d, J = 9.0 Hz, 1H), 8.22-8.14 (m, 3H), 8.12-
8.07 (m, 2H), 8.04-7.96 (m, 3H),  7.35 (d, J = 8.7 Hz, 2H), 7.01 (d, J = 8.7 Hz, 
2H), 6.84(s, 1H), 3.86 (s, 3H), 3.33 (s, 3H), 2.60 (s, 3H); 13C NMR (300 MHz, 
254 
 
CDCl3) δ 166.2, 159.3, 136.9, 131.9, 131.8, 131.4, 130.2, 129.9, 128.3, 127.5, 
126.8, 126.6, 126.1, 125.7, 124.9, 124.7, 124.5, 124.2, 124.1, 122.5, 114.4, 
113.1, 55.5, 50.4, 12.6. HRMS (ESI) calcd for C30H23NNaO3 [M-Na]+: 




1H NMR (300 MHz, CDCl3) δ 7.25-7.13 (m, 4H), 7.02 (t, J = 5.1 Hz, 1H), 6.98 
(d, J = 9.0 Hz, 2H), 6.80 (s, 1H), 3.86 (s, 3H), 3.70 (s, 3H), 2.40 (s, 3H); 13C 
NMR (300 MHz, CDCl3) δ 165.9, 159.4, 137.4, 136.8, 131.5, 127.5, 126.8, 
125.8, 123.8, 121.9, 118.5, 114.4, 111.0,55.5,50.6, 12.6.  HRMS (ESI) calcd for 




1H NMR (300 MHz, CDCl3) δ 7.16 (d, J = 9.0 Hz, 2H), 6.94 (d, J = 8.7 Hz, 2H), 
6.42 (s, 1H), 3.83 (s, 3H), 3.82 (s, 3H), 3.03 (t, J = 11.7 Hz, 1H), 2.35 (s, 3H), 
2.03 (d, J = 12.9 Hz, 2H), 1.75 (t, J = 15.0 Hz, 3H), 1.41 (t, J = 12.6 Hz, 2H), 
1.23 (t, J = 12.2 Hz, 3H),; 13C NMR (300 MHz, CDCl3) δ 166.4, 158.9, 136.4, 
127.4, 126.7, 118.2, 114.2, 110.5, 55.4, 50.3, 35.6, 34.5, 26.9, 26.5, 12.7. HRMS 






1H NMR (300 MHz, CDCl3) δ 7.17 (d, J = 9.0 Hz, 2H), 6.95 (d, J = 9.0 Hz, 2H), 
6.43 (s, 1H), 3.85 (s, 3H), 3.82 (s, 3H), 2.69 (t, J = 7.7 Hz, 2H), 2.36 (s, 3H), 
1.61-1.55 (m, 2H), 1.37-1.28 (m, 8H), 0.88 (t, J = 6.8 Hz, 3H); 13C NMR (300 
MHz, CDCl3) δ 166.7, 159.0, 136.8, 132.3, 127.5, 126.2, 119.8, 114.3, 111.2, 
55.5, 50.4, 31.9, 30.4, 29.7, 29.3, 26.9, 22.7, 14.1, 12.7. HRMS (ESI) calcd for 




1H NMR (300 MHz, CDCl3) δ 7.41-7.26 (m, 5H), 7.17 (d, J = 9.0 Hz, 2H), 7.02 
(d, J = 9.0 Hz, 2H), 3.87 (s, 3H), 3.63 (s, 3H), 2.33 (s, 3H), 1.90 (s, 3H); 13C 
NMR (300 MHz, CDCl3) δ 166.3, 159.4, 136.3, 136.1, 130.4, 130.3, 129.2, 
127.3, 127.1, 125.8, 122.0, 114.5, 110.4, 55.4, 50.3, 12.6, 11.1. HRMS (ESI) 




1H NMR (300 MHz, CDCl3) δ 7.45 (d, J = 6.9 Hz, 2H), 7.37 (t, J = 7.4 Hz, 2H), 
7.32-7.25 (m, 3H), 6.99-6.92 (m, 3H), 3.85 (s, 3H), 3.84(s, 3H), 3.72 (s, 3H); 
13C NMR (300 MHz, CDCl3) δ 166.7, 160.3, 159.4, 133.1, 132.2, 128.5, 127.5, 
256 
 
127.2, 127.0, 126.1, 124.4, 123.1, 121.3, 113.9, 55.4, 52.2, 51.8. HRMS (ESI) 




1H NMR (300 MHz, CDCl3) δ 7.36 (d, J = 7.2 Hz, 2H), 7.29 (t, J = 7.5 Hz, 2H), 
7.19 (t, J = 7.1 Hz, 1H), 7.01 (d, J = 9.0 Hz, 2H), 6.93 (d, J = 9.0 Hz, 2H), 5.11 
(s, 1H), 3.83 (s, 3H), 3.69 (s, 6H), 2.08 (s, 6H); 13C NMR (300 MHz, CDCl3) δ 
168.5, 159.4, 148.3, 146.7, 132.8, 131.1, 128.1, 127.1, 126.2, 114.5, 105.3, 55.5, 




1H NMR (300 MHz, CDCl3) δ 8.47 (s, 1H), 7.94 (q, J = 3.0 Hz, 2H), 7.47 (t, J = 
.2 Hz, 3H), 7.30 (d, J = 9.0 Hz, 2H), 6.96 (d, J = 9.0 Hz, 2H), 3.79 (s, 3H); 13C 
NMR (300 MHz, CDCl3) δ 158.0, 157.8, 144.4, 136.2, 130.7, 128.4, 128.3, 




1H NMR (300 MHz, CDCl3) δ 7.92 (d, J = 13.8 Hz, 1H), 7.54 (d, J = 13.8 Hz, 
1H), 7.51-7.36 (m, 5H); 13C NMR (300 MHz, CDCl3) δ 138.7, 136.7, 131.8, 
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129.7, 12.9.0, 128.9. HRMS (ESI) calcd for HRMS (ESI) calcd for C8H8NO2 
[M-H]+: 150.0554; found 150.0555. 
 
VI. Chapter 7 compound characterization data 
Methyl-2-methyl-5-phenylfuran-3-carboxylate (7-3aa) 
1H NMR (300 MHz, CDCl3) δ 7.64 (d, J = 7.2 Hz, 2H), 7.38 (t, J = 7.5 Hz, 2H), 
7.27 (t, J = 7.4 Hz, 1H), 6.88 (s, 1H), 3.85 (s, 3H), 2.65 (s, 3H); 13C NMR (300 
MHz, CDCl3) δ 164.4, 158.7, 151.7, 130.0, 128.7, 127.6, 123.6, 115.0, 105.3, 
51.3, 13.8. HRMS (EI) calcd for C13H12O3 [M]+: 216.0786; found 216.0783. 
 
Methyl-2-ethyl-5-phenylfuran-3-carboxylate (7-3ab) 
1H NMR (300 MHz, CDCl3) δ 7.64 (d, J = 7.2 Hz, 2H), 7.38 (t, J = 7.6 Hz, 2H), 
7.26 (t, J = 7.4 Hz, 1H), 6.89 (s, 1H), 3.84 (s, 3H), 3.09 (q, J = 7.6 Hz, 2H), 1.33 
(t, J = 7.6 Hz, 3H); 13C NMR (300 MHz, CDCl3) δ 164.2, 163.5, 151.6, 130.0, 
128.6, 127.5, 123.5, 114.1, 105.3, 51.2, 21.2, 12.2. HRMS (EI) calcd for 
C14H14O3 [M]+: 230.0943; found 230.0941. 
 
Methyl-2-isopropyl-5-phenylfuran-3-carboxylate (7-3ac) 
1H NMR (300 MHz, CDCl3) δ 7.65 (d, J = 7.2 Hz, 2H), 7.39 (t, J = 7.6 Hz, 2H), 
7.27 (t, J = 7.4 Hz, 1H), 6.87 (s, 1H), 3.88-3.76 (m,4H), 1.35 (d, J = 7.0 Hz); 13C 
NMR (300 MHz, CDCl3) δ 166.7, 164.4 151.4, 130.2, 128.7, 127.6, 123.6, 





1H NMR (300 MHz, CDCl3) δ 7.64 (d, J = 7.1 Hz, 2H), 7.39 (t, J = 7.6 Hz, 2H), 
7.27 (t, J = 7.4 Hz, 1H), 6.88 (s, 1H), 3.85 (s, 3H), 3.06 (t, J = 7.5 Hz, 3H), 1.73 
(m, 2H), 1.42 (m, 2H), 0.96 (t, J = 7.3 Hz, 3H); 13C NMR (300 MHz, CDCl3) δ 
164.4, 162.8, 151.7, 130.1, 128.7, 127.6, 123.6, 114.6, 105.4, 51.3, 30.2, 27.4, 
22.3, 13.8. HRMS (EI) calcd for C16H18O3 [M]+: 258.1256; found 258.1260. 
 
Ethyl-2-methyl-5-phenylfuran-3-carboxylate (7-3ae) 
1H NMR (300 MHz, CDCl3) δ 7.64 (d, J = 7.1 Hz, 2H), 7.38 (t, J = 7.5 Hz, 2H), 
7.27 (t, J = 7.4 Hz, 1H), 6.89 (s, 1H), 4.32 (q, J = 7.1 Hz, 2H), 2.65 (s, 3H), 1.38 
(t, J = 7.1 Hz, 3H); 13C NMR (300 MHz, CDCl3) δ 164.0, 158.6, 151.7, 130.0, 
128.7, 127.6, 123.6, 115.4, 105.5, 60.2, 14.4, 13.9. HRMS (EI) calcd for 
C14H14O3 [M]+: 230.0943; found 230.0942. 
 
Ethyl-2-propyl-5-phenylfuran-3-carboxylate (7-3af) 
1H NMR (300 MHz, CDCl3) δ 7.65 (d, J = 7.2 Hz, 2H), 7.39 (t, J = 7.6 Hz, 2H), 
7.27 (t, J = 7.4 Hz, 1H), 6.90 (s, 1H), 4.32 (q, J = 7.1 Hz, 2H), 3.05 (t, J = 7.5 
Hz, 2H), 1.85-1.73 (m, 2H) 1.38 (t, J = 7.1 Hz, 3H), 1.02 (t, J = 7.4 Hz, 3H); 13C 
NMR (300 MHz, CDCl3) δ 163.9, 162.4, 151.6, 130.1, 128.6, 127.5, 123.6, 
115.1, 105.4, 60.1, 29.6, 21.5, 14.3, 13.7. HRMS (EI) calcd for C16H18O3 [M]+: 






1H NMR (300 MHz, CDCl3) δ 7.64 (d, J = 7.1 Hz, 2H), 7.38 (t, J = 7.5 Hz, 2H), 
7.27 (t, J = 7.4 Hz, 1H), 6.88 (s, 1H), 4.26 (t, J = 6.7 Hz, 2H), 2.65 (s, 3H), 1.80-
1.68 (m, 2H), 1.51-1.40 (m, 2H), 1.39-1.31 (m, 4H), 0.92 (t, J = 7.0 Hz, 3H); 13C 
NMR (300 MHz, CDCl3) δ 164.1, 158.5, 152.1, 128.7, 127.6, 123.6, 110.1, 
105.5, 64.4, 31.5, 28.7, 25.7, 22.5, 14.0, 13.9. HRMS (EI) calcd for C18H22O3 
[M]+: 286.1569; found 286.1568. 
 
Cyclohexyl-2-methyl-5-phenylfuran-3-carboxylate (7-3ah) 
1H NMR (300 MHz, CDCl3) δ 7.64 (d, J = 7.2 Hz, 2H), 7.38 (t, J = 7.6 Hz, 2H), 
7.26 (t, J = 7.4 Hz, 1H), 6.89 (s, 1H), 4.98 (m, 1H), 2.65 (s, 3H) 1.99-1.89 (m, 
2H), 1.83-1.72 (m, 2H), 1.62-1.30 (m, 6H); 13C NMR (300 MHz, CDCl3) δ 
163.5, 158.3, 151.6, 130.1, 128.7, 127.5, 123.6, 115.9, 105.6, 72.3, 31.7, 25.5, 
23.7, 14.0. HRMS (EI) calcd for C18H20O3 [M]+: 284.1412; found 284.1410. 
 
Benzyl-2-methyl-5-phenylfuran-3-carboxylate (7-3ai) 
1H NMR (300 MHz, CD2Cl2) δ 7.63 (d, J = 7.2 Hz, 2H), 7.47-7.32 (m, 7H), 
7.31-7.25 (m, 1H), 6.92 (s, 1H), 5.30 (s, 2H), 2.65 (s, 3H); 13C NMR (300 MHz, 
CD2Cl2) δ 163.9, 159.3, 152.1, 130.3, 129.0, 128.8, 128.4, 128.3, 123.9, 115.4, 







1H NMR (300 MHz, CDCl3) δ 7.64 (d, J = 8.0 Hz, 2H), 7.38 (t, J = 7.7 Hz, 2H), 
7.26 (t, J = 7.4 Hz, 1H), 6.85 (s, 1H), 2.63 (s, 3H), 1.59 (s, 9H); 13C NMR (300 
MHz, CDCl3) δ 163.4, 157.9, 151.3, 130.2, 128.7, 127.5, 123.6, 117.0, 105.8, 




1H NMR (300 MHz, CDCl3) δ 7.58 (d, J = 7.5 Hz, 2H), 7.32 (t, J = 7.5 Hz, 2H), 
7.20 (t, J = 7.4 Hz, 1H), 6.55 (s, 1H), 3.40 (m, 4H), 2.39 (s, 3H), 1.15 (m, 6H); 
13C NMR (300 MHz, CDCl3) δ 165.5, 151.8,151.4, 130.1, 128.4, 127.2, 123.3, 
118.3, 104.4, 42.7, 39.0, 14.1, 12.7. HRMS (EI) calcd for C16H19NO2 [M]+: 
257.1416; found 257.1413. 
 
(2-Methyl-5-phenylfuran-3-yl-piperidin-1-yl)methanone (7-3al) 
1H NMR (300 MHz, CDCl3) δ 7.61 (d, J = 7.5 Hz, 2H), 7.36 (t, J = 7.5 Hz, 2H), 
7.24 (t, J = 7.4 Hz, 1H), 6.57 (s, 1H), 3.58 (m, 4H), 2.43 (s, 3H), 1.52-1.33 (m, 
6H); 13C NMR (300 MHz, CDCl3) δ 164.9, 152.1, 151.6, 130.2, 128.6, 127.4, 
123.5, 118.0, 105.2, 48.2, 43.0, 26.1, 24.6, 13.0. HRMS (EI) calcd for 







1H NMR (300 MHz, CDCl3) δ 7.64 (d, J = 7.5 Hz, 2H), 7.40 (t, J = 7.8 Hz, 2H), 
7.28 (t, J = 7.1 Hz, 1H), 6.85 (s, 1H), 2.67 (s, 3H), 2.46 (s, 3H); 13C NMR (300 
MHz, CDCl3) δ 194.1, 157.9, 151.6, 129.9, 128.7, 127.7, 123.7, 123.2, 105.1, 
29.2, 14.5. HRMS (EI) calcd for C13H12O2 [M]+: 200.0837; found 200.0835. 
 
2-tert-Butyl-5-iphenylfuran-3-carbonitrile (7-3ao) 
1H NMR (300 MHz, CDCl3) δ 7.62 (d, J = 7.2 Hz, 2H), 7.42 (t, J = 7.4 Hz, 2H), 
7.33 (t, J = 7.2 Hz, 1H), 6.68 (s, 1H), 1.50 (s, 9H); 13C NMR (300 MHz, CDCl3) 
δ 170.3, 152.2, 129.0, 128.8, 128.4, 123.9, 114.8, 106.5, 92.3, 34.8, 28.8. HRMS 
(EI) calcd for C15H15NO [M]+: 225.1154; found 225.1152. 
 
3-Nitro-2,-5-diphenylfuran (7-3ap) 
1H NMR (300 MHz, CDCl3) δ 8.36 (d, J = 7.1 Hz, 2H), 7.85 (d, J = 7.5 Hz, 2H), 
7.66 (t, J = 7.4 Hz, 1H), 7.58-7.45 (m, 6H), 7.05 (s, 1H); 13C NMR (300 MHz, 
CDCl3) δ 170.7, 162.4, 135.7, 134.0, 130.7, 129.1, 128.5, 126.7, 125.9, 100.2. 
HRMS (EI) calcd for C16H11NO3 [M]+: 265.0739; found 265.0745. 
 
Methyl-2-methyl-5-p-tolylfuran-3-carboxylate (7-3ba) 
1H NMR (300 MHz, CDCl3) δ 7.53 (d, J = 8.1 Hz, 2H), 7.19 (d, J = 8.0 Hz, 2H), 
6.82 (s, 1H), 3.85 (s, 3H), 2.64 (s, 3H), 2.37(s, 3H); 13C NMR (300 MHz, 
CDCl3) δ 164.6, 158.4, 152.0, 137.6, 129.4, 129.0, 127.3, 123.6, 123.5, 
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1H NMR (300 MHz, CDCl3) δ 7.50-7.39 (m, 2H), 7.27 (t, J = 7.6 Hz, 1H), 7.09 
(d, J = 7.5 Hz, 1H), 6.87 (s, 1H), 3.85 (s, 3H), 2.65 (s, 3H), 2.39 (s, 3H); 13C 
NMR (300 MHz, CDCl3) δ 164.4, 158.5, 151.9, 138.3, 129.9, 128.5, 128.4, 
124.2, 120.7, 115, 105.2, 51.3, 21.4,  13.8. HRMS (EI) calcd for C14H14O3 [M]+: 
230.0943; found 230.0941. 
 
Methyl-5-(4-ethylphenyl)-2-methylfuran-3-carboxylate (7-3ea) 
1H NMR (300 MHz, CDCl3) δ 7.6 (d, J = 8.4 Hz, 2H), 7.22 (d, J = 8.4 Hz, 2H), 
6.83 (s, 1H), 3.85 (s, 3H), 2.66 (m, 5H), 1.26 (t, J = 7.5 Hz, 3H); 13C NMR (300 
MHz, CDCl3) δ 164.5, 158.3, 152.0, 143.8, 128.1, 127.5, 123.6, 114.9, 104.6, 




1H NMR (300 MHz, CDCl3) δ 7.54 (d, J = 8.3 Hz, 2H), 7.19 (d, J = 8.2 Hz, 2H), 
6.82 (s, 1H), 3.85 (s, 3H), 2.66-2.58 (m, 5H), 1.66-1.55 (m, 3H), 1.42-1.29 (m, 
3H), 0.93 (t, J = 7.3 Hz, 3H); 13C NMR (300 MHz, CDCl3) δ 164.6, 158.4, 
152.0, 142.6, 128.8, 127.5, 123.6, 115.0, 104.6, 51.3, 35.4, 33.5, 22.3, 13.9, 13.8. 




1H NMR (300 MHz, CDCl3) δ 7.58 (d, J = 8.6 Hz, 2H), 7.41 (d, J = 8.5 Hz, 2H), 
6.84 (s, 1H), 3.86 (s, 3H), 2.65 (s, 3H), 1.34 (s, 9H); 13C NMR (300 MHz, 
CDCl3) δ 163.4, 157.9, 151.3, 130.2, 128.7, 127.5, 123.6, 116.8, 105.8, 80.6, 
28.3, 13.9. HRMS (EI) calcd for C17H20O3 [M]+: 272.1412; found 272.1410. 
 
Methyl-5-(4-fluorophenyl)-2-methylfuran-3-carboxylate (7-3ha) 
1H NMR (300 MHz, CDCl3) δ 7.58 (d, J = 8.9 Hz, 2H), 7.06 (d, J = 8.7 Hz, 2H), 
6.79 (s, 1H), 3.84 (s, 3H), 2.63 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 164.3, 
160.6, 158.7, 150.9, 126.3, 125.4, 125.3, 115.9, 115.6, 115.1, 105.0, 51.4, 13.8. 
HRMS (EI) calcd for C13H11FO3 [M]+: 234.0692; found 234.0691. 
 
Methyl-5-(4-chlorophenyl)-2-methylfuran-3-carboxylate (7-3ia) 
1H NMR (300 MHz, CDCl3) δ 7.53 (d, J = 8.6 Hz, 2H), 7.32 (d, J = 8.7 Hz, 2H), 
6.84 (s, 1H), 3.84 (s, 3H), 2.62 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 164.2, 
158.9, 150.6, 133.3, 128.9, 128.4, 124.8, 115.2, 105.8, 51.4, 13.8. HRMS (EI) 
calcd for C13H11ClO3 [M]+: 250.0397; found 250.0395. 
 
Methyl-5-(4-bromophenyl)-2-methylfuran-3-carboxylate (7-3ja) 
1H NMR (300 MHz, CDCl3) δ 7.46 (s, 4H), 6.84 (s, 1H), 3.87 (s, 3H), 2.61 (s, 
3H); 13C NMR (300 MHz, CDCl3) δ 164.1, 158.9, 150.6, 131.8, 128.8, 125.0, 
121.3, 115.2, 105.9, 51.4, 13.8. HRMS (EI) calcd for C13H11BrO3 [M]+: 




1H NMR (300 MHz, CDCl3) δ 7.56 (d, J = 9 Hz, 2H), 6.92 (d, J = 9 Hz, 2H), 
6.73 (s, 1H), 3.86-3.81 (m, 6H), 2.63 (s, 3H); 13C NMR (300 MHz, CDCl3) δ 
164.6, 159.2, 158.1, 151.8, 125.1, 123.1, 115.1, 114.2, 103.7, 55.3, 51.3, 13.8. 
HRMS (EI) calcd for C14H14O4 [M]+: 246.0892; found 246.0896. 
 
Methyl-2-methyl-5-(thiophen-3-yl)furan-3-carboxylate (7-3la) 
1H NMR (300 MHz, CDCl3) δ 7.45 (d, J = 2.9 Hz, 1H), 7.34 (d, J = 5.1 Hz, 1H), 
7.27 (d, J = 5.1 Hz, 1H), 6.69 (s, 1H), 3.84 (s, 3H), 2.63 (s, 3H); 13C NMR (300 
MHz, CDCl3) δ 164.5, 158.2, 148.9, 144.4, 126.4, 124.4, 119.2, 114.7, 105.0, 
51.4, 13.8. HRMS (EI) calcd for C11H10O3S [M]+: 222.0351; found 222.0349. 
 
Methyl-2-methyl-5-(naphthalen-1-yl)furan-3-carboxylate (7-3ma) 
1H NMR (300 MHz, CDCl3) δ 8.36 (d, J = 7.7 Hz, 1H), 7.92-7.82 (m, 2H), 7.73 
(d, J = 7.2 Hz, 1H), 7.58-7.49 (m, 3H), 6.98 (s, 1H), 3.89 (s, 3H), 2.73 (s, 3H); 
13C NMR (300 MHz, CDCl3) δ 164.6, 159.1, 151.1, 133.9, 130.1, 128.9, 128.6, 
126.7, 126.1, 126.0, 125.2, 114.9, 109.8, 51.4, 14.0. HRMS (EI) calcd for 
C17H14O3 [M]+: 266.0943; found 266.0941. 
 
Dimethyl-5-methylfuran-2,4-dicarboxylate (7-3na) 
1H NMR (300 MHz, CDCl3) δ 7.36 (s, 1H), 3.86 (s, 3H), 3.81 (s, 3H), 2.63 (s, 
3H); 13C NMR (300 MHz, CDCl3) δ 163.2, 162.8 158.6, 142.2, 118.5, 115.4, 
52.0, 51.6, 14.1. HRMS (EI) calcd for C9H10O5 [M]+: 198.0528; found 198.0527. 
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Ethyl 2-oxo-1-(phenylethynyl)cyclopentanecarboxylate (7-7) 
1H NMR (300 MHz, CDCl3) δ 7.44 (d, J = 7.8 Hz, 2H), 7.32-7.28 (m, 3H), 4.27 
(q, J = 7.2 Hz, 2H), 2.75-2.65 (m, 1H) 2.55-2.40 (m, 3H), 2.20-2.09(m, 2H) 1.32 
(t, J = 6.9 Hz, 3H); 13C NMR (300 MHz, CDCl3) δ 163.2, 162.8 158.6, 142.2, 
118.5, 115.4, 52.0, 51.6, 14.1. HRMS (EI) calcd for C16H16O3 [M]+: 256.1099; 
found 256.1097. 
 
IR spectra of phenyacetylene, (chloroethynyl)benzene, 










The analytical techniques employed for the quantitative analysis and 
identification of reactants, reaction mixtures and products include Nuclear 
Magnetic Resonance (NMR), Gas Chromatography with flame ionization 
detector (GC-FID), Gas Chromatography Mass Spectrometry (GC-MS), Mass 
Spectrometry with Electrospray Ionization (ESI), Infrared Spectroscopy (IR) and 
UV-Vis molecular absorption spectroscopy (UV-Vis). Each of these techniques 
will be briefly discussed. 
 
A   Nuclear Magnetic Resonance 
1H and 13C nuclear magnetic resonance (NMR) were used to elucidate the 
structures of intermediates, side products and desired products, using a Bruker 
Avance 300 (AV300) or Bruker Avance 500 (AV500) spectrometer, with 
tetramethylsilane (TMS) as an internal standard.  
   1H NMR was employed to distinguish the different types of chemically 
equivalent protons in the compound and to reveal how many of each chemically 
equivalent proton are present. Protons have characteristic chemical shifts based 
on their chemical environment. Analysis of the spin-spin coupling pattern gives 
further information on the identity of neighboring protons. 13C NMR was used to 
complement the 1H NMR to conclusively identify the compounds by measuring 
the characteristic chemical shift of each C atoms in the product. The spectra also 
allow us to gauge the type of C atoms (primary, secondary, tertiary or 
quaternary), based on the intensity of their signals. Purity can be roughly 
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estimated based on the presence of other non-related or non-identifiable protons 
and/or carbon atoms in the 1H and 13C spectrum, respectively.  
 
Principles of Measurements 
Nuclei with odd atomic mass or odd atomic numbers or both have spin angular 
momentum and magnetic moment [1]. This includes 1H and 13C. There are 2I+1 
allowed quantized spin states for each nucleus, where I is the nuclear spin 
quantum number. Upon application of an external magnetic field, the nuclei 
mentioned above, having I = ½, will have 2 quantized spin states; parallel spin 
and anti-parallel spin. The nucleus will precess at its Larmor frequency when a 
magnetic field is applied. This precession generates an oscillating electric field of 
similar frequency and when a brief pulse of intense radiowave of similar 
frequency is applied, resonance occurs. The two fields couple, allowing energy 
to be absorbed by the nucleus.  
   For Fourier transform instruments, pulses containing a range of radiowave 
frequencies were applied to allow simultaneous excitation of different types of 
nuclei in the compound, from the lower state to the upper states. Upon 
relaxation, many different frequencies of electromagnetic radiation are emitted 
simultaneously. A computer then performs a Fourier analysis and extracts the 
individual frequencies, thus generating the NMR spectrum with discrete peaks 
on a frequency (or magnetic field strength) scale.  
   Different protons and carbon atoms resonate at different frequencies, 
depending on their local chemical environment. Thus, they have characteristic 
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chemical shifts. These chemical shifts are measured relative to the frequency 
shift of a standard reference of Tetramethylsilane (TMS). The chemical shift (δ) 
is expressed in parts per million (ppm) and can be calculated by dividing the 
frequency difference between the excited nucleus and the pulse (Hz) to the 
magnet’s operating frequency (MHz). The chemical shift is affected by 
electronegativity effects, with a downfield shift in the presence of electron 
withdrawing atoms, and these effects increase with multiple atoms and decrease 
with distance. 
   In the 1H NMR spectrum, the peak area is proportional to the number of 
protons. Thus, by integrating the area of individual peaks on the spectrum, it is 
possible to both distinguish the different types of hydrogens and their respective 
integration values.  
   Spin-spin coupling is another important information that can be obtained from 
the 1H NMR spectrum. This effect is observable for protons that are separated by 
2 to 5 bonds away, with more pronounced effect with decreasing distance [2]. 
For chemical equivalent protons, the splitting of the peaks follows the (n+1) rule, 
whereby n is the number of adjacent chemical equivalent protons (Figure A1). 
Pascal’s triangle can be used to derive the intensity ratios of the multiplets 
formed from splitting (Figure A2). The distance between the peaks after splitting 
is called coupling constant J. It is measured in Hertz (Hz) and is independent of 




Figure A1: (n+1) Splitting patterns of HA in the presence of 1, 2, and 3 adjacent 
HB protons respectively. A) Doublet (n = 1) B) Triplet (n = 2) C) Quartet (n = 3). 
 
 
Figure A2: Pascal’s triangle. 
 
   Thus, by using chemical shifts, integration values, splitting pattern and the 
magnitude of the J values for each different type of proton, elucidation of the 
structure of the desired product can be achieved with great confidence. 13C NMR 
can then be used to confirm the identification of the product, using the chemical 
shifts of different types of C atoms, when needed. However, because the relative 
abundance of 13C is only 1.109 %, 13C is much less sensitive than its 1H 
counterpart [3]. Also, 13C spectra are broadband decoupled, therefore give only 
one signal for each chemically non-equivalent C atom. The intensity of each C 
signal is roughly related to the number of hydrogens that are attached to it, with 
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primary C atoms showing high intensities and quaternary C atoms showing low 
intensities. Thus, with a combination of both 1H and 13C spectra, identification of 
the compound can be achieved most of the time.  
 
B   Gas Chromatography 
Gas chromatography was employed for quantitative analysis and identification of 
components of reaction mixture, either during progress of reaction or at the end 
of the reaction, to complement the spotting of the reaction mixture on Thin Layer 
Chromatography (TLC) plates. The injected samples are vaporized and the 
components are separated based on their ability to partition between the gaseous 
mobile phase and the stationary phase. Two types of detectors were used: Flame 
ionization detector (FID) and mass spectrometry (MS).  
 
Principles of Measurement 
A schematic of a gas liquid chromatograph is shown (Figure B1). The method 
depends on the distribution of a sample between a mobile phase and a stationary 
phase. The mobile phase is an inert gas, for example helium, which is supplied 
from the carrier gas tank. The chemically inert helium passes through the flow 
regulator, which controls helium pressure and flow, according to the 
predetermined values set up by user. The liquid sample is injected through a 
septum using a calibrated syringe. It goes then into the vaporization chamber 
where the sample vaporizes. A sample splitter allows only a small fraction of 
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analyte to pass to the column, whereas the remainder goes to waste. The 
vaporized analyte is then transported to the capillary column by the mobile  
  
Figure B1: Block diagram of a typical gas-liquid chromatography set up. 
 
phase. The standard column was a fused-silica wall-coated open tubular column 
with a non--polar (5%-phenyl)methylpolysiloxane liquid stationary phase.     
   The retention times of the components of the sample depend on their respective 
distribution constant in the stationary phase. To have a good separation between 
the components of the reaction mixtures, their distribution constants must be 
different enough, while ensuring they are not too large, as that would mean very 
long retention times [4]. Thus, to achieve good resolution within an acceptable 
analysis time, the stationary phase should be compatible with the analyte. 
Because the majority of components in the reaction mixtures were heterocycles 
with high lipophilicity, a column with a non-polar stationary phase HP5 was 
chosen. The column is housed in a thermostated oven, with temperature 
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programming capabilities. The separated analytes are then transported to the 
detector after reaching the end of the column.  
    
Flame Ionization Detector 
The flame ionization detector (FID) works on the basis that most organic 
compounds, when burned in an air-H2 flame, convert to ions and electrons. The 
ions are then collected by applying an electric field between the tip of the burner 
and the collector electrode (Figure B2). A picoammeter is used to measure the 
resulting current before transferring it to the data analyzer and display. The 
assumption is made that the number of ions produced is proportional to the 
number of reduced carbon atoms in the sample. Effective carbon number (ECN) 
[5] can be used to normalize the peaks, in order to obtain molar concentrations of 
the compounds present in the sample. This is achieved by dividing the peak areas 
by the respective calculated ECN. Advantages of FID include low detection limit 
and high sensitivity (1 pg/s) [6]. One main disadvantage of using FID is that it is 
 
Figure B2: A schematic diagram of a typical flame ionization detector, as 




a destructive method of analysis and the injected samples cannot be recovered.  
 
Mass Spectrometry Detector 
GC-MS is an invaluable tool for the identification of components of reaction 
mixtures based on their retention times and molecular ion M+ peak (Figure B3). 
It complements the GC-FID which can quantify the true concentrations of the 
components in the analyte. After passing through the GC column a small part of 
the sample is passed through an interface, before entering the MS and into the 
vacuum chamber. These analytes first pass into the electron impact ion source. 
Here, the molecules are ionized by bombarding them at right angles with a beam 
of energetic electrons (20 to 100 eV) from a heated tungsten filament. This 
results in singly charged positive ions which are directed towards the quadrapole 
mass analyzer via focusing lenses. The quadrupole mass analyzer (Figure C2) 
acts as a mass filter and the filtered ions are then passed to an electron multiplier 
for signal amplification before going to the data system in the computer.  
 
 
Figure B3: A schematic diagram of a typical GC-MS, as adapted from [8]. The 
transfer line is actually the interface between GC and MS.. 
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   The detector can operate in two modes. The first one is the total-ion 
chromatogram mode, where a plot of ion abundances against retention time is 
displayed. This chromatogram is similar to that obtained with the FID. In the 
second mode, a mass chromatogram can also be obtained which shows the 
different fragment ions at any particular retention time. The information of the 
molecular mass together with the fragments formed can be used to identify a 
compound. However, this information would usually be coupled with 1H NMR, 
13C NMR and high resolution mass spectrometry (HRMS) to unambiguously 
identity the compound.  
 
C   Electrospray Ionization Mass Spectrometry 
Mass spectrometry Electronspray ionization (ESI) is used to find the molecular 
weight of pure products before handing over to the scientific oficer for HRMS 
measurements. Normal ESI measuremetns were recorded using Thermo-
Finnigan LCQ mass spectrometer whereas HRMS measurements were recorded 
by the techinician using Bruker micrOTOFQII under ESI mode. 
 
Principles of Measurement 
After injecting the liquid sample, containing dissolved pure product, a high 
voltage is applied, creating fine droplets of charged aerosols of the sample 
(Figure C1). As solvent evaporates, the droplets become smaller and thus have a 
higher charge density, until the charge density reaches the Rayleigh limit, where 




Figure C1: A diagram showing the ESI ionization process as adapted from [9]. 
  
 
Figure C2: A schematic diagram of a quadrupole mass analyzer with both dc 
and ac circuits attached to the two pairs of parallel rods adapted from [8]. 
 
   This process continues until all the solvent is removed from the analyte, 
resulting in a multiply charged molecule. These charged analytes are then passed 
on to the quadruple mass analyzer (Figure C2). A quadruple mass analyzer 
consists of four parallel cylindrical electrodes, with a pair of opposite rods 
connected in opposite poles. On the other hand, an out-of-phase alternating 
current (ac) voltage is applied to each of these pairs of rods. 
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   When ions are accelerated between these rods, fine-tuning of the ac and direct 
current (dc) voltages allow only a certain m/z value to pass through to reach the 
transducer, causing the rest to strike the rods and be neutralized. After reaching 
the transducer, the ions are fed into the data system to produce signals in the 
chromatogram. An advantage of using ESI for HRMS is that these molecules 
when ionized, is less likely to undergo fragmentation, thus [M-H]+ and [M-Na]+ 
peaks can be easily identified. 
 
D   Infrared Spectroscopy  
Infrared spectroscopy was used to monitor the reaction of halogenating terminal 
alkynes (Appendix). The peak corresponding to ν(Csp-H) stretch at 3300 cm-1 
should be absent, to indicate that the reaction has gone to full completion. Since 
both products are liquid at room temperature, spectra were collected by placing a 
thin film of the neat sample between two NaCl plates, using a Bio-Rad FTS 165 
FT-IR spectrometer scanning from 4000cm-1 - 400 cm-1. 
 
Principles of measurements 
To absorb IR radiation, a molecule must undergo a net change in dipole moment 
when it vibrates. If the IR radiation frequency matches the vibrational frequency 
of the molecule, absorption of the radiation occurs which will be measured by 
the detector as attenuation of the incident radiation intensity. Thus every 
molecule with a net change in dipole moment would have characteristic 
absorption spectrum with characteristic absorption peaks, based on the presence 
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of functional groups in the molecule. IR can therefore be used to identify 
functional group(s) present in a molecule or confirm the disappearance of 
characteristic peaks corresponding to functional group(s) of the reactants, to 
signify purity and high conversion and is thus an indispensable tool for 
identification and structure elucidation of pure compounds. 
 
E   UV-Vis Absorption Spectroscopy 
UV-Vis absorption spectroscopy was employed for qualitative determination of 
the extent of π-π interaction in the reaction intermediate during the reaction as 
seen in Chapter 7. A dual-beam UV-Vis spectrophotometer (UV-1601 from 
Shimadzu) was employed, scanning from 260 nm - 800 nm. Dimethyl acetamide 
solvent was used as reference and quartz cells are used for these measurements. 
Each sample is diluted until their λmax absorbance is below 1.0 absorbance units 
(a.u), whereby the Beer-Lambert-Bouguer law applies (Equation A1): 
 
                                   A (a.u.) = - log I/Io = - ε·c·d                   (Equation A1) 
 
Where A is absorbance, I and Io is intensity of light passing through sample and 
reference respectively, ε is molar absorption coeffiecnt, c is concentration and d 
is length of cuvette. 
   Intermediates that contain aromatic and unsaturated moieties which have π-
electrons can absorb ultraviolet or visible light. This UV or visible light will 
excite electrons from highest occupied bonding molecular orbitals (HOMO) to 
lowest unoccupied anti-bonding (LUMO) of higher energy. The HOMO to 
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LUMO energy gap is inversely proportional to the wavelength needed to absorb. 
UV-Vis active molecules have characteristic wavelength of maximum absorption 
λmax, based on the presence of chromophores, like C=C, C=O, C=N, in them.  
 
Principles of measurements 
A schematic diagram of a dual-beam UV-Vis absorption spectrophotometer is 
shown (Figure E1). The incident beam from one light source (UV or visible) 
goes through a monochromator to filter out other wavelenghts. The resultant 
beam is split into two by a rotating quartz half mirror; one beam passes through 
the quartz cell containing the sample, while the other travels through an  
 
 
Figure E1: A schematic diagram of a dual-beam UV-Vis spectrophotometer as 
adapted from [10]. 
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identical quartz cell containing the blank. Photomultipliers convert the attenuated 
signals into electric current and the control unit compares these two currents to 
calculate the absorbance I/Io. Results are then processed and converted to 
absorption spectra displaying absorbance against wavelength.  
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